BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 017212
(375 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 190 bits (482), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 117/284 (41%), Positives = 168/284 (59%), Gaps = 9/284 (3%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
+LEEATN FD +G G FG VY G L+DG VA+KR + + +E+F E++ L+
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 115 RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
RH +LVSL G C R+ E++L+Y+++ NG + HL+G ++ W RL+I I A
Sbjct: 93 RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDP 232
L YLH IIHRDVK+ NILLD NF K+ DFG+S+ TH+ +GT GY+DP
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
EY +LT+KSDV+SFGVVL E++ + A+ + R +NL+ A+ N L ++VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 293 QTLGYESDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
L +K+R ++ + A +CL + RP M DVL L
Sbjct: 271 PNLA----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 190 bits (482), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 117/284 (41%), Positives = 168/284 (59%), Gaps = 9/284 (3%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
+LEEATN FD +G G FG VY G L+DG VA+KR + + +E+F E++ L+
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 115 RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
RH +LVSL G C R+ E++L+Y+++ NG + HL+G ++ W RL+I I A
Sbjct: 93 RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDP 232
L YLH IIHRDVK+ NILLD NF K+ DFG+S+ TH+ +GT GY+DP
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
EY +LT+KSDV+SFGVVL E++ + A+ + R +NL+ A+ N L ++VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 293 QTLGYESDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
L +K+R ++ + A +CL + RP M DVL L
Sbjct: 271 PNLA----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 186 bits (471), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 127/319 (39%), Positives = 177/319 (55%), Gaps = 26/319 (8%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMNEVD 109
FS EL+ A++ F + LG GGFG VY G L DG VAVKRL E + E QF EV+
Sbjct: 28 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP---WPTRL 165
+++ H+NL+ L G C + R LLVY +++NG+VA L R +P + P WP R
Sbjct: 88 MISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCL---RERPESQPPLDWPKRQ 142
Query: 166 KIAIETASALTYLHA---SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+IA+ +A L YLH IIHRDVK NILLD F V DFGL++L HV A
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR--HRHEINLSNLAIN 280
+GT G++ PEY + ++K+DVF +GV+L+ELI+ A D+ R + ++ L +
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 281 KIQNKALHELVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
++ K L LVD L G D +V + I ++A C QS RP M +V +R +E
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEV---VRMLE 315
Query: 340 SDGYDDKKTH---EEMMTQ 355
DG ++ EEM Q
Sbjct: 316 GDGLAERWEEWQKEEMFRQ 334
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 184 bits (467), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 126/319 (39%), Positives = 176/319 (55%), Gaps = 26/319 (8%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMNEVD 109
FS EL+ A++ F + LG GGFG VY G L DG VAVKRL E + E QF EV+
Sbjct: 20 FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP---WPTRL 165
+++ H+NL+ L G C + R LLVY +++NG+VA L R +P + P WP R
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCL---RERPESQPPLDWPKRQ 134
Query: 166 KIAIETASALTYLHA---SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+IA+ +A L YLH IIHRDVK NILLD F V DFGL++L HV A
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR--HRHEINLSNLAIN 280
+G G++ PEY + ++K+DVF +GV+L+ELI+ A D+ R + ++ L +
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 281 KIQNKALHELVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
++ K L LVD L G D +V + I ++A C QS RP M +V +R +E
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEV---VRMLE 307
Query: 340 SDGYDDKKTH---EEMMTQ 355
DG ++ EEM Q
Sbjct: 308 GDGLAERWEEWQKEEMFRQ 326
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 154 bits (389), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 105/300 (35%), Positives = 170/300 (56%), Gaps = 22/300 (7%)
Query: 51 FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
FS+ EL+ TN FD ++G+GGFG VY G + + VAVK+L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
+QF E+ ++A+ +H+NLV L G +S +L LVY ++ NG++ D L P L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 131
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THV 219
W R KIA A+ + +LH + IHRD+K+ NILLD F K++DFGL+R T +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
+ GT Y+ PE + ++T KSD++SFGVVL+E+I+ +PAVD HR ++ L
Sbjct: 192 XSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 248
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ + K + + +D+ + ++D+ ++ A+ +A QCL +K+ RP + V L+++
Sbjct: 249 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 153 bits (387), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 105/300 (35%), Positives = 169/300 (56%), Gaps = 22/300 (7%)
Query: 51 FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
FS+ EL+ TN FD ++G+GGFG VY G + + VAVK+L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
+QF E+ ++A+ +H+NLV L G +S +L LVY ++ NG++ D L P L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 131
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THV 219
W R KIA A+ + +LH + IHRD+K+ NILLD F K++DFGL+R T +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
GT Y+ PE + ++T KSD++SFGVVL+E+I+ +PAVD HR ++ L
Sbjct: 192 XXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 248
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ + K + + +D+ + ++D+ ++ A+ +A QCL +K+ RP + V L+++
Sbjct: 249 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 153 bits (386), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 105/302 (34%), Positives = 169/302 (55%), Gaps = 22/302 (7%)
Query: 51 FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
FS+ EL+ TN FD ++G+GGFG VY G + + VAVK+L +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
+QF E+ ++A+ +H+NLV L G +S +L LVY ++ NG++ D L P L
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 125
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
W R KIA A+ + +LH + IHRD+K+ NILLD F K++DFGL+R V
Sbjct: 126 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 221 TAP-QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
GT Y+ PE + ++T KSD++SFGVVL+E+I+ +PAVD HR ++ L
Sbjct: 186 XXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 242
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ + K + + +D+ + ++D+ ++ A+ +A QCL +K+ RP + V L+++
Sbjct: 243 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298
Query: 339 ES 340
+
Sbjct: 299 TA 300
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 147 bits (372), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 22/299 (7%)
Query: 51 FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
FS+ EL+ TN FD + G+GGFG VY G + + VAVK+L +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
+QF E+ + A+ +H+NLV L G +S +L LVY + NG++ D L P L
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSS-DGDDLCLVYVYXPNGSLLDRLSCLDGTP-PLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
W R KIA A+ + +LH + IHRD+K+ NILLD F K++DFGL+R V
Sbjct: 123 WHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 221 TAP-QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
+ GT Y PE + ++T KSD++SFGVVL+E+I+ +PAVD HR ++ L
Sbjct: 183 XSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 239
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
+ + K + + +D+ + ++ ++ A +A QCL +K+ RP + V L++
Sbjct: 240 EIEDEEKTIEDYIDK----KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 125 bits (314), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 96/277 (34%), Positives = 143/277 (51%), Gaps = 30/277 (10%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGC 125
++G G FGTV+ E G VAVK L E ++ +RV +F+ EV I+ RLRH N+V G
Sbjct: 44 KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--I 183
++ L +V E++S G++ LH A+ L RL +A + A + YLH + I
Sbjct: 103 VTQPP-NLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
+HRD+K+ N+L+D + VKV DFGLSRL + A GTP ++ PE + +K
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA-AGTPEWMAPEVLRDEPSNEK 219
Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN-K 302
SDV+SFGV+L EL T + NL N Q V +G++ +
Sbjct: 220 SDVYSFGVILWEL--------ATLQQPWGNL-----NPAQ-------VVAAVGFKCKRLE 259
Query: 303 VRRTINA-VAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ R +N VA + C +E RP ++D LR +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 95/277 (34%), Positives = 144/277 (51%), Gaps = 30/277 (10%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGC 125
++G G FGTV+ E G VAVK L E ++ +RV +F+ EV I+ RLRH N+V G
Sbjct: 44 KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--I 183
++ L +V E++S G++ LH A+ L RL +A + A + YLH + I
Sbjct: 103 VTQPP-NLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
+HR++K+ N+L+D + VKV DFGLSRL + +A GTP ++ PE + +K
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLRDEPSNEK 219
Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN-K 302
SDV+SFGV+L EL T + NL N Q V +G++ +
Sbjct: 220 SDVYSFGVILWEL--------ATLQQPWGNL-----NPAQ-------VVAAVGFKCKRLE 259
Query: 303 VRRTINA-VAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ R +N VA + C +E RP ++D LR +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L N E F+ E ++ +LRH+ LV LY S
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 251 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL RL ++ + + PE + T KSDV+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 367 SFGILLTELTT 377
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 114 bits (285), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 74 EEP--IXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 190 SFGILLTELTT 200
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 113 bits (283), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 77 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 193 SFGILLTELTT 203
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 366 SFGILLTELTT 376
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 366 SFGILLTELTT 376
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 75 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 191 SFGILLTELTT 201
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G + D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 73 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 189 SFGILLTELTT 199
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 333 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 449 SFGILLTELTT 459
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 112 bits (281), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G + D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 250 EEP--IYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 366 SFGILLTELTT 376
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 112 bits (280), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 65/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ ++RH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E++S G++ D L GE K L P + +A + AS + Y+ + +HRD
Sbjct: 84 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
+ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 200 SFGILLTELTT 210
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 111 bits (277), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 5/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+E+G G FG V+ G + VA+K + E E F+ E +++ +L H LV LYG
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
+ + LV+EF+ +G ++D+L +R G T L + ++ + YL + +IHR
Sbjct: 72 LEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+ N +KV+DFG++R + ST + + PE + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 247 FSFGVVLIELIS 258
+SFGV++ E+ S
Sbjct: 188 WSFGVLMWEVFS 199
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 110 bits (276), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 5/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ LG+G FG V+ G VA+K L E F+ E I+ +L+H LV LY
Sbjct: 15 KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
S + +V E+++ G++ D L + AL P + +A + A+ + Y+ + IHR
Sbjct: 74 SEEP--IYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+++ NIL+ N K+ADFGL+RL ++ + + PE + T KSDV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 247 FSFGVVLIELIS 258
+SFG++L EL++
Sbjct: 190 WSFGILLTELVT 201
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 110 bits (276), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E+++ G++ D L GE K L P + ++ + AS + Y+ + +HRD
Sbjct: 81 EEP--IYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 197 SFGILLTELTT 207
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
+LG G FG V+ G VA+K L E F+ E ++ +LRH+ LV LY S
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +V E+++ G++ D L GE K L P + ++ + AS + Y+ + +HRD
Sbjct: 81 EEP--IYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
++ NIL+ N KVADFGL+RL ++ + + PE + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 248 SFGVVLIELIS 258
SFG++L EL +
Sbjct: 197 SFGILLTELTT 207
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+E+G G FG V+ G + VA+K + E E F+ E +++ +L H LV LYG
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ + LV+EF+ +G ++D+L +R G T L + ++ + YL + +IH
Sbjct: 69 CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N +KV+DFG++R + ST + + PE + + KSD
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 246 VFSFGVVLIELIS 258
V+SFGV++ E+ S
Sbjct: 185 VWSFGVLMWEVFS 197
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 71/242 (29%), Positives = 124/242 (51%), Gaps = 22/242 (9%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ELG G FG V G+ + VAVK + E + ++F E + +L H LV YG
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 127 SRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
S+ + +V E+ISNG + ++L HG+ +P L L++ + + +L + I
Sbjct: 73 SK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESHQFI 126
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
HRD+ N L+D + CVKV+DFG++R + S + + PE ++ + KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 245 DVFSFGVVLIELIS--SMP---------AVDITR-HR-HEINLSNLAINKIQNKALHELV 291
DV++FG+++ E+ S MP + +++ HR + +L++ I +I HEL
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 292 DQ 293
++
Sbjct: 247 EK 248
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+E+G G FG V+ G + VA+K + E E F+ E +++ +L H LV LYG
Sbjct: 12 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ + LV+EF+ +G ++D+L +R G T L + ++ + YL + +IH
Sbjct: 71 CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N +KV+DFG++R + ST + + PE + + KSD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 246 VFSFGVVLIELIS 258
V+SFGV++ E+ S
Sbjct: 187 VWSFGVLMWEVFS 199
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 5/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+E+G G FG V+ G + VA+K + E E F+ E +++ +L H LV LYG
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
+ + LV+EF+ +G ++D+L +R G T L + ++ + YL + +IHR
Sbjct: 75 LEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+ N +KV+DFG++R + ST + + PE + + KSDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 247 FSFGVVLIELIS 258
+SFGV++ E+ S
Sbjct: 191 WSFGVLMWEVFS 202
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 5/193 (2%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+E+G G FG V+ G + VA+K + E + + F+ E +++ +L H LV LYG
Sbjct: 32 VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ + LV+EF+ +G ++D+L +R G T L + ++ + YL + +IH
Sbjct: 91 CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 146
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N +KV+DFG++R + ST + + PE + + KSD
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 246 VFSFGVVLIELIS 258
V+SFGV++ E+ S
Sbjct: 207 VWSFGVLMWEVFS 219
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 108 bits (270), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 21 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 80 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTD 242
RD+ N L+ N VKVADFGLSRL TAP G + PE + +
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 243 KSDVFSFGVVLIEL----ISSMPAVDITR 267
KSDV++FGV+L E+ +S P +D+++
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 221
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 22 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 81 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTD 242
RD+ N L+ N VKVADFGLSRL TAP G + PE + +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 243 KSDVFSFGVVLIEL----ISSMPAVDITR 267
KSDV++FGV+L E+ +S P +D+++
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 222
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+E+G G FG V+ G + VA+K + E E F+ E +++ +L H LV LYG
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ + LV EF+ +G ++D+L +R G T L + ++ + YL + +IH
Sbjct: 72 CLEQA-PICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N +KV+DFG++R + ST + + PE + + KSD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 246 VFSFGVVLIELIS 258
V+SFGV++ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 108 bits (269), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G FG VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 18 KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 77 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 108 bits (269), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 21 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 80 TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQ 221
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 107 bits (268), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 25 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 84 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 25 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 84 TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 33 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 92 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 208 VWAFGVLLWEIATYGMSPYPGIDLSQ 233
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 15 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 75 STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 129
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 186
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 187 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 224
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 225 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 269
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 25 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 84 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 40 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 100 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 154
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 211
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 212 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 249
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 250 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 294
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 41 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 101 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 155
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 212
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 213 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 250
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 251 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 83 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQ 224
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 25 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 84 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 22 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 81 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ 222
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 78 STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 189
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 190 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 227
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 25 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 84 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 22 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 81 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ 222
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 73 STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 184
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 185 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 222
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 53 YGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILA 112
Y E+E A+ S R +G G FGTVY G+ AV + ++ + ++ + F NEV +L
Sbjct: 30 YWEIE-ASEVMLSTR-IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
+ RH N++ G ++ + L +V ++ ++ HLH + K + IA +TA
Sbjct: 88 KTRHVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTA 142
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVD 231
+ YLHA +IIHRD+K+NNI L VK+ DFGL+ + + P G+ ++
Sbjct: 143 QGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 232 PEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH 288
PE + + +SDV+S+G+VL EL++ L + I N+
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMT----------------GELPYSHINNR--- 243
Query: 289 ELVDQTL-----GYESDNKVRRTIN---AVAELAFQCLQSEKDLRPYMVDVLDAL 335
DQ + GY S + + N A+ L C++ K+ RP +L ++
Sbjct: 244 ---DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 79 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 78 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 189
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 190 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 227
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 106 bits (265), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
++ + +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 73 ST--APQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE ++ DK
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 184
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 185 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 222
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 106 bits (265), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 18 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 77 TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 41 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 101 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 155
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
RD+K+NNI L + VK+ DFGL SR +H + G+ ++ PE ++
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 209
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
DK SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 247
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 248 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 18 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 77 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD+ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68 ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
ELG+G FG V+ E QD VAVK L E + + F E ++L L+H+++V
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
+G CT R LL+V+E++ +G + L HG AK PG L L +A
Sbjct: 85 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
+ A+ + YL +HRD+ T N L+ VK+ DFG+SR ++ V
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + T +SDV+SFGVVL E+ +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 73 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
RD+K+NNI L + VK+ DFGL SR +H + G+ ++ PE ++
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 181
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
DK SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 219
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 33 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + + IA +TA + YLHA IIH
Sbjct: 93 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
RD+K+NNI L + VK+ DFGL SR +H + G+ ++ PE ++
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 201
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
DK SDV++FG+VL EL++ L + I N+ DQ +
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 239
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
GY S + KVR A+ L +CL+ ++D RP +L ++
Sbjct: 240 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 287
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68 ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
ELG+G FG V+ E QD VAVK L E + + F E ++L L+H+++V
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
+G CT R LL+V+E++ +G + L HG AK PG L L +A
Sbjct: 79 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
+ A+ + YL +HRD+ T N L+ VK+ DFG+SR ++ V
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + T +SDV+SFGVVL E+ +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68 ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
ELG+G FG V+ E QD VAVK L E + + F E ++L L+H+++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
+G CT R LL+V+E++ +G + L HG AK PG L L +A
Sbjct: 108 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
+ A+ + YL +HRD+ T N L+ VK+ DFG+SR ++ V
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + T +SDV+SFGVVL E+ +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 27/279 (9%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 17 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + IA +TA + YLHA IIH
Sbjct: 77 STKP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 131
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE---YHQCYQLT 241
RD+K+NNI L + VK+ DFGL+ + +H G+ ++ PE +
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGYESD 300
+SDV++FG+VL EL++ L + I N+ + E+V +
Sbjct: 192 FQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLSPDL 235
Query: 301 NKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+KVR + L +CL+ ++D RP +L + ++
Sbjct: 236 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 286 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 341
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
R++ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQ 427
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 224 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 282
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 283 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 338
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
R++ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 339 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 398
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 399 VWAFGVLLWEIATYGMSPYPGIDLSQ 424
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 104 bits (259), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
R+LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 19 RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ EF+ G++ ++L H ER L L+ + + YL
Sbjct: 79 YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 104 bits (259), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+R ++ EF++ G + D+L R + A+ L +A + +SA+ YL + IH
Sbjct: 325 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 380
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
R++ N L+ N VKVADFGLSRL + + PE + + KSD
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
V++FGV+L E+ +S P +D+++
Sbjct: 441 VWAFGVLLWEIATYGMSPYPGIDLSQ 466
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 7/217 (3%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMN 106
G YG E +ELG G FG V YG+ + VA+K + E + ++F+
Sbjct: 1 GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIE 59
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
E ++ L H+ LV LYG ++ R + ++ E+++NG + ++L R + L+
Sbjct: 60 EAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLE 115
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
+ + A+ YL + +HRD+ N L+++ VKV+DFGLSR + S +
Sbjct: 116 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 175
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
+ PE + + KSD+++FGV++ E+ S MP
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 79/282 (28%), Positives = 135/282 (47%), Gaps = 33/282 (11%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+++ +L +V ++ ++ HLH K + IA +TA + YLHA IIH
Sbjct: 89 STKP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPE---YHQCY 238
RD+K+NNI L + VK+ DFGL SR +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSN 200
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGY 297
+ +SDV++FG+VL EL++ L + I N+ + E+V +
Sbjct: 201 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLS 244
Query: 298 ESDNKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+KVR + L +CL+ ++D RP +L + ++
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
VF E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 6 VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 66 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HRD+ N ++ ++F VK+ DFG++R
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q +RP ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 282 IVNLLKD 288
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
YG E +ELG G FG V YG+ + VA+K + E + ++F+ E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKV 72
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
+ L H+ LV LYG ++ R + ++ E+++NG + ++L R + L++ +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
A+ YL + +HRD+ N L+++ VKV+DFGLSR + S + +
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS 188
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
PE + + KSD+++FGV++ E+ S MP
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
VF E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 3 VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 63 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HRD+ N ++ ++F VK+ DFG++R
Sbjct: 122 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 176
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 230
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q +RP ++
Sbjct: 231 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 278
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 279 IVNLLKD 285
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 79/282 (28%), Positives = 135/282 (47%), Gaps = 33/282 (11%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+ +G G FGTVY G+ AV + + ++++ F NEV +L + RH N++ G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
++ + +L +V ++ ++ HLH K + IA +TA + YLHA IIH
Sbjct: 89 ST--APQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPE---YHQCY 238
RD+K+NNI L + VK+ DFGL SR +H + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSN 200
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGY 297
+ +SDV++FG+VL EL++ L + I N+ + E+V +
Sbjct: 201 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLS 244
Query: 298 ESDNKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+KVR + L +CL+ ++D RP +L + ++
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
YG E +ELG G FG V YG+ + VA+K + E + ++F+ E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKV 72
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
+ L H+ LV LYG ++ R + ++ E+++NG + ++L R + L++ +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
A+ YL + +HRD+ N L+++ VKV+DFGLSR + S + +
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
PE + + KSD+++FGV++ E+ S MP
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 161
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 21 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 135
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ELG G FG V YG+ + VA+K + E + ++F+ E ++ L H+ LV LYG
Sbjct: 14 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ R + ++ E+++NG + ++L R + L++ + A+ YL + +HR
Sbjct: 73 TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+++ VKV+DFGLSR + S + + PE + + KSD+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 247 FSFGVVLIELIS--SMP 261
++FGV++ E+ S MP
Sbjct: 189 WAFGVLMWEIYSLGKMP 205
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 136
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 15 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 134
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 102 bits (255), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ELG G FG V YG+ + VA+K + E + ++F+ E ++ L H+ LV LYG
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ R + ++ E+++NG + ++L R + L++ + A+ YL + +HR
Sbjct: 69 TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+++ VKV+DFGLSR + S + + PE + + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 247 FSFGVVLIELIS--SMP 261
++FGV++ E+ S MP
Sbjct: 185 WAFGVLMWEIYSLGKMP 201
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 23 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 137
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P G + PE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ELG G FG V YG+ + VA+K + E + ++F+ E ++ L H+ LV LYG
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ R + ++ E+++NG + ++L R + L++ + A+ YL + +HR
Sbjct: 74 TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+++ VKV+DFGLSR + S + + PE + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 247 FSFGVVLIELIS--SMP 261
++FGV++ E+ S MP
Sbjct: 190 WAFGVLMWEIYSLGKMP 206
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 88/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
V+ E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 6 VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 66 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HRD+ N ++ ++F VK+ DFG++R
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q ++RP ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 281
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 282 IVNLLKD 288
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
IHRD+ T NIL++N VK+ DFGL+++ P V + + PE
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 89/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
VF E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 6 VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 66 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HRD+ N ++ ++F VK+ DFG++R
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ + +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q +RP ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 282 IVNLLKD 288
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 102 bits (253), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ELG G FG V YG+ + VA+K + E + ++F+ E ++ L H+ LV LYG
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ R + ++ E+++NG + ++L R + L++ + A+ YL + +HR
Sbjct: 74 TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D+ N L+++ VKV+DFGLSR + S + + PE + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 247 FSFGVVLIELIS--SMP 261
++FGV++ E+ S MP
Sbjct: 190 WAFGVLMWEIYSLGKMP 206
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 101 bits (252), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67 RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
++LG G FG+V Y LQD G VAVK+L + + + F E++IL L+H N+V
Sbjct: 17 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
G C S R L L+ E++ G++ D+L H ER L L+ + + YL
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 131
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQ 236
IHR++ T NIL++N VK+ DFGL+++ P + G + PE
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
+ + SDV+SFGVVL EL +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 101 bits (252), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
VF E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 6 VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 66 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HRD+ N ++ ++F VK+ DFG++R
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q +RP ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 282 IVNLLKD 288
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 101 bits (252), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
+LG G +G VY G + VAVK L E+ + VE+F+ E ++ ++H NLV L G C
Sbjct: 39 KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 126 TSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
T +V E++ G + D+L R + A+ L +A + +SA+ YL + I
Sbjct: 98 TLEPP--FYIVTEYMPYGNLLDYLRECNREEVTAV---VLLYMATQISSAMEYLEKKNFI 152
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
HRD+ N L+ N VKVADFGLSRL + + PE + KS
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 245 DVFSFGVVLIEL----ISSMPAVDITR 267
DV++FGV+L E+ +S P +D+++
Sbjct: 213 DVWAFGVLLWEIATYGMSPYPGIDLSQ 239
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 69 LGDGGFGTVYYGELQDGRA-----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
+G G FG VY G L+ VA+K L K+ F+ E I+ + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
G S++ + ++++ E++ NG + L R K G + + A+ + YL +
Sbjct: 112 EGVISKY-KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ NIL+++N KV+DFGLSR+ + T+ ++ + + PE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 241 TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
T SDV+SFG+V+ E+++ R LSN + K N L D
Sbjct: 228 TSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAINDGFR------LPTPMD 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
+A+ +L QC Q E+ RP D++ L
Sbjct: 275 CP-----SAIYQLMMQCWQQERARRPKFADIVSIL 304
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
+ LG G FG V+ G + VAVK L V+ F+ E +++ L+H LV LY
Sbjct: 19 KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
+R + ++ E+++ G++ D L + G + P + + + A + Y+ + IHR
Sbjct: 78 TREE-PIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D++ N+L+ + K+ADFGL+R+ ++ + + PE T KSDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 247 FSFGVVLIELIS 258
+SFG++L E+++
Sbjct: 195 WSFGILLYEIVT 206
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 67 RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
RELG+G FG V+ E +D VAVK L + + F E ++L L+H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGE----------RAKPGALPWPTRLKIA 168
YG L++V+E++ +G + L HG R G L L IA
Sbjct: 81 KFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP 227
+ AS + YL + +HRD+ T N L+ N VK+ DFG+SR ++ V
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + T +SDV+SFGV+L E+ +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 85/290 (29%), Positives = 140/290 (48%), Gaps = 43/290 (14%)
Query: 67 RELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
RELG G FG VY G +D G A VAVK + E+ R +F+NE ++ ++
Sbjct: 22 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT---RLKIAIETA 172
V L G S+ + L+V E +++G + +L R + PG P PT +++A E A
Sbjct: 82 VRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP-PTLQEMIQMAAEIA 139
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG---- 228
+ YL+A +HRD+ N ++ ++F VK+ DFG++R + +G G
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 229 -YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL 287
++ PE + T SD++SFGVVL E+ S + ++ LSN + L
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQ-GLSN-------EQVL 241
Query: 288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
++D + DN R V +L C Q +RP +++++ L+D
Sbjct: 242 KFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKD 287
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 99.4 bits (246), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 4/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
++LG G FG V+ G + VAVK L V+ F+ E +++ L+H LV LY
Sbjct: 18 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ + ++ EF++ G++ D L + G + P + + + A + Y+ + IHR
Sbjct: 77 TKE-EPIYIITEFMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D++ N+L+ + K+ADFGL+R+ ++ + + PE T KS+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 247 FSFGVVLIELIS 258
+SFG++L E+++
Sbjct: 194 WSFGILLYEIVT 205
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 24/285 (8%)
Query: 67 RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
RELG+G FG V+ E QD VAVK L + + + F E ++L L+H+++V
Sbjct: 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGERA-------KPGALPWPTRLKIAIET 171
YG L++V+E++ +G + L HG A P L L IA +
Sbjct: 79 KFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYV 230
A+ + YL + +HRD+ T N L+ N VK+ DFG+SR ++ V ++
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALH 288
PE + T +SDV+S GVVL E+ + P ++ + ++ + +
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQ 257
Query: 289 ELVDQTLG-YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
E+ + LG ++ + +R+ I + L LQ+ P +D+L
Sbjct: 258 EVYELMLGCWQREPHMRKNIKGIHTL----LQNLAKASPVYLDIL 298
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 87/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
V+ E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 7 VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 67 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HR++ N ++ ++F VK+ DFG++R
Sbjct: 126 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q ++RP ++
Sbjct: 235 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 282
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 283 IVNLLKD 289
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 86/306 (28%), Positives = 138/306 (45%), Gaps = 28/306 (9%)
Query: 61 NYFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL 114
Y R+LG+G FG V Y DG VAVK L + + + E+DIL L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 115 RHKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
H++++ GC + L LV E++ G++ D+L L L A +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICE 145
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVD 231
+ YLHA IHRD+ N+LLDN+ VK+ DFGL++ P H + +P +
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA 205
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV 291
PE + Y+ SDV+SFGV L EL++ + + + L +A ++ L EL+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264
Query: 292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEE 351
++ E + + V L C ++E RP +++ L+ + HE+
Sbjct: 265 ERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV----------HEK 311
Query: 352 MMTQSP 357
Q+P
Sbjct: 312 YQGQAP 317
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 53/192 (27%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
++LG G FG V+ VAVK + + VE F+ E +++ L+H LV L+
Sbjct: 21 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ + ++ EF++ G++ D L + P P + + + A + ++ + IHR
Sbjct: 80 TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D++ NIL+ + K+ADFGL+R+ ++ + + PE T KSDV
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 247 FSFGVVLIELIS 258
+SFG++L+E+++
Sbjct: 196 WSFGILLMEIVT 207
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 87/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
V+ E E + RELG G FG VY G +D G A VAVK + E+ R
Sbjct: 6 VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S+ + L+V E +++G + +L R + PG
Sbjct: 66 EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P PT +++A E A + YL+A +HR++ N ++ ++F VK+ DFG++R
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SD++SFGVVL E+ S + +
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L ++D + DN R V +L C Q ++RP ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 281
Query: 331 VLDALRD 337
+++ L+D
Sbjct: 282 IVNLLKD 288
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 53/192 (27%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
++LG G FG V+ VAVK + + VE F+ E +++ L+H LV L+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ + ++ EF++ G++ D L + P P + + + A + ++ + IHR
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D++ NIL+ + K+ADFGL+R+ ++ + + PE T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 247 FSFGVVLIELIS 258
+SFG++L+E+++
Sbjct: 369 WSFGILLMEIVT 380
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 97.8 bits (242), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
++++ ELGDG FG VY + ++ +A ++ + + + +E +M E+DILA H N+
Sbjct: 37 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
V L + L ++ EF + G V D + E +P +++++ +T AL YL
Sbjct: 97 VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H + IIHRD+K NIL + +K+ADFG+S + + GTP ++ PE C
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+DV+S G+ LIE+ +I HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM------AEIEPPHHELN 244
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 97.8 bits (242), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
++++ ELGDG FG VY + ++ +A ++ + + + +E +M E+DILA H N+
Sbjct: 37 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
V L + L ++ EF + G V D + E +P +++++ +T AL YL
Sbjct: 97 VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H + IIHRD+K NIL + +K+ADFG+S + + GTP ++ PE C
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+DV+S G+ LIE+ +I HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM------AEIEPPHHELN 244
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 97.8 bits (242), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
FD R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 74 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL +N +K+ADFG S P + T GT Y+ PE +
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + MP +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 18/286 (6%)
Query: 62 YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARLR 115
Y R+LG+G FG V Y DG VAVK L + + + E+DIL L
Sbjct: 15 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H++++ GC + + L LV E++ G++ D+L L L A +
Sbjct: 75 HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 129
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDP 232
+ YLHA IHR++ N+LLDN+ VK+ DFGL++ P + G + P
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E + Y+ SDV+SFGV L EL++ + + + L +A ++ L EL++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 248
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ E + + V L C ++E RP +++ L+ +
Sbjct: 249 RG---ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 151
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 255
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 256 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 149
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 253
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 254 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 152
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 256
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 257 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 153
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 214 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 257
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 258 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 295
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 30 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 90 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 146
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 206
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 207 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 250
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 251 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 288
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 56 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 232
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 233 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 276
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 277 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 314
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 57 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 173
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + + H T + ++ E Q +
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 233
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 234 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 277
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 278 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 315
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
++++ ELGDG FG VY + ++ +A ++ + + + +E +M E+DILA H N+
Sbjct: 37 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
V L + L ++ EF + G V D + E +P +++++ +T AL YL
Sbjct: 97 VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H + IIHRD+K NIL + +K+ADFG+S + GTP ++ PE C
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+DV+S G+ LIE+ P HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELN 244
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 18/286 (6%)
Query: 62 YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARLR 115
Y R+LG+G FG V Y DG VAVK L + + + E+DIL L
Sbjct: 15 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H++++ GC + + L LV E++ G++ D+L L L A +
Sbjct: 75 HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 129
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDP 232
+ YLH+ IHR++ N+LLDN+ VK+ DFGL++ P + G + P
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E + Y+ SDV+SFGV L EL++ + + + L +A ++ L EL++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 248
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
+ E + + V L C ++E RP +++ L+ +
Sbjct: 249 RG---ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + YL +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 153
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + H T + ++ E Q +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 241 TDKSDVFSFGVVLIELIS 258
T KSDV+SFGV+L EL++
Sbjct: 214 TTKSDVWSFGVLLWELMT 231
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
FD R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 74 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL +N +K+ADFG S P+ GT Y+ PE +
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + MP +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 69 LGDGGFG-TVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
LG G FG + + G + +K L + + F+ EV ++ L H N++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ R L + E+I GT+ + ++ PW R+ A + AS + YLH+ +IIHRD
Sbjct: 78 KDKR-LNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS-----TAPQ--------GTPGYVDPEY 234
+ ++N L+ N V VADFGL+RL + T P G P ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPA 262
+K DVFSFG+VL E+I + A
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA 221
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 81 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 133
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 194 VWSFGILLTEIVT 206
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 86 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 199 VWSFGILLTEIVT 211
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 88 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 140
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 201 VWSFGILLTEIVT 213
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 80 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 89 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 141
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 202 VWSFGILLTEIVT 214
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 82 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 195 VWSFGILLTEIVT 207
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 80 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 81/320 (25%), Positives = 146/320 (45%), Gaps = 43/320 (13%)
Query: 43 GNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYEN 96
G++ V+ E E A +RELG G FG VY G + + VA+K + E
Sbjct: 1 GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 97 NYKRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
R +F+NE ++ ++V L G S + L++ E ++ G + +L R +
Sbjct: 61 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 156 ----PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL 208
P P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG+
Sbjct: 120 MENNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 209 SRLFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV 263
+R + +G G ++ PE + T SDV+SFGVVL E+ +
Sbjct: 179 TR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 229
Query: 264 DITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKD 323
+ ++ LSN + L +++ L + DN + + EL C Q
Sbjct: 230 -LAEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPK 276
Query: 324 LRPYMVDVLDALRDIESDGY 343
+RP ++++ ++++ G+
Sbjct: 277 MRPSFLEIISSIKEEMEPGF 296
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 155
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R + H T + ++ E Q +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 241 TDKSDVFSFGVVLIELIS 258
T KSDV+SFGV+L EL++
Sbjct: 216 TTKSDVWSFGVLLWELMT 233
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 85 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 137
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 198 VWSFGILLTEIVT 210
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 155
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 259
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 260 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 297
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 86 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 199 VWSFGILLTEIVT 211
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 152
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 256
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 257 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 90 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 142
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 203 VWSFGILLTEIVT 215
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 80 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL ++ + + PE T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 43 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 159
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 220 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 263
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 264 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 301
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69 LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG VY+G L DG+ + AVK L + V QF+ E I+ H N++SL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G R L+V ++ +G + + + E P + ++ A + +L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 213
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N +LD F VKVADFGL+R ++ H T + ++ E Q +
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
T KSDV+SFGV+L EL++ + P D +N ++ + +Q + L +
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 317
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
+ + E+ +C + ++RP +++ + I S
Sbjct: 318 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR--LKIAIETASALTYLHASDIIHR 186
+ ++ E++ NG++ D L P + L +A + A + ++ + IHR
Sbjct: 75 EP--IYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
D++ NIL+ + K+ADFGL+RL ++ + + PE T KSDV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 247 FSFGVVLIELIS 258
+SFG++L E+++
Sbjct: 189 WSFGILLTEIVT 200
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
++LG G FG V+ VAVK + + VE F+ E +++ L+H LV L+
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
++ + ++ EF++ G++ D L + P P + + + A + ++ + IHR
Sbjct: 247 TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 187 DVKTNNILLDNNFCVKVADFGLSRL---FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
D++ NIL+ + K+ADFGL+R+ FP T PE T K
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIKWTA-------------PEAINFGSFTIK 349
Query: 244 SDVFSFGVVLIELIS 258
SDV+SFG++L+E+++
Sbjct: 350 SDVWSFGILLMEIVT 364
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
F R LG G FG V+ +GR A+K L + K+VE +E +L+ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ ++G T + ++++ ++ ++I G + L K P P A E AL YL
Sbjct: 68 IIRMWG-TFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYL 122
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ DII+RD+K NILLD N +K+ DFG ++ P+ V+ GTP Y+ PE
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVSTK 178
Query: 239 QLTDKSDVFSFGVVLIELIS 258
D +SFG+++ E+++
Sbjct: 179 PYNKSIDWWSFGILIYEMLA 198
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V G+ + G VAVK + N + F+ E ++ +LRH NLV L G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
L +V E+++ G++ D+L R + L LK +++ A+ YL ++ +HRD+
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 128
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
N+L+ + KV+DFGL++ + + + PE + + + KSDV+S
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 249 FGVVLIELIS 258
FG++L E+ S
Sbjct: 185 FGILLWEIYS 194
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V G+ + G VAVK + N + F+ E ++ +LRH NLV L G
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
L +V E+++ G++ D+L R + L LK +++ A+ YL ++ +HRD+
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
N+L+ + KV+DFGL++ + + + PE + + + KSDV+S
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 249 FGVVLIELIS 258
FG++L E+ S
Sbjct: 200 FGILLWEIYS 209
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V G+ + G VAVK + N + F+ E ++ +LRH NLV L G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
L +V E+++ G++ D+L R + L LK +++ A+ YL ++ +HRD+
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
N+L+ + KV+DFGL++ + + + PE + + + KSDV+S
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 249 FGVVLIELIS 258
FG++L E+ S
Sbjct: 372 FGILLWEIYS 381
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 81/320 (25%), Positives = 146/320 (45%), Gaps = 43/320 (13%)
Query: 43 GNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYEN 96
G++ V+ E E A +RELG G FG VY G + + VA+K + E
Sbjct: 1 GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 97 NYKRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
R +F+NE ++ ++V L G S + L++ E ++ G + +L R +
Sbjct: 61 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 156 ----PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL 208
P P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG+
Sbjct: 120 MENNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 209 SRLFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV 263
+R + +G G ++ PE + T SDV+SFGVVL E+ +
Sbjct: 179 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 229
Query: 264 DITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKD 323
+ ++ LSN + L +++ L + DN + + EL C Q
Sbjct: 230 -LAEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPK 276
Query: 324 LRPYMVDVLDALRDIESDGY 343
+RP ++++ ++++ G+
Sbjct: 277 MRPSFLEIISSIKEEMEPGF 296
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
ELGDG FG VY + ++ A+A ++ E + + +E ++ E++ILA H +V L G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 127 SRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
H +L ++ EF G V A L +R L P + + AL +LH+ IIH
Sbjct: 86 Y-HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQL 240
RD+K N+L+ +++ADFG+S ++ T + GTP ++ PE C +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 241 TD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+D++S G+ LIE+ P HE+N
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP------HHELN 226
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
ELGDG FG VY + ++ A+A ++ E + + +E ++ E++ILA H +V L G
Sbjct: 18 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-A 76
Query: 127 SRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
H +L ++ EF G V A L +R L P + + AL +LH+ IIH
Sbjct: 77 YYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQL 240
RD+K N+L+ +++ADFG+S ++ T + GTP ++ PE C +
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 241 TD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+D++S G+ LIE+ P HE+N
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPP------HHELN 218
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 72/281 (25%), Positives = 134/281 (47%), Gaps = 35/281 (12%)
Query: 67 RELGDGGFG-TVYYGELQDGRAVAVKRL--YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
+++G+G FG + +DGR +K + + K E+ EV +LA ++H N+V Y
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ-Y 88
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERA----KPGALPWPTRLKIAIETASALTYLH 179
+ + L +V ++ G + ++ ++ + L W ++ AL ++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVH 142
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K+ NI L + V++ DFG++R+ N ++ A GTP Y+ PE +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKP 201
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEI-NLSNLAINKIQNKA----------LH 288
+KSD+++ G VL EL + +H E ++ NL + I L
Sbjct: 202 YNNKSDIWALGCVLYELCT-------LKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV 329
LV Q ++ + + R ++N++ E F + EK L P ++
Sbjct: 255 SLVSQL--FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLI 293
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 9/190 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V G+ + G VAVK + N + F+ E ++ +LRH NLV L G
Sbjct: 20 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
L +V E+++ G++ D+L R + L LK +++ A+ YL ++ +HRD+
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 134
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
N+L+ + KV+DFGL++ + + + PE + + KSDV+S
Sbjct: 135 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWS 190
Query: 249 FGVVLIELIS 258
FG++L E+ S
Sbjct: 191 FGILLWEIYS 200
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G FG V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR--LKIAIETASALTYLHASDIIHR 186
+ ++ E++ NG++ D L P + L +A + A + ++ + IHR
Sbjct: 76 EP--IYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
+++ NIL+ + K+ADFGL+RL ++ + + PE T KSDV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 247 FSFGVVLIELIS 258
+SFG++L E+++
Sbjct: 190 WSFGILLTEIVT 201
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 86/361 (23%), Positives = 161/361 (44%), Gaps = 54/361 (14%)
Query: 4 MAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYF 63
+ + ++ R++ N + +L+ + + E S D V+ E E A
Sbjct: 1 LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAAD-----------VYVPDEWEVAREKI 49
Query: 64 DSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRH 116
+RELG G FG VY G + + VA+K + E R +F+NE ++
Sbjct: 50 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 109
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT---RLKIAI 169
++V L G S + L++ E ++ G + +L R + P P P+ +++A
Sbjct: 110 HHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-PSLSKMIQMAG 167
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R + +G G
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 223
Query: 229 ----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN 284
++ PE + T SDV+SFGVVL E+ + + ++ LSN
Sbjct: 224 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GLSN-------E 269
Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD 344
+ L +++ L + DN + + EL C Q +RP ++++ ++++ G+
Sbjct: 270 QVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 325
Query: 345 D 345
+
Sbjct: 326 E 326
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 80/309 (25%), Positives = 144/309 (46%), Gaps = 45/309 (14%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYE--NNYKRVEQFMN 106
E E A +RELG G FG VY G + + VA+K + E + +R+E F+N
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 62
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWP 162
E ++ ++V L G S + L++ E ++ G + +L R + P P P
Sbjct: 63 EASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-P 120
Query: 163 T---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 176
Query: 220 STAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
+G G ++ PE + T SDV+SFGVVL E+ + + ++ L
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GL 229
Query: 275 SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA 334
SN + L +++ L + DN + + EL C Q +RP ++++ +
Sbjct: 230 SN-------EQVLRFVMEGGLLDKPDN----CPDMLLELMRMCWQYNPKMRPSFLEIISS 278
Query: 335 LRDIESDGY 343
+++ G+
Sbjct: 279 IKEEMEPGF 287
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
A N + +++G GGFG V+ G L +D VA+K L + ++ ++F EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
++ L H N+V LYG R +V EF+ G + L ++A P + W +L++ ++
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
A + Y+ + I+HRD+++ NI LD N C KVADFGLS+ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISS 259
G ++ PE + T+K+D +SF ++L +++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLY----ENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
+G GGFG VY G VAVK E+ + +E E + A L+H N+++L G
Sbjct: 15 IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH---AS 181
+ L LV EF G + L G+R P L + A++ A + YLH
Sbjct: 74 VCLKEP-NLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNWAVQIARGMNYLHDEAIV 127
Query: 182 DIIHRDVKTNNILLD--------NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
IIHRD+K++NIL+ +N +K+ DFGL+R + + T +S A G ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAA--GAYAWMAPE 184
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ + SDV+S+GV+L EL++
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTG 210
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
F RE+G G FG VY+ ++++ VA+K++ + + E++ + EV L +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-- 175
+ GC R H+ L++ Y G+ +D L + KP ++IA T AL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHK-KPL-----QEVEIAAVTHGALQG 166
Query: 176 -TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
YLH+ ++IHRDVK NILL VK+ DFG + + V GTP ++ PE
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 221
Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMPAV 263
Q K DV+S G+ IEL P +
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H+N+
Sbjct: 29 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +Y + EL +V EF+ G + D + R + + + AL+ LH
Sbjct: 89 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 142
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
A +IHRD+K+++ILL ++ VK++DFG +S+ P V GTP ++ PE
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELI 197
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
+ D++S G+++IE++ P
Sbjct: 198 SRLPYGPEVDIWSLGIMVIEMVDGEP 223
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 71 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 12/215 (5%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G+ + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 1 GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV L K
Sbjct: 61 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXLCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ PE + +K D++S GV+ E + P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H+N+
Sbjct: 31 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +Y + EL +V EF+ G + D + R + + + AL+ LH
Sbjct: 91 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 144
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
A +IHRD+K+++ILL ++ VK++DFG +S+ P V GTP ++ PE
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELI 199
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
+ D++S G+++IE++ P
Sbjct: 200 SRLPYGPEVDIWSLGIMVIEMVDGEP 225
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H+N+
Sbjct: 20 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +Y + EL +V EF+ G + D + R + + + AL+ LH
Sbjct: 80 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
A +IHRD+K+++ILL ++ VK++DFG V GTP ++ PE
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ D++S G+++IE++ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEP 214
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
LG G G V+ G VAVK L + + + F+ E +++ +L+H+ LV LY ++
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ ++ E++ NG++ D L G + L L +A + A + ++ + IH
Sbjct: 80 EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
RD++ NIL+ + K+ADFGL+RL + + + PE T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H+N+
Sbjct: 24 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +Y + EL +V EF+ G + D + R + + + AL+ LH
Sbjct: 84 VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 137
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
A +IHRD+K+++ILL ++ VK++DFG V GTP ++ PE
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 196
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ D++S G+++IE++ P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEP 218
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 20/220 (9%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
++++ ELGD FG VY + ++ +A ++ + + + +E +M E+DILA H N+
Sbjct: 12 DFWEIIGELGD--FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 69
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
V L + L ++ EF + G V D + E +P +++++ +T AL YL
Sbjct: 70 VKLLD-AFYYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H + IIHRD+K NIL + +K+ADFG+S + GTP ++ PE C
Sbjct: 125 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWMAPEVVMCE 184
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
D K+DV+S G+ LIE+ P HE+N
Sbjct: 185 TSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELN 218
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 18/284 (6%)
Query: 62 YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYENNYKRVEQ-FMNEVDILARLR 115
Y R+LG+G FG V Y DG VAVK L E ++ + E++IL L
Sbjct: 9 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H+++V GC + + + LV E++ G++ D+L L L A +
Sbjct: 69 HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 123
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-TP-GYVDP 232
+ YLHA IHR + N+LLDN+ VK+ DFGL++ P + G +P + P
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E + + SDV+SFGV L EL++ + + + H L ++ L EL++
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR 336
+ E + R + L C ++E RP +++ L+
Sbjct: 243 RG---ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 18/284 (6%)
Query: 62 YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYENNYKRVEQ-FMNEVDILARLR 115
Y R+LG+G FG V Y DG VAVK L E ++ + E++IL L
Sbjct: 10 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H+++V GC + + + LV E++ G++ D+L L L A +
Sbjct: 70 HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 124
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-TP-GYVDP 232
+ YLHA IHR + N+LLDN+ VK+ DFGL++ P + G +P + P
Sbjct: 125 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E + + SDV+SFGV L EL++ + + + H L ++ L EL++
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR 336
+ E + R + L C ++E RP +++ L+
Sbjct: 244 RG---ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRH 116
+ +Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H
Sbjct: 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 207
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+N+V +Y + EL +V EF+ G + D + R + + + AL+
Sbjct: 208 ENVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALS 261
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDP 232
LHA +IHRD+K+++ILL ++ VK++DFG +S+ P V GTP ++ P
Sbjct: 262 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAP 316
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPA 262
E + D++S G+++IE++ P
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 4 GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV L K
Sbjct: 64 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 118
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S P + A GT Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDY 175
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ PE + +K D++S GV+ E + P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 1 GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV L K
Sbjct: 61 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ PE + +K D++S GV+ E + P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
F RE+G G FG VY+ ++++ VA+K++ + + E++ + EV L +LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-- 175
+ GC R H+ L++ Y G+ +D L + KP ++IA T AL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHK-KPL-----QEVEIAAVTHGALQG 127
Query: 176 -TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
YLH+ ++IHRDVK NILL VK+ DFG + + V GTP ++ PE
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMPAV 263
Q K DV+S G+ IEL P +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 27 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 87 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 141
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 198
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGKPPFE 224
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRH 116
+ +Y D+ ++G+G G V ++ G+ VAVK++ +R E NEV I+ +H
Sbjct: 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 130
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+N+V +Y + EL +V EF+ G + D + R + + + AL+
Sbjct: 131 ENVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALS 184
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDP 232
LHA +IHRD+K+++ILL ++ VK++DFG +S+ P V GTP ++ P
Sbjct: 185 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAP 239
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPA 262
E + D++S G+++IE++ P
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 81/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
VF E E A +RELG G FG VY G + + VA+K + E R
Sbjct: 5 VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S + L++ E ++ G + +L R + P
Sbjct: 65 EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R
Sbjct: 124 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 178
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SDV+SFGVVL E+ + + +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 232
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L +++ L + DN + + EL C Q +RP ++
Sbjct: 233 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 280
Query: 331 VLDALRDIESDGY 343
++ ++++ G+
Sbjct: 281 IISSIKEEMEPGF 293
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 1 GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV L K
Sbjct: 61 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTELCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ PE + +K D++S GV+ E + P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 73 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
FD R LG G FG VY E Q+ +A+K L+++ ++ VE Q E++I + LRH N
Sbjct: 17 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ +Y R + L+ EF G L+ E K G E A AL Y
Sbjct: 77 ILRMYNYFHDRKR-IYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H +IHRD+K N+L+ +K+ADFG S P+ GT Y+ PE +
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPPEMIEGK 188
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD----ITRHRHEINLSNLAINKIQNKALHELVDQT 294
+K D++ GV+ E + MP D HR +N+ +L + +L+ +
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKL 247
Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
L Y ++ + V E + S + L P
Sbjct: 248 LRYHPPQRL--PLKGVMEHPWVKANSRRVLPP 277
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 73 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 75 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
FD R LG G FG VY E Q+ +A+K L+++ ++ VE Q E++I + LRH N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ +Y R + L+ EF G L+ E K G E A AL Y
Sbjct: 76 ILRMYNYFHDRKR-IYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H +IHRD+K N+L+ +K+ADFG S P+ GT Y+ PE +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPPEMIEGK 187
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD----ITRHRHEINLSNLAINKIQNKALHELVDQT 294
+K D++ GV+ E + MP D HR +N+ +L + +L+ +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKL 246
Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
L Y ++ + V E + S + L P
Sbjct: 247 LRYHPPQRL--PLKGVMEHPWVKANSRRVLPP 276
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 67 RELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
R +G G FG V G L+ G+ AVA+K L Y +R F+ E I+ + H N+
Sbjct: 49 RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR--DFLCEASIMGQFDHPNV 106
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V L G +R + +++V EF+ NG + L R G + + A+ + YL
Sbjct: 107 VHLEGVVTR-GKPVMIVIEFMENGALDAFL---RKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQC 237
+HRD+ NIL+++N KV+DFGLSR+ + V T G + PE Q
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
+ T SDV+S+G+V+ E++S R ++SN + KA+ E GY
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GY 265
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ + +L C Q E+ RP +V +LD +
Sbjct: 266 RLPAPM-DCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
FD R LG G FG VY E Q+ +A+K L+++ ++ VE Q E++I + LRH N
Sbjct: 16 FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ +Y R + L+ EF G L+ E K G E A AL Y
Sbjct: 76 ILRMYNYFHDRKR-IYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H +IHRD+K N+L+ +K+ADFG S P+ GT Y+ PE +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPPEMIEGK 187
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD----ITRHRHEINLSNLAINKIQNKALHELVDQT 294
+K D++ GV+ E + MP D HR +N+ +L + +L+ +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKL 246
Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
L Y ++ + V E + S + L P
Sbjct: 247 LRYHPPQRL--PLKGVMEHPWVKANSRRVLPP 276
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 43/318 (13%)
Query: 45 YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNY 98
+ V+ E E A +RELG G FG VY G + + VA+K + E
Sbjct: 9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 99 KRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-- 155
R +F+NE ++ ++V L G S + L++ E ++ G + +L R +
Sbjct: 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 156 --PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
P P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R
Sbjct: 128 NNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 211 LFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDI 265
+ +G G ++ PE + T SDV+SFGVVL E+ + +
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------L 236
Query: 266 TRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR 325
++ LSN + L +++ L + DN + + EL C Q +R
Sbjct: 237 AEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMR 284
Query: 326 PYMVDVLDALRDIESDGY 343
P ++++ ++++ G+
Sbjct: 285 PSFLEIISSIKEEMEPGF 302
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 80/317 (25%), Positives = 143/317 (45%), Gaps = 41/317 (12%)
Query: 45 YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNY 98
+ V+ E E A +RELG G FG VY G + + VA+K + E
Sbjct: 9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 99 KRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---A 154
R +F+NE ++ ++V L G S + L++ E ++ G + +L R A
Sbjct: 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 155 KPGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
L P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR- 186
Query: 212 FPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
+ +G G ++ PE + T SDV+SFGVVL E+ + +
Sbjct: 187 ---DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LA 237
Query: 267 RHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
++ LSN + L +++ L + DN + + EL C Q +RP
Sbjct: 238 EQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRP 285
Query: 327 YMVDVLDALRDIESDGY 343
++++ ++++ G+
Sbjct: 286 SFLEIISSIKEEMEPGF 302
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 75 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEXIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 9 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 69 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 123
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 180
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFE 206
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 36 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 96 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 150
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 207
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 70 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + A GT Y+ PE +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 14 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 74 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFE 211
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY ++ + + A+K L++ ++ Q EV+I + LRH N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 70 ILRLYGYFHDSTR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + A GT Y+ PE +
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ G V L K E A+AL+Y
Sbjct: 75 ILRLYGYFHDATR-VYLILEYAPRGEVYKELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G+ + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 1 GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV L K
Sbjct: 61 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S P+ GT Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ PE + +K D++S GV+ E + P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
V+ E E A +RELG G FG VY G + + VA+K + E R
Sbjct: 7 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S + L++ E ++ G + +L R + P
Sbjct: 67 EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R
Sbjct: 126 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SDV+SFGVVL E+ + + +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L +++ L + DN + + EL C Q +RP ++
Sbjct: 235 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 282
Query: 331 VLDALRDIESDGY 343
++ ++++ G+
Sbjct: 283 IISSIKEEMEPGF 295
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 7 FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 67 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 121
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 178
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPFE 204
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 70 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 75 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV + E K E A+AL+Y
Sbjct: 70 ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 71 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + T GT Y+ PE +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
V+ E E A +RELG G FG VY G + + VA+K + E R
Sbjct: 7 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S + L++ E ++ G + +L R + P
Sbjct: 67 EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R
Sbjct: 126 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SDV+SFGVVL E+ + + +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L +++ L + DN + + EL C Q +RP ++
Sbjct: 235 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 282
Query: 331 VLDALRDIESDGY 343
++ ++++ G+
Sbjct: 283 IISSIKEEMEPGF 295
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 27/218 (12%)
Query: 59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
A N + +++G GGFG V+ G L +D VA+K L + ++ ++F EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
++ L H N+V LYG R +V EF+ G + L ++A P + W +L++ ++
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
A + Y+ + I+HRD+++ NI LD N C KVADFG S+ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISS 259
G ++ PE + T+K+D +SF ++L +++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 80/312 (25%), Positives = 142/312 (45%), Gaps = 41/312 (13%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
V+ E E A +RELG G FG VY G + + VA+K + E R
Sbjct: 4 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGAL 159
+F+NE ++ ++V L G S + L++ E ++ G + +L R A L
Sbjct: 64 EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 160 PWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV 216
P+ +++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DI 178
Query: 217 THVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE 271
+G G ++ PE + T SDV+SFGVVL E+ + + ++
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ 232
Query: 272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV 331
LSN + L +++ L + DN + + EL C Q +RP +++
Sbjct: 233 -GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEI 280
Query: 332 LDALRDIESDGY 343
+ ++++ G+
Sbjct: 281 ISSIKEEMEPGF 292
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 53 YGELEEA----TNYFDSARELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRV 101
+G +E A +Y +G G FG V G L+ G+ VA+K L Y +R
Sbjct: 2 WGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR- 60
Query: 102 EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
+F++E I+ + H N++ L G + +S ++++ EF+ NG + L R G
Sbjct: 61 -EFLSEASIMGQFEHPNIIRLEGVVT-NSMPVMILTEFMENGALDSFL---RLNDGQFTV 115
Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTH 218
+ + AS + YL +HRD+ NIL+++N KV+DFGLSR + T+
Sbjct: 116 IQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 219 VSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL 277
S+ P + PE + T SD +S+G+V+ E++S R ++SN
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQ 228
Query: 278 -AINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
IN I+ D L D ++ +L C Q +++ RP V+ AL
Sbjct: 229 DVINAIEQ-------DYRLPPPPDCP-----TSLHQLMLDCWQKDRNARPRFPQVVSAL 275
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 69 LGDGGFGTVYYGELQ-DGRA---VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG V G L+ G+ VA+K L K+ F++E I+ + H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G ++ S ++++ EF+ NG++ L R G + + A+ + YL +
Sbjct: 101 GVVTK-STPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTP-GYVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR + T+ S P + PE Q +
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 240 LTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
T SDV+S+G+V+ E++S P D+T IN I+ D L
Sbjct: 217 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQ-------DYRLPP 261
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
D +A+ +L C Q +++ RP +++ L
Sbjct: 262 PMDCP-----SALHQLMLDCWQKDRNHRPKFGQIVNTL 294
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 79/308 (25%), Positives = 141/308 (45%), Gaps = 43/308 (13%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE-QFMNE 107
E E A +RELG G FG VY G + + VA+K + E R +F+NE
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 108 VDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT 163
++ ++V L G S + L++ E ++ G + +L R + P P P+
Sbjct: 66 ASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-PS 123
Query: 164 ---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
+++A E A + YL+A+ +HRD+ N ++ +F VK+ DFG++R +
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETD 179
Query: 221 TAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS 275
+G G ++ PE + T SDV+SFGVVL E+ + + ++ LS
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GLS 232
Query: 276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
N + L +++ L + DN + + EL C Q +RP ++++ ++
Sbjct: 233 N-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSI 281
Query: 336 RDIESDGY 343
++ G+
Sbjct: 282 KEEMEPGF 289
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
L + F+ +G+G +G VY G ++ G+ A+K + + E+ E+++L +
Sbjct: 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKY 77
Query: 115 -RHKNLVSLYGCTSRHSR-----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
H+N+ + YG + + +L LV EF G+V D + + W I
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 135
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
E L++LH +IHRD+K N+LL N VK+ DFG+S V +T GTP
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 194
Query: 229 YVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAV 263
++ PE C + D KSD++S G+ IE+ P +
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
G + A F+ R LG G FG VY E Q +A+K L++ ++ Q EV+
Sbjct: 4 GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
I + LRH N++ LYG +R + L+ E+ GTV + E K
Sbjct: 64 IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 118
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----G 225
E A+AL+Y H+ +IHRD+K N+LL + +K+ADFG S H ++ + G
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCG 171
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
T Y+ PE + +K D++S GV+ E + P +
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
A N + +++G GGFG V+ G L +D VA+K L + ++ ++F EV I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
++ L H N+V LYG R +V EF+ G + L ++A P + W +L++ ++
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
A + Y+ + I+HRD+++ NI LD N C KVADF LS+ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELIS 258
G ++ PE + T+K+D +SF ++L +++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 68 ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
+LG G FG+V Y L D G VAVK+L + + F E+ IL L +V
Sbjct: 14 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 123 YGCTSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
G + R EL LV E++ +G + D L RA+ A +RL + + + + YL +
Sbjct: 74 RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
+HRD+ NIL+++ VK+ADFGL++L P + V P +P + PE
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ +SDV+SFGVVL EL +
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 12 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 72 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P+ GT Y+ PE +
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDYLPPEMIEGR 183
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 71 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P+ GT Y+ PE +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 15 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ G V L K E A+AL+Y
Sbjct: 75 ILRLYGYFHDATR-VYLILEYAPRGEVYKELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P + GT Y+ PE +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLXGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 73 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+ADFG S P+ GT Y+ PE +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 12 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 72 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+A+FG S P + T GT Y+ PE +
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 183
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 13 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 73 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ +IHRD+K N+LL + +K+A+FG S P + T GT Y+ PE +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
+K D++S GV+ E + P +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 80/313 (25%), Positives = 142/313 (45%), Gaps = 43/313 (13%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
V+ E E A +RELG G FG VY G + + VA+K + E R
Sbjct: 1 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
+F+NE ++ ++V L G S + L++ E ++ G + +L R + P
Sbjct: 61 EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
P P+ +++A E A + YL+A+ +HRD+ N + +F VK+ DFG++R
Sbjct: 120 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR----D 174
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
+ +G G ++ PE + T SDV+SFGVVL E+ + + +
Sbjct: 175 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 228
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
+ LSN + L +++ L + DN + + EL C Q +RP ++
Sbjct: 229 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLLELMRMCWQYNPKMRPSFLE 276
Query: 331 VLDALRDIESDGY 343
++ ++++ G+
Sbjct: 277 IISSIKEEMEPGF 289
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
F+ R LG G FG VY E Q +A+K L++ ++ Q EV+I + LRH N
Sbjct: 36 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LYG +R + L+ E+ GTV L K E A+AL+Y
Sbjct: 96 ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 150
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----GTPGYVDPEY 234
H+ +IHRD+K N+LL + +K+ADFG S H ++ + GT Y+ PE
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPPEM 203
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
+ +K D++S GV+ E + P +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68 ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
+LG G FG+V Y L D G VAVK+L + + F E+ IL L +V
Sbjct: 17 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
G + R+ L LV E++ +G + D L RA+ A +RL + + + + YL +
Sbjct: 77 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 132
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
+HRD+ NIL+++ VK+ADFGL++L P + +V P +P + PE
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
+ +SDV+SFGVVL EL S P+ + R
Sbjct: 193 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 226
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68 ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
+LG G FG+V Y L D G VAVK+L + + F E+ IL L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
G + R+ L LV E++ +G + D L RA+ A +RL + + + + YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 145
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
+HRD+ NIL+++ VK+ADFGL++L P + +V P +P + PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
+ +SDV+SFGVVL EL S P+ + R
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 11/213 (5%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
+ S G+ ++ F+ ++G G GTVY ++ G+ VA++++ + E +NE+
Sbjct: 12 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
++ ++ N+V+ Y + EL +V E+++ G++ D + G + R
Sbjct: 69 LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
E AL +LH++ +IHRD+K++NILL + VK+ DFG + ST GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 181
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
++ PE K D++S G++ IE+I P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68 ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
+LG G FG+V Y L D G VAVK+L + + F E+ IL L +V
Sbjct: 18 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
G + R+ L LV E++ +G + D L RA+ A +RL + + + + YL +
Sbjct: 78 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
+HRD+ NIL+++ VK+ADFGL++L P + +V P +P + PE
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
+ +SDV+SFGVVL EL S P+ + R
Sbjct: 194 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 227
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 87.8 bits (216), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + GR VAVK + + N +++ EV I+ L H N+V L+
Sbjct: 21 KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 81 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 133
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
I+HRD+K N+LLD + +K+ADFG S F V + G+P Y PE Q +
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT--VGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
DS ++G+G G V E GR VAVK + +R E NEV I+ +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+Y + EL ++ EF+ G + D + R + + AL YLHA
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQ 160
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
+IHRD+K+++ILL + VK++DFG +S+ P V GTP ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-----GTPYWMAPEVISR 215
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
+ D++S G+++IE++ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 37/279 (13%)
Query: 69 LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ G+ VA+K L Y +R +F++E I+ + H N++
Sbjct: 24 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G + +S ++++ EF+ NG + L R G + + AS + YL
Sbjct: 82 LEGVVT-NSMPVMILTEFMENGALDSFL---RLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTP-GYVDPEYHQC 237
+HRD+ NIL+++N KV+DFGLSR + T S+ P + PE
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLG 296
+ T SD +S+G+V+ E++S R ++SN IN I+ D L
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQDVINAIEQ-------DYRLP 243
Query: 297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
D ++ +L C Q +++ RP V+ AL
Sbjct: 244 PPPD-----CPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
V S G+ E Y + ++G+G G V E G+ VAVK++ +R E NEV
Sbjct: 37 VVSPGDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 93
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
I+ H N+V +Y + EL +V EF+ G + D + R + +
Sbjct: 94 VIMRDYHHDNVVDMYS-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVC 147
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQ 224
+ AL+YLH +IHRD+K+++ILL ++ +K++DFG +S+ P V
Sbjct: 148 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV----- 202
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
GTP ++ PE + D++S G+++IE+I P
Sbjct: 203 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 74 FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
GT YG Q DG+ + K L + E+ M +EV++L L+H N+V Y
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
R + L +V E+ G +A + + L L++ + AL H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
++HRD+K N+ LD VK+ DFGL+R+ NH T + A GTP Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 14/244 (5%)
Query: 68 ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG- 124
++G G FG V+ G L+ D VAVK E ++ +F+ E IL + H N+V L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
CT + + +V E + G L E A+ L T L++ + A+ + YL + I
Sbjct: 181 CTQKQP--IYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
HRD+ N L+ +K++DFG+SR + V S + P + PE + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 244 SDVFSFGVVLIELI----SSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGYE 298
SDV+SFG++L E S P + + R + L ++ A+ L++Q YE
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 299 SDNK 302
+
Sbjct: 356 PGQR 359
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 41 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 98
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 99 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 154
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 215 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 257
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 258 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 24 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 82 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 198 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 240
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 241 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
+ S G+ ++ F+ ++G G GTVY ++ G+ VA++++ + E +NE+
Sbjct: 12 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
++ ++ N+V+ Y + EL +V E+++ G++ D + G + R
Sbjct: 69 LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
E AL +LH++ +IHRD+K++NILL + VK+ DFG +++ P GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--GTP 180
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
++ PE K D++S G++ IE+I P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
+ S G+ ++ F+ ++G G GTVY ++ G+ VA++++ + E +NE+
Sbjct: 13 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
++ ++ N+V+ Y + EL +V E+++ G++ D + G + R
Sbjct: 70 LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 124
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
E AL +LH++ +IHRD+K++NILL + VK+ DFG +++ P GTP
Sbjct: 125 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTP 181
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
++ PE K D++S G++ IE+I P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + GR VA+K + + N +++ EV I+ L H N+V L+
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L L+ E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 81 EVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFR-QIVSAVQYCHQK 133
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
I+HRD+K N+LLD + +K+ADFG S F V A G P Y PE Q +
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 51 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 108
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 109 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 164
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 225 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 267
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 268 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
+ S G+ ++ F+ ++G G GTVY ++ G+ VA++++ + E +NE+
Sbjct: 12 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
++ ++ N+V+ Y + EL +V E+++ G++ D + G + R
Sbjct: 69 LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
E AL +LH++ +IHRD+K++NILL + VK+ DFG +++ P GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTP 180
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
++ PE K D++S G++ IE+I P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 14/244 (5%)
Query: 68 ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG- 124
++G G FG V+ G L+ D VAVK E ++ +F+ E IL + H N+V L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
CT + + +V E + G L E A+ L T L++ + A+ + YL + I
Sbjct: 181 CTQKQP--IYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
HRD+ N L+ +K++DFG+SR + V S + P + PE + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 244 SDVFSFGVVLIELI----SSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGYE 298
SDV+SFG++L E S P + + R + L ++ A+ L++Q YE
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 299 SDNK 302
+
Sbjct: 356 PGQR 359
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 40/283 (14%)
Query: 67 RELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
R +G G FG V G L+ G+ VA+K L Y +R F+ E I+ + H N+
Sbjct: 28 RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNI 85
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
+ L G ++ S+ +++V E++ NG++ L + + L+ ++ + YL
Sbjct: 86 IHLEGVVTK-SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYLS 141
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQC 237
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 238 YQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
+ T SDV+S+G+V+ E++S P ++T N+ KA+ E
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMT-------------NQDVIKAVEE------ 242
Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPY---MVDVLDAL 335
GY + + A+ +L C Q E++ RP +V++LD L
Sbjct: 243 GYRLPSPM-DCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 85 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 19 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 79 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 19 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 79 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 85 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 75 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + GR VA+K + + N +++ EV I+ L H N+V L+
Sbjct: 18 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L L+ E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 78 EVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFR-QIVSAVQYCHQK 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
I+HRD+K N+LLD + +K+ADFG S F V G+P Y PE Q +
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLP 210
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 69 LGDGGFGTVYYGELQ-DGRA---VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY 123
+G G FG V G L+ G+ VA+K L K+ F++E I+ + H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G ++ S ++++ EF+ NG++ L R G + + A+ + YL +
Sbjct: 75 GVVTK-STPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTP-GYVDPEYHQCYQ 239
+HR + NIL+++N KV+DFGLSR + T+ S P + PE Q +
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 240 LTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
T SDV+S+G+V+ E++S P D+T IN I+ D L
Sbjct: 191 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQ-------DYRLPP 235
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
D +A+ +L C Q +++ RP +++ L
Sbjct: 236 PMDCP-----SALHQLMLDCWQKDRNHRPKFGQIVNTL 268
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 75 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAVK + + N +++ EV I+ L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
I+HRD+K N+LLD + +K+ADFG S F + A G P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFT--FGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68 ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
+LGDG FG V GE G+ +VAVK L + + E F+ EV+ + L H+NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
LYG + + +V E G++ D L R G T + A++ A + YL +
Sbjct: 75 RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
IHRD+ N+LL VK+ DFGL R P + H V + P + PE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGL+R+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 11/213 (5%)
Query: 50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
+ S G+ ++ F+ ++G G GTVY ++ G+ VA++++ + E +NE+
Sbjct: 13 IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
++ ++ N+V+ Y + EL +V E+++ G++ D + G + R
Sbjct: 70 LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 124
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
E AL +LH++ +IHR++K++NILL + VK+ DFG + ST GTP
Sbjct: 125 -ECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 182
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
++ PE K D++S G++ IE+I P
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + A GT YV PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAVK + + N +++ EV I+ L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K N+LLD + +K+ADFG S F N + G+P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAVK + + N +++ EV I+ L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K N+LLD + +K+ADFG S F N + G+P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 L-TDKSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 39 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY C + +L + NG + ++ K G+ E SAL YL
Sbjct: 99 FVKLYFCF-QDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 153
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 154 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLP 237
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 11/221 (4%)
Query: 63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENN-YK--RVEQFMNEVDILARLRHKN 118
F LG G F VY E + G VA+K + + YK V++ NEV I +L+H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LY S + LV E NG + +L R KP + I T + YL
Sbjct: 73 ILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITG--MLYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H+ I+HRD+ +N+LL N +K+ADFGL ++L H H + GTP Y+ PE
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATR 186
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA 278
+SDV+S G + L+ P D ++ +N LA
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 74 FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
GT YG Q DG+ + K L + E+ M +EV++L L+H N+V Y
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
R + L +V E+ G +A + + L L++ + AL H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
++HRD+K N+ LD VK+ DFGL+R+ NH T + GTP Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 69 LGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLY 123
+G G G V YG L Q VA+K L +R + F++E I+ + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G +R R ++V E++ NG++ L R G + + + + YL
Sbjct: 117 GVVTR-GRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+HRD+ N+L+D+N KV+DFGLSR+ + + +T + + PE +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLGYESD 300
SDV+SFGVV+ E+++ R N++N I+ ++ GY
Sbjct: 233 SASDVWSFGVVMWEVLA-------YGERPYWNMTNRDVISSVEE-----------GYRLP 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ +A+ +L C ++ RP +V VLDAL
Sbjct: 275 APM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E + NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 24 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E + NG++ L A+ + L+ AS + YL
Sbjct: 82 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 198 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 240
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 241 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAV+ + + N +++ EV I+ L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K N+LLD + +K+ADFG S F N + G+P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E++ NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGL R+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 6/200 (3%)
Query: 63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKN 118
F +++G G F VY L DG VA+K++ + K + E+D+L +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ Y + EL +V E G ++ + + + +P T K ++ SAL ++
Sbjct: 94 VIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H+ ++HRD+K N+ + VK+ D GL R F + T + GTP Y+ PE
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHEN 211
Query: 239 QLTDKSDVFSFGVVLIELIS 258
KSD++S G +L E+ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAA 231
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ G+ VA+K L Y + +R F++E I+ + H N++
Sbjct: 37 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 94
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ + ++++ E++ NG++ L R G + + S + YL
Sbjct: 95 LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFG+SR+ + T G + PE +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+V+ E++S R ++SN + KA+ E GY
Sbjct: 211 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 253
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ I A+ +L C Q E+ RP +V++LD L
Sbjct: 254 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
+ SD+++ G ++ +L++ +P
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLP 232
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ +VA+K L Y +R F+ E I+ + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ S+ +++V E + NG++ L A+ + L+ AS + YL
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFGLSR+ + T G + PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+VL E++S R +SN + K VD+ GY
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ A+ +L C Q +++ RP +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 69 LGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLY 123
+G G G V YG L Q VA+K L +R + F++E I+ + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G +R R ++V E++ NG++ L R G + + + + YL
Sbjct: 117 GVVTR-GRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQLT 241
+HRD+ N+L+D+N KV+DFGLSR+ + T G + PE +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLGYESD 300
SDV+SFGVV+ E+++ R N++N I+ ++ GY
Sbjct: 233 SASDVWSFGVVMWEVLA-------YGERPYWNMTNRDVISSVEE-----------GYRLP 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ +A+ +L C ++ RP +V VLDAL
Sbjct: 275 APM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ G+ VA+K L Y + +R F++E I+ + H N++
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 79
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ + ++++ E++ NG++ L R G + + S + YL
Sbjct: 80 LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFG+SR+ + T G + PE +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+V+ E++S R ++SN + KA+ E GY
Sbjct: 196 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 238
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ I A+ +L C Q E+ RP +V++LD L
Sbjct: 239 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAVK + + N +++ EV I+ L H N+V L+
Sbjct: 13 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 73 EVIETE-KTLYLVMEYASGGEVFDYLVAHGWMKEKEA-----RAKFR-QIVSAVQYCHQK 125
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K N+LLD + +K+ADFG S F N + G+P Y PE Q +
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 181
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLP 205
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 25/257 (9%)
Query: 88 VAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-ELLLVYEFISNGTV 145
VA+KR+ E +++ + E+ +++ H N+VS Y TS + EL LV + +S G+V
Sbjct: 43 VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY--TSFVVKDELWLVMKLLSGGSV 100
Query: 146 ADHLH-----GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC 200
D + GE K G L T I E L YLH + IHRDVK NILL +
Sbjct: 101 LDIIKHIVAKGEH-KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 201 VKVADFGLSRLFPN--HVTH--VSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIE 255
V++ADFG+S +T V GTP ++ PE + + D K+D++SFG+ IE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 LISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAF 315
L + H+ + + +QN + G + +++ + ++
Sbjct: 220 LATGAAPY------HKYPPMKVLMLTLQN----DPPSLETGVQDKEMLKKYGKSFRKMIS 269
Query: 316 QCLQSEKDLRPYMVDVL 332
CLQ + + RP ++L
Sbjct: 270 LCLQKDPEKRPTAAELL 286
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 65 SARELGDGGFGTVYYGEL----QDGRAVAVKRLYE-NNYKRVEQFMNEVDILARLRHKNL 119
S R +G G FG VY+GE Q+ A+K L ++VE F+ E ++ L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
++L G ++ ++ +G + + + P + ++ A + YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLA 141
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQ 236
+HRD+ N +LD +F VKVADFGL+R + + + + E Q
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN-------LAINKIQNKALHE 289
Y+ T KSDV+SFGV+L EL++ RH +L++ L + +L++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTR--GAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259
Query: 290 LVDQTLGYESDNKVRRTINAVA 311
++ Q +E+D VR T +
Sbjct: 260 VMQQC--WEADPAVRPTFRVLV 279
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 25/257 (9%)
Query: 88 VAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-ELLLVYEFISNGTV 145
VA+KR+ E +++ + E+ +++ H N+VS Y TS + EL LV + +S G+V
Sbjct: 38 VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY--TSFVVKDELWLVMKLLSGGSV 95
Query: 146 ADHLH-----GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC 200
D + GE K G L T I E L YLH + IHRDVK NILL +
Sbjct: 96 LDIIKHIVAKGEH-KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 201 VKVADFGLSRLFPN--HVTH--VSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIE 255
V++ADFG+S +T V GTP ++ PE + + D K+D++SFG+ IE
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 214
Query: 256 LISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAF 315
L + H+ + + +QN + G + +++ + ++
Sbjct: 215 LATGAAPY------HKYPPMKVLMLTLQN----DPPSLETGVQDKEMLKKYGKSFRKMIS 264
Query: 316 QCLQSEKDLRPYMVDVL 332
CLQ + + RP ++L
Sbjct: 265 LCLQKDPEKRPTAAELL 281
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69 LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
+G G FG V G L+ G+ VA+K L Y + +R F++E I+ + H N++
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 73
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G ++ + ++++ E++ NG++ L R G + + S + YL
Sbjct: 74 LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
+HRD+ NIL+++N KV+DFG+SR+ + T G + PE +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
T SDV+S+G+V+ E++S R ++SN + KA+ E GY
Sbjct: 190 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 232
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
+ I A+ +L C Q E+ RP +V++LD L
Sbjct: 233 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAV+ + + N +++ EV I+ L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRD+K N+LLD + +K+ADFG S F N + G+P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
+ DV+S GV+L L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 91 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 145
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + + GT YV PE
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLP 229
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 77/226 (34%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 41 KGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYK 99
K GN G+ V S L + F+ R LG G FG V +++ G AVK L ++
Sbjct: 7 KEGN--GIGVNSSNRL--GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 100 R---VEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
+ VE M E IL+ R H L L+ C R L V EF++ G + H+ R
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRF 121
Query: 156 PGALPWPTRLKI-AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL-FP 213
A R + A E SAL +LH II+RD+K +N+LLD+ K+ADFG+ +
Sbjct: 122 DEA-----RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
N VT + GTP Y+ PE Q D ++ GV+L E++
Sbjct: 177 NGVTTATFC--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 95 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 149
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + + GT YV PE
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLP 233
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V + + + VA+K++ + ++ F+ E+ L+R+ H N+V LYG
Sbjct: 17 VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACLN 73
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETASALTYLHASD--- 182
+ LV E+ G++ + LHG A+P LP+ T + ++ + + YLH+
Sbjct: 74 ---PVCLVMEYAEGGSLYNVLHG--AEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 183 IIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+IHRD+K N+LL +K+ DFG + H+T+ +G+ ++ PE + +
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYS 182
Query: 242 DKSDVFSFGVVLIELIS 258
+K DVFS+G++L E+I+
Sbjct: 183 EKCDVFSWGIILWEVIT 199
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V + + + VA+K++ + ++ F+ E+ L+R+ H N+V LYG
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACLN 72
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETASALTYLHASD--- 182
+ LV E+ G++ + LHG A+P LP+ T + ++ + + YLH+
Sbjct: 73 ---PVCLVMEYAEGGSLYNVLHG--AEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 183 IIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+IHRD+K N+LL +K+ DFG + H+T+ +G+ ++ PE + +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYS 181
Query: 242 DKSDVFSFGVVLIELIS 258
+K DVFS+G++L E+I+
Sbjct: 182 EKCDVFSWGIILWEVIT 198
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 91 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 145
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG +++ P + GT YV PE
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLP 229
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLP 232
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+D R VAVK L + + +F E A L H +V++Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--STAPQGTPGYVDPEYHQCYQ 239
IIHRDVK NIL+ VKV DFG++R + V + A GT Y+ PE +
Sbjct: 136 GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEP 217
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 16 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 76 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG +++ P + GT YV PE
Sbjct: 131 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLP 214
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 9 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 69 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 123
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 124 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLP 207
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 35/286 (12%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYE-NNYKRVEQF-MNEVDILARLRHKNLVSLYGC 125
+G+G +G V +D GR VA+K+ E ++ K V++ M E+ +L +LRH+NLV+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
+ R LV+EF+ + T+ D L P L + K + + + + H+ +IIH
Sbjct: 93 CKKKKR-WYLVFEFVDH-TILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLF--PNHV------THVSTAPQGTPGYVDPEYHQC 237
RD+K NIL+ + VK+ DFG +R P V T AP+ G D +Y +
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG--DVKYGKA 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAV----DITRHRH-EINLSNLA------INKIQNKA 286
DV++ G ++ E+ P DI + H + L NL NK A
Sbjct: 206 ------VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
L + + + + V +LA +CL + D RP+ ++L
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 70 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLP 208
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 95 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 149
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLP 233
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 94 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 37 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 97 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLP 235
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
+ +G G F V + G+ VAVK + + N +++ EV I L H N+V L+
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L LV E+ S G V D+L HG + A R K + SA+ Y H
Sbjct: 80 EVIETE-KTLYLVXEYASGGEVFDYLVAHGRXKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
I+HRD+K N+LLD + +K+ADFG S F + A G P Y PE Q +
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFT--FGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 242 DKS-DVFSFGVVLIELIS-SMP 261
DV+S GV+L L+S S+P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+D R VAVK L + + +F E A L H +V++Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
IIHRDVK NI++ VKV DFG++R N VT + A GT Y+ PE +
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 11 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 71 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 126 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLP 209
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+D R VAVK L + + +F E A L H +V++Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
IIHRDVK NI++ VKV DFG++R N VT + A GT Y+ PE +
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F TV EL R A+K L + + +V E D+++RL H
Sbjct: 12 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 72 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 127 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLP 210
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 74 FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
GT YG Q DG+ + K L + E+ M +EV++L L+H N+V Y
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
R + L +V E+ G +A + + L L++ + AL H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
++HRD+K N+ LD VK+ DFGL+R+ NH + GTP Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63 FDSARELGDGGFGT-VYYGELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F + LG+G F T V EL R A+K L + + +V E D+++RL H
Sbjct: 32 FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V LY T + +L + NG + ++ K G+ E SAL YL
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H IIHRD+K NILL+ + +++ DFG ++ L P + GT YV PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67 RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
R LG+G FG VY G + + VAVK ++ E+FM+E I+ L H ++V
Sbjct: 14 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G +++ E G + +L ER K +L T + +++ A+ YL +
Sbjct: 74 LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 128
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+ +HRD+ NIL+ + CVK+ DFGLSR + + ++ + ++ PE + T
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 242 DKSDVFSFGVVLIELIS 258
SDV+ F V + E++S
Sbjct: 189 TASDVWMFAVCMWEILS 205
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67 RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
R LG+G FG VY G + + VAVK ++ E+FM+E I+ L H ++V
Sbjct: 30 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G +++ E G + +L ER K +L T + +++ A+ YL +
Sbjct: 90 LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+ +HRD+ NIL+ + CVK+ DFGLSR + + ++ + ++ PE + T
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 242 DKSDVFSFGVVLIELIS 258
SDV+ F V + E++S
Sbjct: 205 TASDVWMFAVCMWEILS 221
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67 RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
R LG+G FG VY G + + VAVK ++ E+FM+E I+ L H ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G +++ E G + +L ER K +L T + +++ A+ YL +
Sbjct: 78 LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+ +HRD+ NIL+ + CVK+ DFGLSR + + ++ + ++ PE + T
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 242 DKSDVFSFGVVLIELIS 258
SDV+ F V + E++S
Sbjct: 193 TASDVWMFAVCMWEILS 209
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 69 LGDGGFGTVYYG-ELQDGRAV----AVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSL 122
LG G FGTVY G + +G V A+K L E + +FM+E I+A + H +LV L
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
G S + LV + + +G + +++H + G+ L ++ A + YL
Sbjct: 83 LGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGS---QLLLNWCVQIAKGMMYLEERR 137
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
++HRD+ N+L+ + VK+ DFGL+RL + P ++ E + T
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 242 DKSDVFSFGVVLIELIS 258
+SDV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTIWELMT 214
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 62 YFDSARELGDGGFGTV---YYGELQD--GRAVAVKRLY-ENNYKRVEQFMNEVDILARLR 115
+ R+LG+G FG V Y D G VAVK L E+ + E++IL L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H+N+V G CT + L+ EF+ +G++ ++L + K + +LK A++
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDP 232
+ YL + +HRD+ N+L+++ VK+ DFGL++ V + P
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
E + SDV+SFGV L EL++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 62 YFDSARELGDGGFGTV---YYGELQD--GRAVAVKRLY-ENNYKRVEQFMNEVDILARLR 115
+ R+LG+G FG V Y D G VAVK L E+ + E++IL L
Sbjct: 10 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H+N+V G CT + L+ EF+ +G++ ++L + K + +LK A++
Sbjct: 70 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 126
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDP 232
+ YL + +HRD+ N+L+++ VK+ DFGL++ V + P
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
E + SDV+SFGV L EL++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 69 LGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSL 122
LG G FGTVY G + +G VA+K L E + +FM+E I+A + H +LV L
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
G S + LV + + +G + +++H + G+ L ++ A + YL
Sbjct: 106 LGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ---LLLNWCVQIAKGMMYLEERR 160
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
++HRD+ N+L+ + VK+ DFGL+RL + P ++ E + T
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 242 DKSDVFSFGVVLIELIS 258
+SDV+S+GV + EL++
Sbjct: 221 HQSDVWSYGVTIWELMT 237
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
FD +LG+G +G+VY + G+ VA+K++ + +++ + E+ I+ + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
YG +++ +L +V E+ G+V+D + R + L I T L YLH
Sbjct: 89 YYGSYFKNT-DLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
IHRD+K NILL+ K+ADFG++ + + + GTP ++ PE Q
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV-IGTPFWMAPEVIQEIGYN 203
Query: 242 DKSDVFSFGVVLIELISSMP 261
+D++S G+ IE+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKP 223
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 61 NYFDSARELGDGGFGTVYYGEL--QDGRA--VAVK--RLYENNYKRVEQFMNEVDILARL 114
N + LG+G FG+V G L +DG + VAVK +L ++ + +E+F++E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 115 RHKNLVSLYG-CTSRHSREL---LLVYEFISNGTVADHLHGERAKPGA--LPWPTRLKIA 168
H N++ L G C S+ + +++ F+ G + +L R + G +P T LK
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTP 227
++ A + YL + +HRD+ N +L ++ V VADFGLS +++ +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
++ E T KSDV++FGV + E+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEI 242
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYG----ELQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + + +L + + A + ++AL YL +
Sbjct: 455 KLIGVITENP--VWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F +G GGFG V+ + + DG+ +KR+ NN E+ EV LA+L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 122 LYGC--------------TSRHSRELLLV-YEFISNGTVADHLHGERAKPGALPWPTRLK 166
GC +SR + L + EF GT+ + R + L L+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALE 126
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
+ + + Y+H+ +I+RD+K +NI L + VK+ DFGL N + +GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGT 184
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
Y+ PE + D+++ G++L EL+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE------LQDGRAVAVKRLYENNYKRVEQ-FMNEVD 109
E N + R++G+G FG V+ + VAVK L E ++ F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG------------TVADHLHGE---RA 154
++A + N+V L G + + + L++E+++ G TV H + RA
Sbjct: 103 LMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 155 K---PGALPWPT--RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS 209
+ PG P +L IA + A+ + YL +HRD+ T N L+ N VK+ADFGLS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 210 RLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
R + + + P ++ PE + T +SDV+++GVVL E+ S
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 75 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 18 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 78 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 132
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 193 TSASDVWMFGVCMWEIL 209
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+ R VAVK L + + +F E A L H +V++Y
Sbjct: 20 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
IIHRDVK NI++ VKV DFG++R N VT + A GT Y+ PE +
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 75 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + ++ + ++ PE +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 72 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 187 TSASDVWMFGVCMWEIL 203
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 80 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 134
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 195 TSASDVWMFGVCMWEIL 211
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 17 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 77 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 131
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 192 TSASDVWMFGVCMWEIL 208
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 75 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 43 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 103 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 157
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ +N CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 218 TSASDVWMFGVCMWEIL 234
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 59 ATNYFDSARELGDGGFGTVYYGELQDG---RAVAV-------KRLYENNYKRVEQF---- 104
+YF R+LG G +G V + ++G +A+ V K Y ++ K +E+F
Sbjct: 35 GESYF-KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 105 MNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
NE+ +L L H N++ L+ + LV EF G + + + R K
Sbjct: 94 YNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANI 151
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFPNHVTHVST 221
+K + S + YLH +I+HRD+K NILL+N +K+ DFGLS F +
Sbjct: 152 MK---QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLR 206
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
GT Y+ PE + + +K DV+S GV++ L+ P
Sbjct: 207 DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQ--FMNEVDILARLRHKNL 119
++ ++G+G +G V+ +D G+ VA+K+ E+ V + + E+ +L +L+H NL
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V+L R R L LV+E+ + + + +R P L I +T A+ + H
Sbjct: 65 VNLLE-VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL----VKSITWQTLQAVNFCH 119
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-Y 238
+ IHRDVK NIL+ + +K+ DFG +RL + T Y PE
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATRWYRSPELLVGDT 178
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
Q DV++ G V EL+S +P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+ R VAVK L + + +F E A L H +V++Y
Sbjct: 20 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
IIHRDVK NI++ VKV DFG++R N VT + A GT Y+ PE +
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG GG V+ +L+ R VAVK L + + +F E A L H +V++Y
Sbjct: 37 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ L Y E++ T+ D +H E G + +++ + AL + H +
Sbjct: 97 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 152
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
IIHRDVK NI++ VKV DFG++R N VT + A GT Y+ PE +
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 211
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
+ +SDV+S G VL E+++ P
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEP 234
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL---YG 124
LG G F V+ + + G+ A+K + ++ R NE+ +L +++H+N+V+L Y
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
T+ + LV + +S G + D + ER G + + SA+ YLH + I+
Sbjct: 77 STTHY----YLVMQLVSGGELFDRIL-ER---GVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 185 HRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
HRD+K N+L + N + + DFGLS++ N + +STA GTPGYV PE +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTA-CGTPGYVAPEVLAQKPYS 185
Query: 242 DKSDVFSFGVVLIELISSMP 261
D +S GV+ L+ P
Sbjct: 186 KAVDCWSIGVITYILLCGYP 205
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F +G GGFG V+ + + DG+ ++R+ NN E+ EV LA+L H N+V
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVH 69
Query: 122 LYGC---------------------------TSRHSRELLLV-YEFISNGTVADHLHGER 153
GC +SR + L + EF GT+ + R
Sbjct: 70 YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 154 AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP 213
+ L L++ + + Y+H+ +IHRD+K +NI L + VK+ DFGL
Sbjct: 130 GE--KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
N T +GT Y+ PE + D+++ G++L EL+
Sbjct: 188 NDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 53/297 (17%)
Query: 66 ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
+ LG+G FG V GRA VAVK L EN + + ++E ++L ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
++ LYG S+ LLL+ E+ G++ L R PG A
Sbjct: 88 VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
L + A + + + YL ++HRD+ NIL+ +K++DFGLSR ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 219 VSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL 277
V + P ++ E + T +SDV+SFGV+L E+++ L
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------LGGN 251
Query: 278 AINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVDV 331
I + L L+ ++ +++ R N E L QC + E D RP D+
Sbjct: 252 PYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 68 ELGDGGFGTVYYGELQD-GRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
+LG GG TVY E VA+K ++ + +++F EV ++L H+N+VS+
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
LV E+I T+++++ G L T + + + + H I
Sbjct: 78 DVDEEDDC-YYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
+HRD+K NIL+D+N +K+ DFG+++ + GT Y PE + +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 244 SDVFSFGVVLIELISSMP 261
+D++S G+VL E++ P
Sbjct: 193 TDIYSIGIVLYEMLVGEP 210
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
FD R +G G + V L+ + VK+ N+ + ++ E + + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
LV L+ C SR L V E+++ G + H+ +R LP + E + AL Y
Sbjct: 114 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 168
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
LH II+RD+K +N+LLD+ +K+ D+G+ + L P T GTP Y+ PE
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEIL 225
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
+ D ++ GV++ E+++ DI
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
FD R +G G + V L+ + VK+ N+ + ++ E + + H
Sbjct: 22 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
LV L+ C SR L V E+++ G + H+ +R LP + E + AL Y
Sbjct: 82 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 136
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
LH II+RD+K +N+LLD+ +K+ D+G+ + L P T GTP Y+ PE
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 193
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
+ D ++ GV++ E+++ DI
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYG 124
LG G FG V GE Q G VAVK L + V + E+ L RH +++ LY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
S + + +V E++S G + D++ K G + ++ + SA+ Y H ++
Sbjct: 79 VISTPT-DFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
HRD+K N+LLD + K+ADFGLS + + G+P Y PE + Y
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPEVISGRLYA-GP 190
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
+ D++S GV+L L+ D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 68 ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
ELG+ FG VY G L + +AVA+K L + + E+F +E + ARL+H N+V
Sbjct: 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTRLKIA 168
L G ++ + L +++ + S+G + + L +R AL P + +
Sbjct: 93 CLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHV 219
+ A+ + YL + ++H+D+ T N+L+ + VK++D GL R L N + +
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + SD++S+GVVL E+ S
Sbjct: 212 R--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYG----ELQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 455 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 61/301 (20%)
Query: 66 ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
+ LG+G FG V GRA VAVK L EN + + ++E ++L ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
++ LYG S+ LLL+ E+ G++ L R PG A
Sbjct: 88 VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
L + A + + + YL ++HRD+ NIL+ +K++DFGLSR V
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR----DVYE 202
Query: 219 VSTAPQGTPGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
+ + + G + ++ L D +SDV+SFGV+L E+++
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------------- 247
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVD 330
L I + L L+ ++ +++ R N E L QC + E D RP D
Sbjct: 248 LGGNPYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 331 V 331
+
Sbjct: 302 I 302
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
FD R +G G + V L+ + VK+ N+ + ++ E + + H
Sbjct: 7 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
LV L+ C SR L V E+++ G + H+ +R LP + E + AL Y
Sbjct: 67 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 121
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
LH II+RD+K +N+LLD+ +K+ D+G+ + L P T GTP Y+ PE
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 178
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
+ D ++ GV++ E+++ DI
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 69 LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
LG G FG V + + + A+K L ++ + VE M E +LA L + L L+
Sbjct: 27 LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
C R L V E+++ G + H+ + G P + A E + L +LH I
Sbjct: 87 SCFQTVDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLT 241
I+RD+K +N++LD+ +K+ADFG+ + H+ T + GTP Y+ PE YQ
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDYIAPEI-IAYQPY 197
Query: 242 DKS-DVFSFGVVLIELISSMPAVD 264
KS D +++GV+L E+++ P D
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFD 221
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 61/301 (20%)
Query: 66 ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
+ LG+G FG V GRA VAVK L EN + + ++E ++L ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
++ LYG S+ LLL+ E+ G++ L R PG A
Sbjct: 88 VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
L + A + + + YL ++HRD+ NIL+ +K++DFGLSR V
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYE 202
Query: 219 VSTAPQGTPGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
+ + + G + ++ L D +SDV+SFGV+L E+++
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------------- 247
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVD 330
L I + L L+ ++ +++ R N E L QC + E D RP D
Sbjct: 248 LGGNPYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 331 V 331
+
Sbjct: 302 I 302
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
F+ R LG G FG VY E + VA+K L+++ ++ VE Q E++I A L H N
Sbjct: 25 FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LY R + L+ E+ G L+ E K I E A AL Y
Sbjct: 85 ILRLYNYFY-DRRRIYLILEYAPRG----ELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
H +IHRD+K N+LL +K+ADFG S P+ GT Y+ PE +
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---GTLDYLPPEMIEGR 196
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRH 268
+K D++ GV+ EL+ P + H
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFESASH 226
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
FD R +G G + V L+ + VK+ N+ + ++ E + + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
LV L+ C SR L V E+++ G + H+ +R LP + E + AL Y
Sbjct: 71 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 125
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
LH II+RD+K +N+LLD+ +K+ D+G+ + L P T GTP Y+ PE
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 182
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
+ D ++ GV++ E+++ DI
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYG 124
LG G FG V GE Q G VAVK L + V + E+ L RH +++ LY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
S + + +V E++S G + D++ K G + ++ + SA+ Y H ++
Sbjct: 79 VISTPT-DFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
HRD+K N+LLD + K+ADFGLS + + G+P Y PE + Y
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRDSCGSPNYAAPEVISGRLYA-GP 190
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
+ D++S GV+L L+ D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 69/280 (24%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKR----VEQFMNEVDILARLR 115
+ F R+LG G FG V+ L + R+ ++R+ + N R +EQ E+++L L
Sbjct: 22 DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ ++ + + +V E G + + + +A+ AL ++ + +AL
Sbjct: 79 HPNIIKIFEVFEDY-HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
Y H+ ++H+D+K NIL + + +K+ DFGL+ LF + ST GT Y+ P
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E + +T K D++S GVV+ L++ + + ++ ++Q KA ++ +
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGC-----------LPFTGTSLEEVQQKATYKEPN 243
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
+ + R +L Q L + + RP VL
Sbjct: 244 YAV------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 66 ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
R +G+G FG V+ G AVA+K V E+F+ E + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
L G + + + ++ E + G + L + +L + + A + ++AL YL +
Sbjct: 75 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
+HRD+ N+L+ CVK+ DFGLSR + + ++ + ++ PE +
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
T SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 68 ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
ELG+ FG VY G L + +AVA+K L + + E+F +E + ARL+H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTRLKIA 168
L G ++ + L +++ + S+G + + L +R AL P + +
Sbjct: 76 CLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHV 219
+ A+ + YL + ++H+D+ T N+L+ + VK++D GL R L N + +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + SD++S+GVVL E+ S
Sbjct: 195 R--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIITLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I A L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINAML 62
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 113
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILAR-LRHK 117
F + +G G FG V + AVK L + K + M+E ++L + ++H
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
LV L+ + + + +L V ++I+ G + HL ER P A E ASAL Y
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGY 154
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE-- 233
LH+ +I++RD+K NILLD+ + + DFGL + ++ H ST GTP Y+ PE
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPA 262
+ Q Y T D + G VL E++ +P
Sbjct: 212 HKQPYDRT--VDWWCLGAVLYEMLYGLPP 238
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F ++G G FG V+ G + + + VA+K + E +E E+ +L++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG + ++ L ++ E++ G+ D L +PG L I E L YLH+
Sbjct: 69 KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
IHRD+K N+LL + VK+ADFG++ + +T GTP ++ PE +
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 181
Query: 241 TDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F ++G G FG V+ G + + + VA+K + E +E E+ +L++ +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG + ++ L ++ E++ G+ D L +PG L I E L YLH+
Sbjct: 89 KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 142
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
IHRD+K N+LL + VK+ADFG++ + +T GTP ++ PE +
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 201
Query: 241 TDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 202 DSKADIWSLGITAIELARGEP 222
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
LG G FG V G+ + G VAVK L + ++ + E+ L RH +++ LY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
S S ++ +V E++S G + D++ K G L ++ + S + Y H ++
Sbjct: 84 VISTPS-DIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
HRD+K N+LLD + K+ADFGLS + + G+P Y PE + Y
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPEVISGRLYA-GP 195
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
+ D++S GV+L L+ D
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + +T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G A+P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53 YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
+ + E+ + +D LG G F V E + + VA+K + + + E M NE+ +
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
L +++H N+V+L L L+ + +S G + D + + G ++ +
Sbjct: 70 LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
A+ YLH I+HRD+K N+L LD + + ++DFGLS++ P V +STA GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTA-CGT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
PGYV PE + D +S GV+ L+ P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 10 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 70 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 124 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 180
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCG 206
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + +G G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D +KVADFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 38/223 (17%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEXSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R + ++
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXX 213
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
+ T G ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53 YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
+ + E+ + +D LG G F V E + + VA+K + + + E M NE+ +
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
L +++H N+V+L L L+ + +S G + D + + G ++ +
Sbjct: 70 LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
A+ YLH I+HRD+K N+L LD + + ++DFGLS++ P V +STA GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTAC-GT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
PGYV PE + D +S GV+ L+ P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53 YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
+ + E+ + +D LG G F V E + + VA+K + + + E M NE+ +
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
L +++H N+V+L L L+ + +S G + D + + G ++ +
Sbjct: 70 LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
A+ YLH I+HRD+K N+L LD + + ++DFGLS++ P V +STA GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTAC-GT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
PGYV PE + D +S GV+ L+ P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 64 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGATWTLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLXGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLAGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFM-----NEVDILA 112
AT+ ++ E+G G +GTVY + G VA+K + N + EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 113 RLR---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
RL H N+V L TSR RE+ LV+E + + ++A P LP T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIK 123
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
+ + L +LHA+ I+HRD+K NIL+ + VK+ADFGL+R++ +
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV--V 181
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
T Y PE D++S G + E+ P
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53 YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
+ + E+ + +D LG G F V E + + VA+K + + + E M NE+ +
Sbjct: 10 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
L +++H N+V+L L L+ + +S G + D + + G ++ +
Sbjct: 70 LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
A+ YLH I+HRD+K N+L LD + + ++DFGLS++ P V +STA GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTA-CGT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
PGYV PE + D +S GV+ L+ P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
AT+ ++ E+G G +GTVY + G VA+K + N + + EV +L RL
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
H N+V L TSR RE+ LV+E + + ++A P LP T +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L +LHA+ I+HRD+K NIL+ + VK+ADFGL+R++ + T
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
Y PE D++S G + E+ P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 68 ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLY 123
ELG G FG+V G + + VA+K L + K E+ M E I+ +L + +V L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G + L+LV E G + L G+R + +P ++ + + + YL +
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQLT 241
+HRD+ N+LL N K++DFGLS+ ++ + +A + + PE + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 242 DKSDVFSFGVVLIELIS 258
+SDV+S+GV + E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 8 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 68 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 121
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 178
Query: 234 YHQCYQLTDKSDVFSFGVVLIELI 257
+ D + GVV+ E++
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMM 202
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 32 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPW 161
+ I++ L +H+N+V+L G CT H +L++ E+ G + + L + K P
Sbjct: 92 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 162 PTR--LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
R L + + A + +L + + IHRDV N+LL N K+ DFGL+R N ++
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 220 STAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE T +SDV+S+G++L E+ S
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F +G G FG V+ G + + + VA+K + E +E E+ +L++ +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP-GALPWPTRLKIAIETASALTYLH 179
YG + S+ L ++ E++ G+ D L RA P T LK E L YLH
Sbjct: 85 KYYGSYLKGSK-LWIIMEYLGGGSALDLL---RAGPFDEFQIATMLK---EILKGLDYLH 137
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
+ IHRD+K N+LL VK+ADFG++ + +T GTP ++ PE Q
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSA 196
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 197 YDSKADIWSLGITAIELAKGEP 218
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N FD + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
YLH+ D+++RD+K N++LD + +K+ DFGL + ++ +T GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ D + GVV+ E++
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPW 161
+ I++ L +H+N+V+L G CT H +L++ E+ G + + L + K P
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 162 PTR--LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
R L + + A + +L + + IHRDV N+LL N K+ DFGL+R N ++
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 220 STAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE T +SDV+S+G++L E+ S
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++L H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 111 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW---P 162
+ I++ L +H+N+V+L G CT H +L++ E+ G + + L R +P L + P
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL--RRKRPPGLEYSYNP 155
Query: 163 TR-----------LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ L + + A + +L + + IHRDV N+LL N K+ DFGL+R
Sbjct: 156 SHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N ++ P ++ PE T +SDV+S+G++L E+ S
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++L H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 97 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + +G G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D +KVADFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
AT+ ++ E+G G +GTVY + G VA+K + N + + EV +L RL
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
H N+V L TSR RE+ LV+E + + ++A P LP T +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L +LHA+ I+HRD+K NIL+ + VK+ADFGL+R++ + T
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
Y PE D++S G + E+ P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + +G G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D +KVADFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 32 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 92 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 149
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 210 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 246
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 29 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 89 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 146
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 207 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 243
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 33 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+ T
Sbjct: 93 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKTPEDLYKDFLTLEHL 150
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
+ + + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 225 GTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 211 RLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN++ L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIIHLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F ++G G FG V+ G + + + VA+K + E +E E+ +L++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG + ++ L ++ E++ G+ D L +PG L I E L YLH+
Sbjct: 84 KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 137
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
IHRD+K N+LL + VK+ADFG++ +L + GTP ++ PE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 195
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 146 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 203
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 264 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +++ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 44 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 27 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 87 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 144
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 205 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 241
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 63 FDSARELGDGGFGTVYYGEL--QDGR--AVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
F R LG G FG+V +L +DG VAVK L + +E+F+ E + H
Sbjct: 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 117 KNLVSLYGCT--SRHSREL---LLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAI 169
++ L G + SR L +++ F+ +G + L R P LP T ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ A + YL + + IHRD+ N +L + V VADFGLSR + QG
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASK 200
Query: 230 VDPEYHQCYQLTDK-----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN 284
+ ++ L D SDV++FGV + E+++ I+N
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR---------------GQTPYAGIEN 245
Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
E+ + +G + + V +L +QC ++ RP
Sbjct: 246 A---EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 25 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTV-------ADHLHGERAKPGA 158
+ I++ L +H+N+V+L G CT H +L++ E+ G + A+ + G PG
Sbjct: 85 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 159 LP--------WPTRLK----IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF 206
P P L+ + + A + +L + + IHRDV N+LL N K+ DF
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 207 GLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
GL+R N ++ P ++ PE T +SDV+S+G++L E+ S
Sbjct: 203 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 33 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 93 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEFSFNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXX 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
+ T G ++ PE + + Y T +SDV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 247
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F ++G G FG V+ G + + + VA+K + E +E E+ +L++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG + ++ L ++ E++ G+ D L +PG L I E L YLH+
Sbjct: 69 KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
IHRD+K N+LL + VK+ADFG++ +L + GTP ++ PE +
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 180
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----------I 167
N+V+L G ++ L+++ EF G ++ +L +R + +P+ K
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKDLYKDFLTLEHLICY 149
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 210 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 241
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----------I 167
N+V+L G ++ L+++ EF G ++ +L +R + +P+ K
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKDLYKDFLTLEHLIXY 149
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 210 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 241
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYENNYKR-VEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ + + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 30 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 90 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 142
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 143 YLHSLDLIYRDLKPENLLIDEQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 198
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYP 223
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 7 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 60
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 61 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 112
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAG 202
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFM-NEVDILA 112
+ E+ F+ LG G F V E + G+ AVK + + K E + NE+ +L
Sbjct: 16 QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLR 75
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
+++H+N+V+L L LV + +S G + D + + G + +
Sbjct: 76 KIKHENIVALEDIY-ESPNHLYLVMQLVSGGELFDRI----VEKGFYTEKDASTLIRQVL 130
Query: 173 SALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
A+ YLH I+HRD+K N+L D + ++DFGLS++ V + GTPGY
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGY 188
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
V PE + D +S GV+ L+ P
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 220
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELIS 258
PE + + + DV+S G+VL +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA 203
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 34 GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------L 165
N+V+L G ++ L+++ EF G ++ +L +R + +P+ +
Sbjct: 94 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKPEDLYKDFLTLEHLI 151
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
+ + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 226 TP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 212 LPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
++F R LG GGFG V+ +++ G+ A K+L + K+ + + M E ILA++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
+ +VSL Y ++ +L LV ++ G + H++ P + + S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+LH +II+RD+K N+LLD++ V+++D GL+ T + GTPG++ PE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
+ D F+ GV L E+I+ A R R E K++NK L + +++Q
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
+ Y
Sbjct: 410 VTY 412
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE L E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
AT+ ++ E+G G +GTVY + G VA+K + N + + EV +L RL
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
H N+V L TSR RE+ LV+E + + ++A P LP T +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L +LHA+ I+HRD+K NIL+ + VK+ADFGL+R++ + T
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
Y PE D++S G + E+ P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 9 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
H+N+V YG H RE L E+ S G + D R +P +P P + +
Sbjct: 63 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 113
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
V PE + + + DV+S G+VL +++
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
++F R LG GGFG V+ +++ G+ A K+L + K+ + + M E ILA++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
+ +VSL Y ++ +L LV ++ G + H++ P + + S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+LH +II+RD+K N+LLD++ V+++D GL+ T + GTPG++ PE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
+ D F+ GV L E+I+ A R R E K++NK L + +++Q
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
+ Y
Sbjct: 410 VTY 412
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G +G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELIS 258
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLA 202
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
++F R LG GGFG V+ +++ G+ A K+L + K+ + + M E ILA++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
+ +VSL Y ++ +L LV ++ G + H++ P + + S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+LH +II+RD+K N+LLD++ V+++D GL+ T + GTPG++ PE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
+ D F+ GV L E+I+ A R R E K++NK L + +++Q
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
+ Y
Sbjct: 410 VTY 412
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69 LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
+G+G FG V ++ DG + A+KR+ E K + F E+++L +L H N+++L
Sbjct: 23 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
G H L L E+ +G + D L R + L L A +
Sbjct: 83 G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
A + YL IHRD+ NIL+ N+ K+ADFGLSR V T + ++
Sbjct: 142 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 199
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
E T SDV+S+GV+L E++S
Sbjct: 200 IESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
F+ + LG GGFG V+ + + D A+KR+ N + E+ M EV LA+L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 121 SLY-GCTSRHSRELLL-----VYEFIS-----NGTVADHLHG-----ERAKPGALPWPTR 164
+ +++ E L VY +I + D ++G ER + L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL----- 121
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-----------SRLFP 213
I ++ A A+ +LH+ ++HRD+K +NI + VKV DFGL + L P
Sbjct: 122 -HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
T GT Y+ PE + K D+FS G++L EL+ + + R R +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPF-STQMERVRTLTD 239
Query: 274 LSNL 277
+ NL
Sbjct: 240 VRNL 243
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 111 VRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
++F R LG GGFG V+ +++ G+ A K+L + K+ + + M E ILA++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
+ +VSL Y ++ +L LV ++ G + H++ P + + S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+LH +II+RD+K N+LLD++ V+++D GL+ T + GTPG++ PE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
+ D F+ GV L E+I+ A R R E K++NK L + +++Q
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
+ Y
Sbjct: 410 VTY 412
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 38 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G +P A + ++ + E
Sbjct: 98 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 150
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 151 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 206
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYP 231
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69 LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
+G+G FG V ++ DG + A+KR+ E K + F E+++L +L H N+++L
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
G H L L E+ +G + D L R + L L A +
Sbjct: 93 G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
A + YL IHRD+ NIL+ N+ K+ADFGLSR V T + ++
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 209
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
E T SDV+S+GV+L E++S
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 53 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 113 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 172 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 275
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 276 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 35/243 (14%)
Query: 63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F+ LG G FG V D R A+K++ + +++ ++EV +LA L H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
Y + L + E+ NGT+ D +H E + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
E AL+Y+H+ IIHRD+K NI +D + VK+ DFGL++ + + Q PG
Sbjct: 127 E---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 229 ------------YVDPE-YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDITRHRHE 271
YV E +K D++S G++ E+I + M V+I +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243
Query: 272 INL 274
+++
Sbjct: 244 VSI 246
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 43 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 103 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 162 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 265
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 266 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 96 VRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 258
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 259 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 64 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G +P A + ++ + E
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 63 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 123 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 182 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 285
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 286 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 14/249 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V+ E + + A+K L ++ VE M E +L+
Sbjct: 20 FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ CT + L V E+++ G + H+ L T A E L +L
Sbjct: 80 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATF--YAAEIILGLQFL 135
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQC 237
H+ I++RD+K +NILLD + +K+ADFG+ + N + T GTP Y+ PE
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 238 YQLTDKSDVFSFGVVLIELI---SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
+ D +SFGV+L E++ S D H I + N + K +L+ +
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 253
Query: 295 LGYESDNKV 303
E + ++
Sbjct: 254 FVREPEKRL 262
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 97 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 29 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 89 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 141
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 142 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEYLAPEIIL 197
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYP 222
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQDG-----RAVAVKRLYENNYKRVEQFMNEVDILARL 114
+ + ++LG G +G V +D RA+ + R + + + EV +L L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLL--CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
H N++ LY R LV E G + D + R K + +K + S
Sbjct: 94 DHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIK---QVLSG 148
Query: 175 LTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
+TYLH +I+HRD+K N+LL++ + +K+ DFGLS +F N GT Y+
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIA 206
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
PE + + +K DV+S GV+L L++ P
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 96 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 258
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 259 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 28 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 88 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 147 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 250
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 251 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 69 LGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSL 122
LG G FGTVY G + DG VA+K L EN + ++ ++E ++A + + L
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
G + +L V + + G + DH+ R + G+ L ++ A ++YL
Sbjct: 85 LGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGS---QDLLNWCMQIAKGMSYLEDVR 139
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
++HRD+ N+L+ + VK+ DFGL+RL T P ++ E + T
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 242 DKSDVFSFGVVLIELIS 258
+SDV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
+ I++ L +H+N+V+L G CT H +L++ E+ G + + L R K L
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAF 154
Query: 166 KIAIETAS-------------ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
IA TAS + +L + + IHRDV N+LL N K+ DFGL+R
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 213 PNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N ++ P ++ PE T +SDV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ ++ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYP 236
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ + S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVAYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLIIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIII 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 137 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 299
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 300 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 67 RELGDGGFGTVYYGELQD---GRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSL 122
R L +GGF VY E QD GR A+KRL N ++ + EV + +L H N+V
Sbjct: 34 RVLAEGGFAFVY--EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 123 YGCTS-------RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
S E LL+ E + G + + L ++ G L T LKI +T A+
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAV 149
Query: 176 TYLH--ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--------- 224
++H IIHRD+K N+LL N +K+ DFG + ++ + +A +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 225 --GTPGYVDPEYHQCYQ---LTDKSDVFSFGVVL 253
TP Y PE Y + +K D+++ G +L
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 111 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQDG--RAVAVKRLYENNYKRVEQFMNEVDILARLRHK 117
+++F+ ELG G VY + Q G + A+K L + K++ + E+ +L RL H
Sbjct: 52 SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHP 108
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHL-----HGERAKPGALPWPTRLKIAIETA 172
N++ L + E+ LV E ++ G + D + + ER A+ +
Sbjct: 109 NIIKLKEIFETPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVK---------QIL 158
Query: 173 SALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
A+ YLH + I+HRD+K N+L + +K+ADFGLS++ + V + GTPGY
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGY 216
Query: 230 VDPEYHQCYQLTDKSDVFSFGVV 252
PE + + D++S G++
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGII 239
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 54 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 114 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG++R + P ++ P
Sbjct: 173 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 276
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 277 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K +E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFGL++ + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 26 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 86 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 143
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 199
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 251
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66 ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E ++ VAVK L ++ K + ++E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
HKN+++L G ++ L ++ + S G + ++L R PG + +
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVGYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ + A + YL + IHRD+ N+L+ N +K+ADFGL+R N + T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 25 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 85 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 142
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 198
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 250
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 22 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 82 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 139
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 195
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 247
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 33 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 93 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 78 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSK 135
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 191
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R +V
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 186
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R +V
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 247 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 282
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G +P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 33 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 93 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 23 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 83 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 236
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 134 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 191
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66 ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
+ LG+G FG V E + R VAVK L + K + ++E++++ + +
Sbjct: 33 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
HKN+++L G ++ L ++ E+ S G + ++L R PG L
Sbjct: 93 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQA-REPPGLEYSYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
+ A + A + YL + IHRD+ N+L+ + +K+ADFGL+R + H+
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
+ T G ++ PE + + Y T +SDV+SFGV+L E+ S P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
++ + R LG G FG V + + G+ AVK + + K+ E + EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY LV E + G + D + + +I + S +
Sbjct: 85 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TY+H + I+HRD+K N+LL++ + +++ DFGLS F + GT Y+ P
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
E H Y +K DV+S GV+L L+S P
Sbjct: 198 EVLHGTYD--EKCDVWSTGVILYILLSGCP 225
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 23 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R +V
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
P ++ PE + + Y T +SDV+SFGV+L E+ S P V I
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
++ + R LG G FG V + + G+ AVK + + K+ E + EV +L +L
Sbjct: 49 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY LV E + G + D + + +I + S +
Sbjct: 109 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 163
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TY+H + I+HRD+K N+LL++ + +++ DFGLS F + GT Y+ P
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 221
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
E H Y +K DV+S GV+L L+S P
Sbjct: 222 EVLHGTYD--EKCDVWSTGVILYILLSGCP 249
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 23 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R +V
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
P ++ PE + + Y T +SDV+SFGV+L E+ S P V I
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 23 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 236
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
++ + R LG G FG V + + G+ AVK + + K+ E + EV +L +L
Sbjct: 48 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY LV E + G + D + + +I + S +
Sbjct: 108 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 162
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TY+H + I+HRD+K N+LL++ + +++ DFGLS F + GT Y+ P
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 220
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
E H Y +K DV+S GV+L L+S P
Sbjct: 221 EVLHGTYD--EKCDVWSTGVILYILLSGCP 248
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVK---RLYENNYKRVEQFMNEVD---ILARLRHKNLVS 121
LG G FGTV+ G + +G ++ + ++ E+ R + F D + L H ++V
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 97
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G S L LV +++ G++ DH+ R GAL L ++ A + YL
Sbjct: 98 LLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
++HR++ N+LL + V+VADFG++ L P + + TP ++ E +
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 241 TDKSDVFSFGVVLIELIS 258
T +SDV+S+GV + EL++
Sbjct: 213 THQSDVWSYGVTVWELMT 230
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 72 GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
G FG V+ +L + VAVK ++ K+ Q EV L ++H+N++ G R +
Sbjct: 35 GRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 132 ---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------- 179
+L L+ F G+++D L K + W IA A L YLH
Sbjct: 93 VDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 180 -ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPEYHQC 237
I HRD+K+ N+LL NN +ADFGL+ F + T Q GT Y+ PE +
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 238 ---YQLTD--KSDVFSFGVVLIELISSMPAVD 264
+Q + D+++ G+VL EL S A D
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 34 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW---PTRL--------- 165
N+V+L G ++ L+++ EF G ++ +L +R + +P+ P L
Sbjct: 94 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKEAPEDLYKDFLTLEH 151
Query: 166 --KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 212 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 247
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ P
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPAIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 61 NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHK 117
+Y+D ELG G FG V+ E GR K + N ++++ NE+ I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
L++L+ E++L+ EF+S G + D + E K ++ A E L +
Sbjct: 109 KLINLHDAFE-DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKH 164
Query: 178 LHASDIIHRDVKTNNILLDNNFC--VKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
+H I+H D+K NI+ + VK+ DFGL ++L P+ + V+TA T + PE
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEI 221
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSM 260
+ +D+++ GV+ L+S +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGL 247
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 68 ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLY 123
ELG G FG+V G + + VA+K L + K E+ M E I+ +L + +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
G + L+LV E G + L G+R + +P ++ + + + YL +
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQLT 241
+HR++ N+LL N K++DFGLS+ ++ + +A + + PE + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 242 DKSDVFSFGVVLIELIS 258
+SDV+S+GV + E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ R LG G FG V + ++ G A+K L + K++E +NE I +
Sbjct: 44 FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D +KVADFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 69 LGDGGFGTVY----YGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLV 120
LG G FG V YG + G + VAVK L E + E M+E+ ++ +L H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAK-------------------PGALP 160
+L G CT S + L++E+ G + ++L +R K L
Sbjct: 113 NLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
+ L A + A + +L +HRD+ N+L+ + VK+ DFGL+R + +V
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 221 TAPQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + Y T KSDV+S+G++L E+ S
Sbjct: 231 RGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFS 269
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
++ + R LG G FG V + + G+ AVK + + K+ E + EV +L +L
Sbjct: 31 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY LV E + G + D + + +I + S +
Sbjct: 91 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 145
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTP 227
TY+H + I+HRD+K N+LL++ + +++ DFGLS TH + + GT
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTA 198
Query: 228 GYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
Y+ PE H Y +K DV+S GV+L L+S P
Sbjct: 199 YYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCP 231
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 14/243 (5%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYG 124
LG G FG V+ E + + A+K L ++ VE M E +L+ ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
CT + L V E+++ G + H+ + L T A E L +LH+ I+
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF--YAAEIILGLQFLHSKGIV 140
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTDK 243
+RD+K +NILLD + +K+ADFG+ + N + T GTP Y+ PE +
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHS 198
Query: 244 SDVFSFGVVLIELI---SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
D +SFGV+L E++ S D H I + N + K +L+ + E +
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPE 258
Query: 301 NKV 303
++
Sbjct: 259 KRL 261
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 46/279 (16%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
LG G +G VY G +L + +A+K + E + + + E+ + L+HKN+V G S
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS---ALTYLHASDII 184
+ + + E + G+++ L R+K G L I T L YLH + I+
Sbjct: 90 ENGF-IKIFMEQVPGGSLSALL---RSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 185 HRDVKTNNILLDN-NFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
HRD+K +N+L++ + +K++DFG S+ N T T GT Y+ PE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE------II 195
Query: 242 DK--------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
DK +D++S G +IE+ + P +E+ A+ K+ +H + +
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELGEPQAAMFKVGMFKVHPEIPE 249
Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
++ E+ +C + + D R D+L
Sbjct: 250 SMSAEA-----------KAFILKCFEPDPDKRACANDLL 277
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVK---RLYENNYKRVEQFMNEVD---ILARLRHKNLVS 121
LG G FGTV+ G + +G ++ + ++ E+ R + F D + L H ++V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 79
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
L G S L LV +++ G++ DH+ R GAL L ++ A + YL
Sbjct: 80 LLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
++HR++ N+LL + V+VADFG++ L P + + TP ++ E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 241 TDKSDVFSFGVVLIELIS 258
T +SDV+S+GV + EL++
Sbjct: 195 THQSDVWSYGVTVWELMT 212
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 36 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 96 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 148
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 204
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYP 229
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63 FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
+D + LG+G G V +L R AVAVK + + KR E E+ I L
Sbjct: 8 WDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
H+N+V YG H RE + Y E+ S G + D + + +P P + +
Sbjct: 62 NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
+ + YLH I HRD+K N+LLD +K++DFGL+ +F N+ + GT YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
PE + + + DV+S G+VL +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69 LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
LG G FG V + Q AV V K + EV++L +L H N++ L+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
S +V E + G + D + K +I + S +TY+H +I+H
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
RD+K NILL++ + +K+ DFGLS F + GT Y+ PE + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
K DV+S GV+L L+S P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
F +G G FG VY G + VA+K + E +E E+ +L++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
+G + S +L ++ E++ G+ D L KPG L I E L YLH+
Sbjct: 81 RYFGSYLK-STKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 134
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
IHRD+K N+LL VK+ADFG++ +L + GTP ++ PE +
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
K+D++S G+ IEL P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67 RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
R LG G FG VY G++ VAVK L E ++ E F+ E I+++ H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
V G S S ++ E ++ G + L R ++P +L L +A + A
Sbjct: 97 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
YL + IHRD+ N LL K+ DFG+++ + P ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
E T K+D +SFGV+L E+ S L + N+ + E V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
T G D + V + QC Q + + RP +L+ + D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66 ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
+ LG G FG V +G + R VAVK L E + M+E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
N+V+L G ++ L+++ EF G ++ +L +R + +P+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + + A + +L + IHRD+ NILL VK+ DFGL+R V
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
P ++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 64 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G ++P A + ++ + E
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69 LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
+G+G FG V ++ DG + A+KR+ E K + F E+++L +L H N+++L
Sbjct: 30 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
G H L L E+ +G + D L R + L L A +
Sbjct: 90 G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
A + YL IHR++ NIL+ N+ K+ADFGLSR V T + ++
Sbjct: 149 ARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 206
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
E T SDV+S+GV+L E++S
Sbjct: 207 IESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K +E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D ++V DFGL++ + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G +P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
+ E N + LG G FG V G+ VAVK L + E M+E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
+ I++ L +H+N+V+L G CT H +L++ E+ G + + L R K L
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAF 154
Query: 166 KIAIET-------------ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
IA T A + +L + + IHRDV N+LL N K+ DFGL+R
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 213 PNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N ++ P ++ PE T +SDV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 46/279 (16%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
LG G +G VY G +L + +A+K + E + + + E+ + L+HKN+V G S
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS---ALTYLHASDII 184
+ + + E + G+++ L R+K G L I T L YLH + I+
Sbjct: 76 ENGF-IKIFMEQVPGGSLSALL---RSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 185 HRDVKTNNILLDN-NFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
HRD+K +N+L++ + +K++DFG S+ N T T GT Y+ PE +
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE------II 181
Query: 242 DK--------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
DK +D++S G +IE+ + P +E+ A+ K+ +H + +
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELGEPQAAMFKVGMFKVHPEIPE 235
Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
++ E+ +C + + D R D+L
Sbjct: 236 SMSAEA-----------KAFILKCFEPDPDKRACANDLL 263
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 36 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E++ G + HL G +P A + ++ + E
Sbjct: 96 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 148
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP Y+ PE
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 204
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYP 229
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
++ LG GGFG V QD G VA+K+ E + K E++ E+ I+ +L H N+V
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 121 SLY----GCTSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
S G +L LL E+ G + +L+ G P R ++ + +SAL
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 176 TYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
YLH + IIHRD+K NI+L K+ D G ++ + T GT Y+ P
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAP 192
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
E + + T D +SFG + E I+
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECIT 218
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
++ LG GGFG V QD G VA+K+ E + K E++ E+ I+ +L H N+V
Sbjct: 17 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 121 SLY----GCTSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
S G +L LL E+ G + +L+ G P R ++ + +SAL
Sbjct: 77 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 176 TYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
YLH + IIHRD+K NI+L K+ D G ++ + T GT Y+ P
Sbjct: 136 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAP 193
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
E + + T D +SFG + E I+
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECIT 219
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
FD + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+++ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+L+D ++V DFG F V + GTP + PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEALAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 43 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D ++V DFG F V + GTP Y+ PE
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69 LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
LG G FG V + Q AV V K + EV++L +L H N++ L+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
S +V E + G + D + K +I + S +TY+H +I+H
Sbjct: 90 LE-DSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDNNF--C-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
RD+K NILL++ C +K+ DFGLS F + GT Y+ PE + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
K DV+S GV+L L+S P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V + ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
LV L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 66 ARELGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSL 122
+++G G +G V+ G+ + G VAVK + E ++ R + V +RH+N++
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTV----LMRHENILGF 96
Query: 123 YGCTSRHS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
+ + +L L+ ++ NG++ D+L K L + LK+A + S L +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 180 AS--------DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPG 228
I HRD+K+ NIL+ N +AD GL+ F + V P GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 229 YVDPE---------YHQCYQLTDKSDVFSFGVVLIEL 256
Y+ PE + Q Y + +D++SFG++L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIM---ADMYSFGLILWEV 245
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
L L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
L L + + + L +V E+ G + HL G ++P A + ++ + E
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69 LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
LG G FG V + Q AV V K + EV++L +L H N++ L+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
S +V E + G + D + K +I + S +TY+H +I+H
Sbjct: 90 LE-DSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDNNF--C-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
RD+K NILL++ C +K+ DFGLS F + GT Y+ PE + +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
K DV+S GV+L L+S P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
GEL++ + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 20 GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 77
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 78 HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 132
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 189
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
PE Q + +SD++S G+ L+E+
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEM 215
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 18/237 (7%)
Query: 28 NTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTV-YYGELQDGR 86
TSS P +D K G Q F E + + ELG G +G V + G+
Sbjct: 24 QTSSTPPRDLD-SKACISIGNQNF-----EVKADDLEPIMELGRGAYGVVEKMRHVPSGQ 77
Query: 87 AVAVKRLYEN-NYKRVEQFMNEVDILAR-LRHKNLVSLYGCTSRHSRELLLVYEFISNGT 144
+AVKR+ N + ++ + ++DI R + V+ YG R ++ + E + T
Sbjct: 78 IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWICMELMD--T 134
Query: 145 VADHLHGERAKPG-ALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVK 202
D + + G +P KIA+ AL +LH+ +IHRDVK +N+L++ VK
Sbjct: 135 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 194
Query: 203 VADFGLSRLFPNHVTHVSTA---PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
+ DFG+S + V A P P ++PE +Q + KSD++S G+ +IEL
Sbjct: 195 MCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ-KGYSVKSDIWSLGITMIEL 250
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 69 LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
LG G FG V E + + AVK L ++ + VE M E +LA + L L+
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
C R L V E+++ G + H+ + G P + A E A L +L + I
Sbjct: 88 SCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTD 242
I+RD+K +N++LD+ +K+ADFG+ + N V+T GTP Y+ PE YQ
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 199
Query: 243 KS-DVFSFGVVLIELISS 259
KS D ++FGV+L E+++
Sbjct: 200 KSVDWWAFGVLLYEMLAG 217
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
GEL++ + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 28 GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 86 HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 140
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 197
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
PE Q + +SD++S G+ L+E+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEM 223
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
GEL++ + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 63 GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 120
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 121 HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 175
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 232
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
PE Q + +SD++S G+ L+E+
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEM 258
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
++ + R LG G FG V + + G+ AVK + + K+ E + EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N+ LY LV E + G + D + + +I + S +
Sbjct: 85 HPNIXKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TY H + I+HRD+K N+LL++ + +++ DFGLS F + GT Y+ P
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAP 197
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
E H Y +K DV+S GV+L L+S P
Sbjct: 198 EVLHGTYD--EKCDVWSTGVILYILLSGCP 225
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 35/243 (14%)
Query: 63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F+ LG G FG V D R A+K++ + +++ ++EV +LA L H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
Y + L + E+ N T+ D +H E + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
E AL+Y+H+ IIHRD+K NI +D + VK+ DFGL++ + + Q PG
Sbjct: 127 E---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 229 ------------YVDPE-YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDITRHRHE 271
YV E +K D++S G++ E+I + M V+I +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243
Query: 272 INL 274
+++
Sbjct: 244 VSI 246
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 63 FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
F+ + LG G FG V ++ G A+K L + K++E +NE IL +
Sbjct: 44 FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
L L + + + L +V E+ G + HL G +P A + ++ + E
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
YLH+ D+I+RD+K N+++D +KV DFG F V + GTP Y+ PE
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
D ++ GV++ E+ + P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEV 108
+ GEL++ + F+ ELG G G V+ + V ++L K Q + E+
Sbjct: 1 MALGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
+L +V YG E+ + E + G++ L K G +P K++
Sbjct: 59 QVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVS 113
Query: 169 IETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
I LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ GT
Sbjct: 114 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTR 170
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
Y+ PE Q + +SD++S G+ L+E+
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEM 199
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+G G +G V+ G Q G VAVK E ++ R + N V LRH+N++
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
TSRHS +L L+ + G++ D+L + L + L+I + AS L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
I HRD+K+ NIL+ N +AD GL+ + V P+ GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
PE C+ + D+++FG+VL E+ M
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+G G +G V+ G Q G VAVK E ++ R + N V LRH+N++
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
TSRHS +L L+ + G++ D+L + L + L+I + AS L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
I HRD+K+ NIL+ N +AD GL+ + V P+ GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
PE C+ + D+++FG+VL E+ M
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 120
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 232
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 120
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 232
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 69 LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
LG G FG V E + + AVK L ++ + VE M E +LA + L L+
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
C R L V E+++ G + H+ + G P + A E A L +L + I
Sbjct: 409 SCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTD 242
I+RD+K +N++LD+ +K+ADFG+ + N V+T GTP Y+ PE YQ
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 520
Query: 243 KS-DVFSFGVVLIELISS 259
KS D ++FGV+L E+++
Sbjct: 521 KSVDWWAFGVLLYEMLAG 538
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 56 LEEATNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILAR 113
+E + + ELG G +G V + G+ +AVKR+ N + ++ + ++DI R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 114 -LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIET 171
+ V+ YG R ++ + E + T D + + G +P KIA+
Sbjct: 62 TVDCPFTVTFYGALFREG-DVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH---VSTAPQGTP 227
AL +LH+ +IHRDVK +N+L++ VK+ DFG+S + V P P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
++PE +Q + KSD++S G+ +IEL
Sbjct: 179 ERINPELNQ-KGYSVKSDIWSLGITMIEL 206
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
+E + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 61 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
E Q + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
+E + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 61 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
E Q + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
L A ++ E+G+G +G V+ +L++G R VA+KR+ + + EV +L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L H N+V L+ CT SR RE L LV+E + + ++ +P T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETI 122
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
+ + L +LH+ ++HRD+K NIL+ ++ +K+ADFGL+R++ + S
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 180
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
T Y PE D++S G + E+ P
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
L A ++ E+G+G +G V+ +L++G R VA+KR+ + + EV +L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNG--TVADHLHGERAKPGALPWP 162
L H N+V L+ CT SR RE L LV+E + T D + +PG +P
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPG-VPTE 120
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
T + + L +LH+ ++HRD+K NIL+ ++ +K+ADFGL+R++ + S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
T Y PE D++S G + E+ P
Sbjct: 181 --VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
+E + F+ ELG G G V+ + V ++L K Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+V YG E+ + E + G++ L K G +P K++I
Sbjct: 61 CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
LTYL I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
E Q + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
F+ ELG G G V+ + V ++L K Q + E+ +L +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG E+ + E + G++ L K G +P K++I LTYL
Sbjct: 68 GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+ PE Q
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 240 LTDKSDVFSFGVVLIEL 256
+ +SD++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+G G +G V+ G Q G VAVK E ++ R + N V LRH+N++
Sbjct: 45 VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 99
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
TSRHS +L L+ + G++ D+L + L + L+I + AS L +LH
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
I HRD+K+ NIL+ N +AD GL+ + V P+ GT Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
PE C+ + D+++FG+VL E+ M
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKNLVSLYG 124
LG+G FG V + + VA+K + K+ + M E+ L LRH +++ LY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
+ + ++++V E+ + G + D++ + + + + A+ Y H I+
Sbjct: 77 VITTPT-DIVMVIEY-AGGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
HRD+K N+LLD+N VK+ADFGLS + + + G+P Y PE + Y
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVINGKLYA-GP 187
Query: 243 KSDVFSFGVVL-IELISSMPAVD 264
+ DV+S G+VL + L+ +P D
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDD 210
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
F+ ELG G G V+ + V ++L K Q + E+ +L +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
YG E+ + E + G++ L K G +P K++I LTYL
Sbjct: 68 GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
I+HRDVK +NIL+++ +K+ DFG+S + ++ + GT Y+ PE Q
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 240 LTDKSDVFSFGVVLIEL 256
+ +SD++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 69 LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
LG G FG V+ E G +A K + K E+ NE+ ++ +L H NL+ LY
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
+ +++LV E++ G + D + E L +K + + ++H I+H D
Sbjct: 157 SKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212
Query: 188 VKTNNILLDNNFC--VKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
+K NIL N +K+ DFGL+R + P V+ GTP ++ PE ++ +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPT 269
Query: 245 DVFSFGVVLIELISSM 260
D++S GV+ L+S +
Sbjct: 270 DMWSVGVIAYMLLSGL 285
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
L A ++ E+G+G +G V+ +L++G R VA+KR+ + + EV +L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L H N+V L+ CT SR RE L LV+E + + ++ +P T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETI 122
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
+ + L +LH+ ++HRD+K NIL+ ++ +K+ADFGL+R++ + S
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 180
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
T Y PE D++S G + E+ P
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13 RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
R + + S + S+ S KV +K G+ V + G+ + +Y D+ + +
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 62
Query: 70 GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L H N+V L Y
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+ L LV +++ H RAK LP + +L Y+H+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
I HRD+K N+LLD + V K+ DFG ++ +VS Y+ Y++ +L
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 228
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
T DV+S G VL EL+ P
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQP 255
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13 RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
R + + S + S+ S KV +K G+ V + G+ + +Y D+ + +
Sbjct: 6 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 64
Query: 70 GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L H N+V L Y
Sbjct: 65 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+ L LV +++ H RAK LP + +L Y+H+
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
I HRD+K N+LLD + V K+ DFG ++ +VS Y+ Y++ +L
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 230
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
T DV+S G VL EL+ P
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQP 257
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 88 VAVKRLYENNYKRV-EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTV 145
V +RL + V E E IL ++ H ++++L + S + LV++ + G +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGEL 187
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD 205
D+L + AL I A+++LHA++I+HRD+K NILLD+N ++++D
Sbjct: 188 FDYL----TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 206 FGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQ------LTDKSDVFSFGVVLI 254
FG S H+ + GTPGY+ PE +C + D+++ GV+L
Sbjct: 244 FGFS-------CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 255 ELISSMPAVDITRHRHEI 272
L++ P HR +I
Sbjct: 297 TLLAGSPPF---WHRRQI 311
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
E +Y+D+ ELG G F V LQ KR +++ + V E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL ++H N+++L+ + +++L+ E ++ G + D L A+ +L +
Sbjct: 67 ILKEIQHPNVITLHEVYENKT-DVILIGELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
+ + + YLH+ I H D+K NI LLD N +K+ DFGL+ F N ++
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13 RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
R + + S + S+ S KV +K G+ V + G+ + +Y D+ + +
Sbjct: 8 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 66
Query: 70 GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L H N+V L Y
Sbjct: 67 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+ L LV +++ H RAK LP + +L Y+H+
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
I HRD+K N+LLD + V K+ DFG ++ +VS Y+ Y++ +L
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 232
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
T DV+S G VL EL+ P
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQP 259
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13 RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
R + + S + S+ S KV +K G+ V + G+ + +Y D+ + +
Sbjct: 49 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 107
Query: 70 GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L H N+V L Y
Sbjct: 108 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+ L LV +++ H RAK LP + +L Y+H+
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
I HRD+K N+LLD + V K+ DFG ++ +VS Y+ Y++ +L
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 273
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
T DV+S G VL EL+ P
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQP 300
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
+G G +G V+ G L G +VAVK E ++ R + N V LRH N++
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-- 180
TSR+S +L L+ + +G++ D L + +P L++A+ A L +LH
Sbjct: 71 DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH-----LALRLAVSAACGLAHLHVEI 125
Query: 181 ------SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
I HRD K+ N+L+ +N +AD GL+ + + + P+ GT Y+
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 232 PEY------HQCYQLTDKSDVFSFGVVLIEL 256
PE C++ +D+++FG+VL E+
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
F+ + LG G FG V+ + G + A+K L + K RV M E DIL +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
H +V L+ + L L+ +F+ G + L E + +K + E A A
Sbjct: 85 HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
L +LH+ II+RD+K NILLD +K+ DFGLS+ + H A GT Y+ P
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E T +D +SFGV++ E+++
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/246 (29%), Positives = 115/246 (46%), Gaps = 33/246 (13%)
Query: 34 SSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVA 89
S KV +K G+ V + G+ + +Y D+ + +G+G FG VY +L D G VA
Sbjct: 19 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVA 77
Query: 90 VKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNG 143
+K++ ++ ++F N E+ I+ +L H N+V L Y + L LV +++
Sbjct: 78 IKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 132
Query: 144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-K 202
H RAK LP + +L Y+H+ I HRD+K N+LLD + V K
Sbjct: 133 VYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 191
Query: 203 VADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIE 255
+ DFG ++ +VS Y+ Y++ +L T DV+S G VL E
Sbjct: 192 LCDFGSAKQLVRGEPNVS--------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 256 LISSMP 261
L+ P
Sbjct: 244 LLLGQP 249
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
F+ + LG G FG V+ + G + A+K L + K RV M E DIL +
Sbjct: 27 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
H +V L+ + L L+ +F+ G + L E + +K + E A A
Sbjct: 86 HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 139
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
L +LH+ II+RD+K NILLD +K+ DFGLS+ + H A GT Y+ P
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 196
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E T +D +SFGV++ E+++
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTG 223
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 12/223 (5%)
Query: 59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRH 116
+++ F +LG+G + TVY G G VA+K + ++ + E+ ++ L+H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA----IETA 172
+N+V LY ++ L LV+EF+ N + + G P L + +
Sbjct: 63 ENIVRLYDVIHTENK-LTLVFEFMDNDLKK---YMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
L + H + I+HRD+K N+L++ +K+ DFGL+R F V S+ T Y P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTLWYRAP 177
Query: 233 EYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
+ + S D++S G +L E+I+ P T ++ L
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
F+ + LG G FG V+ + G + A+K L + K RV M E DIL +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
H +V L+ + L L+ +F+ G + L E + +K + E A A
Sbjct: 85 HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
L +LH+ II+RD+K NILLD +K+ DFGLS+ + H A GT Y+ P
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E T +D +SFGV++ E+++
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLR-HKN 118
++ ++LG G +G V+ + + G VAVK++++ N ++ E+ IL L H+N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 119 LVSLYGCT-SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
+V+L + + R++ LV++++ LH + L + + + + Y
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETD-----LHAV-IRANILEPVHKQYVVYQLIKVIKY 124
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT----------- 226
LH+ ++HRD+K +NILL+ VKVADFGLSR F N + P
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 227 ---PGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
YV +++ ++ T D++S G +L E++ P
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/246 (30%), Positives = 116/246 (47%), Gaps = 35/246 (14%)
Query: 35 SKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAV 90
SKV +K G+ V + G+ + +Y D+ + +G+G FG VY +L D G VA+
Sbjct: 4 SKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAI 62
Query: 91 KRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGT 144
K++ ++ ++F N E+ I+ +L H N+V L Y + L LV +++
Sbjct: 63 KKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 117
Query: 145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KV 203
H RAK LP + +L Y+H+ I HRD+K N+LLD + V K+
Sbjct: 118 YRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 176
Query: 204 ADFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIE 255
DFG L R PN V+ + + AP+ G D T DV+S G VL E
Sbjct: 177 CDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAE 227
Query: 256 LISSMP 261
L+ P
Sbjct: 228 LLLGQP 233
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 57 EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-KRVEQFMNEVDILARL 114
+E Y++ +G GGF V + G VA+K + +N + + E++ L L
Sbjct: 6 DELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNL 65
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
RH+++ LY + ++ +V E+ G + D++ + TR+ + + SA
Sbjct: 66 RHQHICQLYHVLET-ANKIFMVLEYCPGGELFDYIISQDRLSEE---ETRV-VFRQIVSA 120
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPE 233
+ Y+H+ HRD+K N+L D +K+ DFGL ++ N H+ T G+ Y PE
Sbjct: 121 VAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTC-CGSLAYAAPE 179
Query: 234 YHQCYQ-LTDKSDVFSFGVVLIELISSMPAVD 264
Q L ++DV+S G++L L+ D
Sbjct: 180 LIQGKSYLGSEADVWSMGILLYVLMCGFLPFD 211
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 83 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 136
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 33 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 93 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 146
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 33 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 93 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 146
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 31 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 91 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 35/268 (13%)
Query: 13 RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
R + + S + S+ S KV +K G+ V + G+ + +Y D+ + +
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 62
Query: 70 GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L H N+V L Y
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+ L LV +++ H RAK LP + +L Y+H+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST----APQGTPGYVDPE 233
I HRD+K N+LLD + V K+ DFG L R PN V+ + + AP+ G D
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD-- 233
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMP 261
T DV+S G VL EL+ P
Sbjct: 234 ------YTSSIDVWSAGCVLAELLLGQP 255
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 11 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 71 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 124
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 17 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 77 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 35/247 (14%)
Query: 34 SSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVA 89
S KV +K G+ V + G+ + +Y D+ + +G+G FG VY +L D G VA
Sbjct: 3 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVA 61
Query: 90 VKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNG 143
+K++ ++ ++F N E+ I+ +L H N+V L Y + L LV +++
Sbjct: 62 IKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 116
Query: 144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-K 202
H RAK LP + +L Y+H+ I HRD+K N+LLD + V K
Sbjct: 117 VYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 175
Query: 203 VADFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLI 254
+ DFG L R PN V+ + + AP+ G D T DV+S G VL
Sbjct: 176 LCDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLA 226
Query: 255 ELISSMP 261
EL+ P
Sbjct: 227 ELLLGQP 233
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 73 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 126
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
++G+G +G VY + G A+K RL + + + E+ IL L+H N+V LY
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
R L+LV+E HL + K G L T ++ + + Y H
Sbjct: 69 IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
++HRD+K N+L++ +K+ADFGL+R F V T T Y P+ +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ D++S G + E+++ P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
++G+G +G VY + G A+K RL + + + E+ IL L+H N+V LY
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
R L+LV+E HL + K G L T ++ + + Y H
Sbjct: 69 IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
++HRD+K N+L++ +K+ADFGL+R F V T T Y P+ +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ D++S G + E+++ P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAP 199
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68 ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
++G+G +G VY + G A+K RL + + + E+ IL L+H N+V LY
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
R L+LV+E HL + K G L T ++ + + Y H
Sbjct: 69 IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
++HRD+K N+L++ +K+ADFGL+R F V T T Y P+ +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
+ D++S G + E+++ P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 17 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 77 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + T + + PE Y+
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 72 GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
G FG V+ +L + VAVK ++ K+ Q E+ ++H+NL+ R S
Sbjct: 26 GRFGCVWKAQLMND-FVAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 132 ---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------- 179
EL L+ F G++ D+L G + W +A + L+YLH
Sbjct: 84 LEVELWLITAFHDKGSLTDYLKG-----NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 180 --ASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
I HRD K+ N+LL ++ +ADFGL+ R P + GT Y+ PE +
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 237 C---YQLTD--KSDVFSFGVVLIELISSMPAVD 264
+Q + D+++ G+VL EL+S A D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V L ++ L LV+EF+S + D + +P P + L + H
Sbjct: 68 VKLLDVIHTENK-LYLVFEFLSMD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 123
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE C
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 181
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
+ D++S G + E+++
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT 202
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V L ++ L LV+EF+S + D + +P P + L + H
Sbjct: 67 VKLLDVIHTENK-LYLVFEFLSMD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 122
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE C
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 180
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
+ D++S G + E+++
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT 201
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 78 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 132
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
++ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F+ LG G FG V D R A+K++ + +++ ++EV +LA L H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
Y + L + E+ N T+ D +H E + + +
Sbjct: 67 YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL--------------SRLFPNH 215
E AL+Y+H+ IIHR++K NI +D + VK+ DFGL S+ P
Sbjct: 127 E---ALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 216 VTHVSTAPQGTPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELI 257
++++A GT YV E +K D +S G++ E I
Sbjct: 184 SDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 80 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 78 PHVCRLLGICLTSTVQLIM--QLMPFGXLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 132
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMETFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 CREEIEREVSILRQVLHPNIITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
V + GTP +V PE L ++D++S GV+ L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 31 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 84
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 85 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 143
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+L Y+H+ I HRD+K N+LLD + V K+ DFG ++ +VS Y
Sbjct: 144 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 195
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
+ Y++ +L T DV+S G VL EL+ P
Sbjct: 196 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 79 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 81 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 135
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 23 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 76
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 77 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+L Y+H+ I HRD+K N+LLD + V K+ DFG ++ +VS Y
Sbjct: 136 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 187
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
+ Y++ +L T DV+S G VL EL+ P
Sbjct: 188 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 54 GELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDI 110
G L + N F ++G+G +G VY + G VA+K RL + E+ +
Sbjct: 1 GPLVDMEN-FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 59
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLK 166
L L H N+V L ++ L LV+EF+ A L G +P P
Sbjct: 60 LKELNHPNIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKS 111
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
+ L + H+ ++HRD+K N+L++ +K+ADFGL+R F V T T
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVT 170
Query: 227 PGYVDPE-YHQCYQLTDKSDVFSFGVVLIELIS 258
Y PE C + D++S G + E+++
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+++ +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 435 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 488
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 35/245 (14%)
Query: 36 KVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVK 91
KV +K G+ V + G+ + +Y D+ + +G+G FG VY +L D G VA+K
Sbjct: 1 KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIK 59
Query: 92 RLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGTV 145
++ ++ ++F N E+ I+ +L H N+V L Y + L LV +++
Sbjct: 60 KVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 114
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KVA 204
H RAK LP + +L Y+H+ I HRD+K N+LLD + V K+
Sbjct: 115 RVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 173
Query: 205 DFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
DFG L R PN V+ + + AP+ G D T DV+S G VL EL
Sbjct: 174 DFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAEL 224
Query: 257 ISSMP 261
+ P
Sbjct: 225 LLGQP 229
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 35/245 (14%)
Query: 36 KVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVK 91
KV +K G+ V + G+ + +Y D+ + +G+G FG VY +L D G VA+K
Sbjct: 12 KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIK 70
Query: 92 RLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGTV 145
++ ++ ++F N E+ I+ +L H N+V L Y + L LV +++
Sbjct: 71 KVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 125
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KVA 204
H RAK LP + +L Y+H+ I HRD+K N+LLD + V K+
Sbjct: 126 RVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 184
Query: 205 DFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
DFG L R PN V+ + + AP+ G D T DV+S G VL EL
Sbjct: 185 DFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAEL 235
Query: 257 ISSMP 261
+ P
Sbjct: 236 LLGQP 240
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N F+ + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 211 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 264
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
YLH+ ++++RD+K N++LD + +K+ DFGL + + T GTP Y+ PE
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 323
Query: 235 HQCYQLTDKSDVFSFGVVLIELI 257
+ D + GVV+ E++
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMM 346
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 123
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 66 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 176
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67 RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
+ELG G FGTV G Q AV + + N+ ++ + E +++ +L + +V
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+ G S +LV E G + +L R +++ + + + YL S
Sbjct: 436 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 489
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
+ +HRD+ N+LL K++DFGLS+ + G + PE Y+
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 240 LTDKSDVFSFGVVLIELIS 258
+ KSDV+SFGV++ E S
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 64 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 64 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 75 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 129
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N F+ + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 208 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 261
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
YLH+ ++++RD+K N++LD + +K+ DFGL + + T GTP Y+ PE
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 235 HQCYQLTDKSDVFSFGVVLIELI 257
+ D + GVV+ E++
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMM 343
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 37 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 95 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 149
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 72 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 126
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 162
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
+G G FG V+ G+ + G VAVK ++ + +R E+ LRH+N++ ++
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
+ +L LV ++ +G++ D+L+ + +K+A+ TAS L +LH
Sbjct: 70 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 124
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
I HRD+K+ NIL+ N +AD GL+ + + AP GT Y+ PE
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
+ ++ ++D+++ G+V E+
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-----EVDILARLRHKNLVSL 122
LG+G F TVY ++ + VA+K++ + + +N E+ +L L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 123 YGCTSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKI-AIETASALTYL 178
H + LV++F+ + D+ + P+ +K + T L YL
Sbjct: 78 LDAFG-HKSNISLVFDFMETDLEVIIKDN--------SLVLTPSHIKAYMLMTLQGLEYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEYHQ 236
H I+HRD+K NN+LLD N +K+ADFGL++ F PN T Y PE
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV---TRWYRAPELLF 185
Query: 237 CYQLTDKS-DVFSFGVVLIELISSMP 261
++ D+++ G +L EL+ +P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVP 211
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 68 ELGDGGFGTV-YYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRH-KNLVSLYG 124
E+G G +G+V G+ +AVKR+ + K +Q + ++D++ R +V YG
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DI 183
R + + E +S + + +P KI + T AL +L + I
Sbjct: 89 ALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA---PQGTPGYVDPEY-HQCYQ 239
IHRD+K +NILLD + +K+ DFG+S + + A P P +DP Q Y
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 240 LTDKSDVFSFGVVLIEL 256
+ +SDV+S G+ L EL
Sbjct: 208 V--RSDVWSLGITLYEL 222
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 75/261 (28%), Positives = 107/261 (40%), Gaps = 51/261 (19%)
Query: 51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN-----NYKRVEQF 104
F G L E + +G G +G V RA+ A+K + +N N K VE+
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 105 MNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH-------GERA--- 154
EV ++ +L H N+ LY + + LV E G + D L+ G+ A
Sbjct: 76 KTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 155 -KPGALPWPTRLKIAI-------------------------ETASALTYLHASDIIHRDV 188
K P P + AI + SAL YLH I HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 189 KTNNILLDNN--FCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYHQCYQLT-- 241
K N L N F +K+ DFGLS+ F N + T GTP +V PE +
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 242 DKSDVFSFGVVL-IELISSMP 261
K D +S GV+L + L+ ++P
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVP 275
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 72 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 182
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT 206
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
+ + LG+G FG V G+ VA+K + + + + + E+ L LRH +
Sbjct: 16 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
++ LY + E+++V E+ N D + + A+ + + S
Sbjct: 76 IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 124
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
A+ Y H I+HRD+K N+LLD + VK+ADFGLS + + + G+P Y PE
Sbjct: 125 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 182
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
+ Y + DV+S GV+L + L +P D
Sbjct: 183 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 215
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
+ + LG+G FG V G+ VA+K + + + + + E+ L LRH +
Sbjct: 6 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
++ LY + E+++V E+ N D + + A+ + + S
Sbjct: 66 IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 114
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
A+ Y H I+HRD+K N+LLD + VK+ADFGLS + + + G+P Y PE
Sbjct: 115 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 172
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
+ Y + DV+S GV+L + L +P D
Sbjct: 173 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 205
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
+ + LG+G FG V G+ VA+K + + + + + E+ L LRH +
Sbjct: 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
++ LY + E+++V E+ N D + + A+ + + S
Sbjct: 75 IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 123
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
A+ Y H I+HRD+K N+LLD + VK+ADFGLS + + + G+P Y PE
Sbjct: 124 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 181
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
+ Y + DV+S GV+L + L +P D
Sbjct: 182 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 214
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 61 NYFDSARELGDGGFGTVYY----GELQDGRAVAVKRLYENNYK---RVEQFMNEVDILAR 113
++F+ + LG G FG V+ G A+K L + K RV M E DILA
Sbjct: 28 SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILAD 86
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETA 172
+ H +V L+ + L L+ +F+ G + L E + +K + E A
Sbjct: 87 VNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELA 140
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
L +LH+ II+RD+K NILLD +K+ DFGLS+ +H + GT Y+ P
Sbjct: 141 LGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF-CGTVEYMAP 199
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS-SMP 261
E + +D +S+GV++ E+++ S+P
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL--YGCTSRHSRELL---LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L + +S ++++ LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
V + GTP +V PE L ++D++S GV+ L+S + P + T+ N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
++++
Sbjct: 231 TSVS 234
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
+ + LG+G FG V G+ VA+K + + + + + E+ L LRH +
Sbjct: 10 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
++ LY + E+++V E+ N D + + A+ + + S
Sbjct: 70 IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 118
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
A+ Y H I+HRD+K N+LLD + VK+ADFGLS + + + G+P Y PE
Sbjct: 119 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 176
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
+ Y + DV+S GV+L + L +P D
Sbjct: 177 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 209
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQ-----FMNEVDILARLR 115
++F+ R +G G FG V + D + + + Y N K VE+ E+ I+ L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H LV+L+ + + ++ +V + + G + HL + T E AL
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMAL 128
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
YL IIHRD+K +NILLD + V + DF ++ + P T ++T GT Y+ PE
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTM-AGTKPYMAPEMF 186
Query: 236 QCYQLTDKS---DVFSFGVVLIELI 257
+ S D +S GV EL+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELL 211
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLV 120
+ ++G+G +G VY + GR VA+KR L + + E+ +L L H N+V
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 121 SLYGCTSRHS-RELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAI-ETASALT 176
SL HS R L LV+EF+ V D K G +++KI + + +
Sbjct: 83 SLIDVI--HSERCLTLVFEFMEKDLKKVLDE-----NKTGLQD--SQIKIYLYQLLRGVA 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YH 235
+ H I+HRD+K N+L++++ +K+ADFGL+R F V T T Y P+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVVTLWYRAPDVLM 192
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
+ + D++S G + E+I+ P
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKP 218
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 27 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 87 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 141
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 142 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 202 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 25/238 (10%)
Query: 57 EEATNYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVD 109
E+ ++++ ELG G F V G ++ A +K+ ++ +R E+ EV+
Sbjct: 8 EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
IL +RH N+++L+ + +++L+ E +S G + D L A+ +L +
Sbjct: 68 ILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLK 122
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAP 223
+ + YLH+ I H D+K NI LLD N +K+ DFG++ N ++
Sbjct: 123 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 179
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
GTP +V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 234
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 61 NYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+++D ELG G FG V+ E G A K + + E E+ ++ LRH L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V+L+ E++++YEF+S G + + + E K + ++ + L ++H
Sbjct: 111 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 166
Query: 180 ASDIIHRDVKTNNILLDNNFC--VKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
++ +H D+K NI+ +K+ DFGL+ L P V+T GT + PE +
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
+ +D++S GV+ L+S +
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGL 247
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
+ E N + LG G FG V YG ++ A VAVK L + + E M+E
Sbjct: 33 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 92
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
+ +L+ L H N+V+L G CT L++ E+ G + + L +R P
Sbjct: 93 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 150
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ + + A + +L + + IHRD+ NILL + K+ DFGL+R
Sbjct: 151 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 210
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N +V P ++ PE T +SDV+S+G+ L EL S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
+ E N + LG G FG V YG ++ A VAVK L + + E M+E
Sbjct: 40 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
+ +L+ L H N+V+L G CT L++ E+ G + + L +R P
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ + + A + +L + + IHRD+ NILL + K+ DFGL+R
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARH 217
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N +V P ++ PE T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 71 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 125
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 186 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 79 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 80 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
V + GTP +V PE L ++D++S GV+ L+S + P + T+ N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
++++
Sbjct: 231 TSVS 234
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V L ++ L LV+EF+ + D + +P P + L + H
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 120
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE C
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 178
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
+ D++S G + E+++
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 62/289 (21%)
Query: 68 ELGDGGFGTVYYG------------ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
E+G G F TVY G ELQD + +R ++F E + L L+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER---------QRFKEEAEXLKGLQ 83
Query: 116 HKNLVSLYG---CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP----WPTRLKIA 168
H N+V Y T + + ++LV E ++GT+ +L +R K + W ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQI--- 138
Query: 169 IETASALTYLH--ASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQG 225
L +LH IIHRD+K +NI + VK+ D GL+ L + A G
Sbjct: 139 ---LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIG 192
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
TP + PE ++ + + DV++FG +E + S ++ QN
Sbjct: 193 TPEFXAPEXYE-EKYDESVDVYAFGXCXLEXAT----------------SEYPYSECQNA 235
Query: 286 A-LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
A ++ V + S +KV I V E+ C++ KD R + D+L+
Sbjct: 236 AQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERYSIKDLLN 282
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N F+ + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 9 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 69 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 122
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
YLH+ ++++RD+K N++LD + +K+ DFGL + + +T GTP Y+ P
Sbjct: 123 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 179
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E + D + GVV+ E++
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCG 206
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 84 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
+ E N + LG G FG V YG ++ A VAVK L + + E M+E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
+ +L+ L H N+V+L G CT L++ E+ G + + L +R P
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ + + A + +L + + IHRD+ NILL + K+ DFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N +V P ++ PE T +SDV+S+G+ L EL S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 61 NYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
+++D ELG G FG V+ E G A K + + E E+ ++ LRH L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V+L+ E++++YEF+S G + + + E K + ++ + L ++H
Sbjct: 217 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 272
Query: 180 ASDIIHRDVKTNNILLDNNFC--VKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
++ +H D+K NI+ +K+ DFGL+ L P V+T GT + PE +
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
+ +D++S GV+ L+S +
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGL 353
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+S A L G +P P + L
Sbjct: 68 VKLLDVIHTENK-LYLVFEFLSMDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 80 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ---FMNEVDILARLR 115
++ + ++LG G +G V + + G A+K + +++ ++EV +L +L
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY R LV E G + D + R K + +K + S
Sbjct: 63 HPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK---QVLSGT 117
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TYLH +I+HRD+K N+LL++ + +K+ DFGLS F V GT Y+ P
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIAP 175
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
E + + +K DV+S GV+L L+ P
Sbjct: 176 EVLR-KKYDEKCDVWSCGVILYILLCGYP 203
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 23 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 83 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 137
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 138 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 198 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 80 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+S A L G +P P + L
Sbjct: 66 VKLLDVIHTENK-LYLVFEFLSMDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 74 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAEGMN 128
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 129 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 189 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 102 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 157 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 217 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
+ E N + LG G FG V YG ++ A VAVK L + + E M+E
Sbjct: 35 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 94
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
+ +L+ L H N+V+L G CT L++ E+ G + + L +R P
Sbjct: 95 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 152
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ + + A + +L + + IHRD+ NILL + K+ DFGL+R
Sbjct: 153 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 212
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N +V P ++ PE T +SDV+S+G+ L EL S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLV 120
+ ++G+G +G VY + GR VA+KR L + + E+ +L L H N+V
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 121 SLYGCTSRHS-RELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAI-ETASALT 176
SL HS R L LV+EF+ V D K G +++KI + + +
Sbjct: 83 SLIDVI--HSERCLTLVFEFMEKDLKKVLDE-----NKTGLQD--SQIKIYLYQLLRGVA 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTPGYVDPE 233
+ H I+HRD+K N+L++++ +K+ADFGL+R F V TH T Y P+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 234 -YHQCYQLTDKSDVFSFGVVLIELISSMP 261
+ + D++S G + E+I+ P
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
V + GTP +V PE L ++D++S GV+ L+S + P + T+ N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
++++
Sbjct: 231 TSVS 234
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N F+ + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 10 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 70 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 123
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
YLH+ ++++RD+K N++LD + +K+ DFGL + + +T GTP Y+ P
Sbjct: 124 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 180
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E + D + GVV+ E++
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCG 207
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ + + F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+L Y+H+ I HRD+K N+LLD + V K+ DFG ++ +VS Y
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
+ Y++ +L T DV+S G VL EL+ P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
+ E N + LG G FG V YG ++ A VAVK L + + E M+E
Sbjct: 40 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
+ +L+ L H N+V+L G CT L++ E+ G + + L +R P
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
+ + + A + +L + + IHRD+ NILL + K+ DFGL+R
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 217
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
N +V P ++ PE T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQL--ITQLMPFGXLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61 NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
N F+ + LG G FG V E GR A+K L + V + E +L RH
Sbjct: 8 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
L +L H R L V E+ + G + HL ER R + E SAL
Sbjct: 68 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 121
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
YLH+ ++++RD+K N++LD + +K+ DFGL + + +T GTP Y+ P
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 178
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
E + D + GVV+ E++
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCG 205
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 19 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 72
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 73 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 131
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 132 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 190
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 191 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 222
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ + + F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+L Y+H+ I HRD+K N+LLD + V K+ DFG ++ +VS Y
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
+ Y++ +L T DV+S G VL EL+ P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ ++ ++F N E+ I+ +L
Sbjct: 22 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 75
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 76 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 135 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 193
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 194 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 225
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
N F R +G GGFG VY D G+ A+K L + KR++ E L +L
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 244
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
VS C + H+ + L + + ++ G + HL ++ G A E
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 300
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 357
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
PE Q D S D FS G +L +L+ T+ +HEI+ L +
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 408
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
V + GTP +V PE L ++D++S GV+ L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRH 116
N F R LG GGFG V +++ G+ A K+L + K+ + +NE IL ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETAS 173
+ +VSL Y ++ + L LV ++ G + H++ G+ P A + A E
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGQAGFPEA----RAVFYAAEICC 297
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
L LH I++RD+K NILLD++ ++++D GL+ P T GT GY+ PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ + T D ++ G +L E+I+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAG 381
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 68 ELGDGGFGTVYYGE-LQDGRAVAVKRLYEN-NYKRVEQFMNEVDILAR-LRHKNLVSLYG 124
ELG G +G V + G+ AVKR+ N + ++ + ++DI R + V+ YG
Sbjct: 41 ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIETASALTYLHAS-D 182
R ++ + E T D + + G +P KIA+ AL +LH+
Sbjct: 101 ALFREG-DVWICXELXD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH---VSTAPQGTPGYVDPEYHQCYQ 239
+IHRDVK +N+L++ VK DFG+S + V P P ++PE +Q
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ-KG 216
Query: 240 LTDKSDVFSFGVVLIEL 256
+ KSD++S G+ IEL
Sbjct: 217 YSVKSDIWSLGITXIEL 233
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
N F R +G GGFG VY D G+ A+K L + KR++ E L +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
VS C + H+ + L + + ++ G + HL ++ G A E
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
PE Q D S D FS G +L +L+ T+ +HEI+ L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ---FMNEVDILARLR 115
++ + ++LG G +G V + + G A+K + +++ ++EV +L +L
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
H N++ LY R LV E G + D + R K + +K + S
Sbjct: 80 HPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK---QVLSGT 134
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
TYLH +I+HRD+K N+LL++ + +K+ DFGLS F V GT Y+ P
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIAP 192
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
E + + +K DV+S GV+L L+ P
Sbjct: 193 EVLR-KKYDEKCDVWSCGVILYILLCGYP 220
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRH 116
N F R LG GGFG V +++ G+ A K+L + K+ + +NE IL ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETAS 173
+ +VSL Y ++ + L LV ++ G + H++ G+ P A + A E
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGQAGFPEA----RAVFYAAEICC 297
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
L LH I++RD+K NILLD++ ++++D GL+ P T GT GY+ PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
+ + T D ++ G +L E+I+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAG 381
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
G++ F ++E +++D ELG G F V E G A K + + +
Sbjct: 1 GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
E+ EV IL ++ H N+++L+ + +++L+ E +S G + D L A+ +L
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
+ + YLH I H D+K NI LLD N +K+ DFGL+ +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
V + GTP +V PE L ++D++S GV+ L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKRVEQ-----FMNEVDILAR 113
+D + +G G FG E+Q R A +++Y + ++ +++ F E DI+A
Sbjct: 77 YDVVKVIGRGAFG-----EVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+V L+ C + + L +V E++ G + + + +P E
Sbjct: 132 ANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVL 185
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDP 232
AL +H+ +IHRDVK +N+LLD + +K+ADFG ++ + H TA GTP Y+ P
Sbjct: 186 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISP 244
Query: 233 EYHQCYQLTD-----KSDVFSFGVVLIELI 257
E + Q D + D +S GV L E++
Sbjct: 245 EVLKS-QGGDGYYGRECDWWSVGVFLFEML 273
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
N F R +G GGFG VY D G+ A+K L + KR++ E L +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
VS C + H+ + L + + ++ G + HL ++ G A E
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
PE Q D S D FS G +L +L+ T+ +HEI+ L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
N F R +G GGFG VY D G+ A+K L + KR++ E L +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
VS C + H+ + L + + ++ G + HL ++ G A E
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
L ++H +++RD+K NILLD + V+++D GL+ F H S GT GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
PE Q D S D FS G +L +L+ T+ +HEI+ L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
++ +D ELG G F V G + + K+L +++++E+ E I +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 135
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ ++ Y H++ I+HR++K N+LL + VK+ADFGL+ + A G
Sbjct: 136 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 192
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + + D+++ GV+L I L+ P D +HR
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
++ +D ELG G F V G + + K+L +++++E+ E I +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 112
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ ++ Y H++ I+HR++K N+LL + VK+ADFGL+ + A G
Sbjct: 113 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + + D+++ GV+L I L+ P D +HR
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
++ +D ELG G F V G + + K+L +++++E+ E I +
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 61 LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 111
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ ++ Y H++ I+HR++K N+LL + VK+ADFGL+ + A G
Sbjct: 112 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 168
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + + D+++ GV+L I L+ P D +HR
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 213
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
++ +D ELG G F V G + + K+L +++++E+ E I +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 112
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ ++ Y H++ I+HR++K N+LL + VK+ADFGL+ + A G
Sbjct: 113 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + + D+++ GV+L I L+ P D +HR
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 66 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 67 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V L ++ L LV+EF+ A G +P P + L + H
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDL--KKFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 120
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCY 238
+ ++HRD+K N+L++ +K+ADFGL+R F V T Y PE C
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLGCK 179
Query: 239 QLTDKSDVFSFGVVLIELIS 258
+ D++S G + E+++
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 81 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 135
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 64 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 66 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+ RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 64 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+ RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 64 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + L G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 84 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 68 VKLLDVIHTENK-LYLVFEFLHQDLKTFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 68 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 67 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 68 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 79 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L++ + + G + D++ + G+ L ++ A +
Sbjct: 79 PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 69 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 120
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 178
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT 203
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 67 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 66 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T Y PE
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEIL 176
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 114/234 (48%), Gaps = 25/234 (10%)
Query: 61 NYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVDILAR 113
++++ ELG G F V G ++ A +K+ ++ +R E+ EV+IL
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+RH N+++L+ + +++L+ E +S G + D L A+ +L + +
Sbjct: 65 IRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 119
Query: 174 ALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAPQGTP 227
+ YLH+ I H D+K NI LLD N +K+ DFG++ N ++ GTP
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTP 175
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
+V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 227
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 58 EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
+ +Y D+ + +G+G FG VY +L D G VA+K++ + + F N E+ I+ +L
Sbjct: 18 QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
H N+V L Y + L LV +++ H RAK LP +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
+L Y+H+ I HRD+K N+LLD + V K+ DFG L R PN V+ + +
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
AP+ G D T DV+S G VL EL+ P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
E + EVDIL ++ H N++ L T + LV++ + G + D+L + L
Sbjct: 55 EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 109
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
KI + LH +I+HRD+K NILLD++ +K+ DFG S +L P
Sbjct: 110 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
GTP Y+ PE +C + D + D++S GV++ L++ P
Sbjct: 170 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 13/202 (6%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
V L ++ L LV+E + T D + +P P + L +
Sbjct: 64 VKLLDVIHTENK-LYLVFEHVHQDLKTFMD-----ASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQ 236
H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT 198
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 25/234 (10%)
Query: 61 NYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVDILAR 113
++++ ELG G F V G ++ A +K+ + +R E+ EV+IL
Sbjct: 26 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+RH N+++L+ + +++L+ E +S G + D L A+ +L + +
Sbjct: 86 IRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 140
Query: 174 ALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAPQGTP 227
+ YLH+ I H D+K NI LLD N +K+ DFG++ N ++ GTP
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTP 196
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
+V PE L ++D++S GV+ L+S + P + T+ N+S A+N
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 248
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
E + EVDIL ++ H N++ L T + LV++ + G + D+L + L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
KI + LH +I+HRD+K NILLD++ +K+ DFG S +L P
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
GTP Y+ PE +C + D + D++S GV++ L++ P
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+ L E + ++ ++E ++A + +
Sbjct: 51 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA---LPWPTRLKIAIETAS 173
++ L G + +L + + + G + D++ + G+ L W ++ A
Sbjct: 111 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 162
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYV 230
+ YL ++HRD+ N+L+ VK+ DFGL++L P +
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
+ H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 223 ESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
E + EVDIL ++ H N++ L T + LV++ + G + D+L + L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
KI + LH +I+HRD+K NILLD++ +K+ DFG S +L P
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
GTP Y+ PE +C + D + D++S GV++ L++ P
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 63 FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
F+ R LG GG+G V+ G+ A+K L + N K E +IL +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
+H +V L + L L+ E++S G + L E G T E + A
Sbjct: 79 KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMA 133
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
L +LH II+RD+K NI+L++ VK+ DFGL + + VTH GT Y+ P
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAP 190
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
E D +S G ++ ++++ P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAP 219
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + L G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 84 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 65 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 236 QCYQLTDKS-DVFSFGVVLIELIS 258
+ + D++S G + E+++
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT 199
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + L G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFGL++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 79 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 77 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
F + LG G FGTVY G + +G VA+K L E + ++ ++E ++A + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
++ L G + +L + + + G + D++ + G+ L ++ A +
Sbjct: 84 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
YL ++HRD+ N+L+ VK+ DFG ++L P ++
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
H+ Y T +SDV+S+GV + EL++ +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+EF+ A L G +P P + L
Sbjct: 72 VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T T Y PE
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 182
Query: 236 QCYQLTDKS-DVFSFGVVLIELIS 258
+ + D++S G + E+++
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLVSLYGC 125
LG G GT+ Y + D R VAVKR+ + R Q + E D H N++ Y C
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIR-YFC 85
Query: 126 TSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
T + R+ + + T+ +++ + A G P + + +T S L +LH+ +I+
Sbjct: 86 TEK-DRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLHSLNIV 140
Query: 185 HRDVKTNNILLD-----NNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEY--H 235
HRD+K +NIL+ ++DFGL + H + GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 236 QCYQ-LTDKSDVFSFGVVLIELIS 258
C + T D+FS G V +IS
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVIS 224
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMN 106
Q GEL++ + F+ ELG G G V + + + ++L K Q +
Sbjct: 6 QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
E+ +L +V YG E+ + E + G++ D + E + +P K
Sbjct: 64 ELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSL-DQVLKEAKR---IPEEILGK 118
Query: 167 IAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
++I L YL I+HRDVK +NIL+++ +K+ DFG+S + ++ + G
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVG 175
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
T Y+ PE Q + +SD++S G+ L+EL
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKRVEQ-FM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ Q +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 63 FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
F+ R LG GG+G V+ G+ A+K L + N K E +IL +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
+H +V L + L L+ E++S G + L E G T E + A
Sbjct: 79 KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMA 133
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
L +LH II+RD+K NI+L++ VK+ DFGL + + VTH GT Y+ P
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIEYMAP 190
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
E D +S G ++ ++++ P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAP 219
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 15 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 67
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 68 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 124
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 125 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 15 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 67
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 68 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 124
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 125 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQDG-RAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
++ ++G+G +GTV+ + ++ VA+KR L +++ + E+ +L L+HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 120 VSLYGCTSRHS-RELLLVYEFISNGTVA--DHLHGERAKPGALPWPTRLK-IAIETASAL 175
V L+ HS ++L LV+EF D +G+ P +K + L
Sbjct: 64 VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLD-------PEIVKSFLFQLLKGL 114
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+ H+ +++HRD+K N+L++ N +K+ADFGL+R F V +A T Y P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 236 QCYQLTDKS-DVFSFGVVLIELISS 259
+L S D++S G + EL ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANA 198
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 22 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 74
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 75 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 131
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 132 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 185 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 23 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 75
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 76 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 132
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 133 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 185
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 186 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 14 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 66
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 67 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 123
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 124 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 176
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 177 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA+K + + + + + +N E++IL +L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 75 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 35/212 (16%)
Query: 69 LGDGGFGTV--YYGELQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVS---- 121
+G+G +G V Y ++ R VA+K++ ++ ++ + E+ IL R RH+N++
Sbjct: 51 IGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 122 LYGCTSRHSRELLLV--------YEFISNGTVA-DHLHGERAKPGALPWPTRLKIAIETA 172
L T R++ +V Y+ + + ++ DH+ +
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI---------------CYFLYQIL 154
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV-THVSTAPQGTPGYV 230
L Y+H+++++HRD+K +N+L++ +K+ DFGL+R+ P H T T T Y
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
PE + KS D++S G +L E++S+ P
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA+K + + + + + +N E++IL +L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 75 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA+K + + + + + +N E++IL +L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 75 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA+K + + + + + +N E++IL +L H
Sbjct: 14 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 74 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 121
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 179
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 229
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA+K + + + + + +N E++IL +L H
Sbjct: 21 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 81 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 186
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 236
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
LG+G +G V + G VA+K++ + + + E+ IL +H+N+++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHAS 181
S E+ ++ E + LH R + ++ I +T A+ LH S
Sbjct: 79 RPDSFENFNEVYIIQELMQTD-----LH--RVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQ-GTPGYVDPEYHQCY 238
++IHRD+K +N+L+++N +KV DFGL+R+ S T Q G YV +++
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 239 QLTDKS-------DVFSFGVVLIELISSMPAVDITRHRHEINL 274
++ S DV+S G +L EL P +RH++ L
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRVEQFMNEVDILARLRHKN 118
Y+ +G G +G V +Q G + A K++ + + V++F E++I+ L H N
Sbjct: 9 QYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LY T + ++ LV E + G + + + +R + +I + SA+ Y
Sbjct: 68 IIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYC 122
Query: 179 HASDIIHRDVKTNNILL---DNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
H ++ HRD+K N L + +K+ DFGL +R P + GTP YV P+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 179
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
+ + D +S GV++ L+ P
Sbjct: 180 LEGL-YGPECDEWSAGVMMYVLLCGYP 205
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
F ++G+G +G VY + G VA+K RL + E+ +L L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
V L ++ L LV+E + A L G +P P + L
Sbjct: 68 VKLLDVIHTENK-LYLVFEHVDQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
+ H+ ++HRD+K N+L++ +K+ADFGL+R F V T+ T Y PE
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
C + D++S G + E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 17 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 70 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 61 NYFDSARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRVEQFMNEVDILARLRHKN 118
Y+ +G G +G V +Q G + A K++ + + V++F E++I+ L H N
Sbjct: 26 QYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
++ LY T + ++ LV E + G + + + +R + +I + SA+ Y
Sbjct: 85 IIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYC 139
Query: 179 HASDIIHRDVKTNNILL---DNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
H ++ HRD+K N L + +K+ DFGL +R P + GTP YV P+
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 196
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
+ + D +S GV++ L+ P
Sbjct: 197 LEGL-YGPECDEWSAGVMMYVLLCGYP 222
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 17 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 70 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA++++ ++ ++ +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 17 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 70 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 19/251 (7%)
Query: 69 LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
LG GGF + E+ G+ V K L ++R E+ E+ I L H+++V
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 82
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 83 HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 137
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
+IHRD+K N+ L+ + VK+ DFGL+ T GTP Y+ PE +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 196
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
+ DV+S G ++ L+ P + + + I + +I K N L+ + L ++
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 254
Query: 300 DNKVRRTINAV 310
D R TIN +
Sbjct: 255 DPTARPTINEL 265
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRH-K 117
N ++ E+G G G V+ + G +AVK++ + N + ++ + ++D++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
+V +G T + ++ + E + GT A+ L ++ G +P K+ + AL Y
Sbjct: 85 YIVQCFG-TFITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYY 139
Query: 178 LHAS-DIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVS--TAPQGTPGYVDPE 233
L +IHRDVK +NILLD +K+ DFG+S RL + S A P +DP
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
++DV+S G+ L+EL +
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATG 225
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69 LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
LG GGF + E+ G+ V K L ++R E+ E+ I L H+++V
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 86
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 87 HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 141
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
+IHRD+K N+ L+ + VK+ DFGL+ T GTP Y+ PE +
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 200
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
+ DV+S G ++ L+ P + + + I + +I K N L+ + L ++
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 258
Query: 300 DNKVRRTIN 308
D R TIN
Sbjct: 259 DPTARPTIN 267
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 19 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 72 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 25 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 77
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 78 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 134
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 135 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 187
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 188 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 17 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 70 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 65/252 (25%), Positives = 108/252 (42%), Gaps = 21/252 (8%)
Query: 69 LGDGGFGTVYYGELQDGRA-------VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
LG GGF + E+ D + K L ++R E+ E+ I L H+++V
Sbjct: 25 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 82 FHGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRN 136
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+IHRD+K N+ L+ + VK+ DFGL+ T GTP Y+ PE +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHS 195
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYE 298
+ DV+S G ++ L+ P + + + I + +I K N L+ + L +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--Q 253
Query: 299 SDNKVRRTINAV 310
+D R TIN +
Sbjct: 254 TDPTARPTINEL 265
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 21 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T Y PE + KS D++S G +L E++S+ P
Sbjct: 184 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y L R VA+K++ ++ ++ +
Sbjct: 22 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 74
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 75 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 131
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 132 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T Y PE + KS D++S G +L E++S+ P
Sbjct: 185 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 17 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 70 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 37 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 89
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL R RH+N++ + T +++ +V + + HL +
Sbjct: 90 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 146
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 147 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 199
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 200 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
LG+G +G V + G VA+K++ + + + E+ IL +H+N+++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEF--------ISNGTVAD-HLHGERAKPGALPWPTRLKIAIETAS 173
S E+ ++ E IS ++D H+ +T
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ---------------YFIYQTLR 123
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---------PNHVTHVSTAPQ 224
A+ LH S++IHRD+K +N+L+++N +KV DFGL+R+ P T
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 225 GTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
T Y PE + + DV+S G +L EL P +RH++ L
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 37 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 89
Query: 106 NEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
E+ IL R RH+N++ + + E + +++ AD + K L
Sbjct: 90 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHIC 147
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV-THVSTAP 223
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H T T
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 224 QGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T Y PE + KS D++S G +L E++S+ P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCT 126
LG+G + V LQ+G+ AVK + + + EV+ L + + +KN++ L
Sbjct: 21 LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
+R LV+E + G++ H+ ++ ++ + A+AL +LH I HR
Sbjct: 81 EDDTR-FYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLHTKGIAHR 135
Query: 187 DVKTNNILLDNN---FCVKVADF--GLSRLFPNHVTHVS----TAPQGTPGYVDPEYHQC 237
D+K NIL ++ VK+ DF G N T ++ T P G+ Y+ PE +
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 238 Y--QLT---DKSDVFSFGVVLIELISSMP 261
+ Q T + D++S GVVL ++S P
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLSGYP 224
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69 LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
LG GGF + E+ G+ V K L ++R E+ E+ I L H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 80
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 81 HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
+IHRD+K N+ L+ + VK+ DFGL+ + GTP Y+ PE +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
+ DV+S G ++ L+ P + + + I + +I K N L+ + L ++
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 252
Query: 300 DNKVRRTIN 308
D R TIN
Sbjct: 253 DPTARPTIN 261
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69 LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
LG GGF + E+ G+ V K L ++R E+ E+ I L H+++V
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 104
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 105 HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 159
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
+IHRD+K N+ L+ + VK+ DFGL+ + GTP Y+ PE +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
+ DV+S G ++ L+ P + + + I + +I K N L+ + L ++
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 276
Query: 300 DNKVRRTIN 308
D R TIN
Sbjct: 277 DPTARPTIN 285
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI--LARLRHKNLVSLY--- 123
+G G +G VY G L D R VAVK ++ + F+NE +I + + H N+
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 124 -GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS- 181
T+ E LLV E+ NG++ +L + W + ++A L YLH
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHTEL 131
Query: 182 --------DIIHRDVKTNNILLDNNFCVKVADFGLS------RLF-PNHVTHVSTAPQGT 226
I HRD+ + N+L+ N+ ++DFGLS RL P + + + GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 227 PGYVDPEYHQ-CYQLTD------KSDVFSFGVVLIELI 257
Y+ PE + L D + D+++ G++ E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 21/250 (8%)
Query: 69 LGDGGFGTVYYGELQDGRA-------VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
LG GGF + E+ D + K L ++R E+ E+ I L H+++V
Sbjct: 49 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 105
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
+G + + +V E ++ + LH R AL P + YLH +
Sbjct: 106 FHGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRN 160
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
+IHRD+K N+ L+ + VK+ DFGL+ + GTP Y+ PE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYE 298
+ DV+S G ++ L+ P + + + I + +I K N L+ + L +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--Q 277
Query: 299 SDNKVRRTIN 308
+D R TIN
Sbjct: 278 TDPTARPTIN 287
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQDG-RAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
++ ++G+G +GTV+ + ++ VA+KR L +++ + E+ +L L+HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 120 VSLYGCTSRHS-RELLLVYEFISNGTVA--DHLHGERAKPGALPWPTRLK-IAIETASAL 175
V L+ HS ++L LV+EF D +G+ P +K + L
Sbjct: 64 VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLD-------PEIVKSFLFQLLKGL 114
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+ H+ +++HRD+K N+L++ N +K+A+FGL+R F V +A T Y P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 236 QCYQLTDKS-DVFSFGVVLIELISS 259
+L S D++S G + EL ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANA 198
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 66 ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
R LG GGF Y E+ G+ V L + + K E+ E+ I L + ++
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +G + +V E ++ + LH R A+ P +T + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
+ +IHRD+K N+ L+++ VK+ DFGL+ T GTP Y+ PE
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVLCKKG 218
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
+ + D++S G +L L+ P + S L I+ K ++
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK------------KN 257
Query: 300 DNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSP 357
+ V R IN VA L + L ++ LRP + ++L + + GY + +T P
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSCLTVPP 314
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA++ + + + + + +N E++IL +L H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 214 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 261
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 319
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 369
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
++ LG G G V E + + VA++ + + + + + +N E++IL +L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
++ + + + +V E + G + D + G + RLK A +
Sbjct: 200 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 247
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
A+ YLH + IIHRD+K N+LL + + +K+ DFG S++ T + GTP
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 305
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
Y+ PE + D +S GV+L +S P + HR +++L +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 355
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 28/157 (17%)
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGAL 159
+EQ E+ IL +L H N+V L + + L +V+E ++ G V +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------------ 127
Query: 160 PWPTRLKIAIETA--------SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
PT ++ + A + YLH IIHRD+K +N+L+ + +K+ADFG+S
Sbjct: 128 -VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
F +S GTP ++ PE L++ +FS
Sbjct: 187 FKGSDALLSNT-VGTPAFMAPE-----SLSETRKIFS 217
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
LG+G +G V + G VA+K++ + + + E+ IL +H+N+++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHAS 181
S E+ ++ E + LH R + ++ I +T A+ LH S
Sbjct: 79 RPDSFENFNEVYIIQELMQTD-----LH--RVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
++IHRD+K +N+L+++N +KV DFGL+R+ S G V+ + Y+
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 242 D----------KSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
+ DV+S G +L EL P +RH++ L
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 16/126 (12%)
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL------------- 211
L I I+ A A+ +LH+ ++HRD+K +NI + VKV DFGL
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE 271
P + TH GT Y+ PE + K D+FS G++L EL+ S + + R R
Sbjct: 227 MPAYATHXGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-STQMERVRII 283
Query: 272 INLSNL 277
++ NL
Sbjct: 284 TDVRNL 289
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE 102
N HG F G + Y D + LG GG G V+ D + VA+K++ + + V+
Sbjct: 3 NIHG---FDLG-----SRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK 53
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELL----LVYEFISNGTVADHLHGERA---K 155
+ E+ I+ RL H N+V ++ +L + E S V +++ + A +
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 156 PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPN 214
G L + L Y+H+++++HRD+K N+ ++ + +K+ DFGL+R+
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 215 HVTHVSTAPQG--TPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELIS 258
H +H +G T Y P T D+++ G + E+++
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 62 YFDSA----RELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDIL 111
YF S ELG G F V G+ + + K+L +++++E+ E I
Sbjct: 19 YFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARIC 75
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLK 166
L+H N+V L+ S L +++ ++ G VA + E +
Sbjct: 76 RLLKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYSEADASHCIQ------ 128
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAP 223
+ A+ + H ++HRD+K N+LL + VK+ADFGL+
Sbjct: 129 ---QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGF 184
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
GTPGY+ PE + D+++ GV+L I L+ P D +HR
Sbjct: 185 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 231
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 50/305 (16%)
Query: 66 ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
R LG GGF Y E+ G+ V L + + K E+ E+ I L + ++
Sbjct: 31 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 88
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +G + +V E ++ + LH R A+ P +T + YLH
Sbjct: 89 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 143
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPE 233
+ +IHRD+K N+ L+++ VK+ DFGL+ T + + GTP Y+ PE
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPE 196
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
+ + D++S G +L L+ P + S L I+ K
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK-------- 239
Query: 294 TLGYESDNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM 352
+++ V R IN VA L + L ++ LRP + ++L + + GY +
Sbjct: 240 ----KNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSC 293
Query: 353 MTQSP 357
+T P
Sbjct: 294 LTVPP 298
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 38/299 (12%)
Query: 66 ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
R LG GGF Y E+ G+ V L + + K E+ E+ I L + ++
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +G + +V E ++ + LH R A+ P +T + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
+ +IHRD+K N+ L+++ VK+ DFGL+ GTP Y+ PE
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
+ + D++S G +L L+ P + S L I+ K ++
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK------------KN 257
Query: 300 DNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSP 357
+ V R IN VA L + L ++ LRP + ++L + + GY + +T P
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSCLTVPP 314
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 60 TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
++ ++ +++G G FG + Q VAVK + E K E E+ LRH N
Sbjct: 17 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 75
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+V T H L +V E+ S G + + + G + S ++
Sbjct: 76 IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 128
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
Y HA + HRD+K N LLD + +K+ DFG S+ H ST GTP Y+ PE
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 186
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
+ K +DV+S GV L + L+ + P D
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVS 121
+ + + +G+G FG V+ +L + VA+K++ ++ ++F N E+ I+ ++H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 122 L----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
L Y + L LV E++ H + K +P + +L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLA 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY- 234
Y+H+ I HRD+K N+LLD V K+ DFG +++ +VS + Y PE
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI--CSRYYRAPELI 213
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
T D++S G V+ EL+ P
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQP 240
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 50/305 (16%)
Query: 66 ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
R LG GGF Y E+ G+ V L + + K E+ E+ I L + ++
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V +G + +V E ++ + LH R A+ P +T + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPE 233
+ +IHRD+K N+ L+++ VK+ DFGL+ T + + GTP Y+ PE
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPE 212
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
+ + D++S G +L L+ P + S L I+ K
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK-------- 255
Query: 294 TLGYESDNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM 352
+++ V R IN VA L + L ++ LRP + ++L + + GY +
Sbjct: 256 ----KNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSC 309
Query: 353 MTQSP 357
+T P
Sbjct: 310 LTVPP 314
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
+E + Y A+ +G G FG V+ + G+ VA+K++ N K E F + E+ IL
Sbjct: 15 DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHS------RELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L+H+N+V+L C ++ S + LV++F + +A L K +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
+K ++ + L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F PN
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
VT P+ G Y P D++ G ++ E+ + P +
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
+H++ L
Sbjct: 236 QHQLAL 241
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 19 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL RH+N++ + T +++ +V + + HL +
Sbjct: 72 REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 60 TNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
T+ + ELG G F V G+ + + K+L +++++E+ E I
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 60 LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLS-RLFPNHVTHVSTAPQ 224
+ ++ + H + I+HRD+K N+LL VK+ADFGL+ + + A
Sbjct: 111 -QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
GTPGY+ PE + D+++ GV+L I L+ P D +HR
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
+E + Y A+ +G G FG V+ + G+ VA+K++ N K E F + E+ IL
Sbjct: 15 DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L+H+N+V+L C ++ S + LV++F + +A L K +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
+K ++ + L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F PN
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
VT P+ G Y P D++ G ++ E+ + P +
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
+H++ L
Sbjct: 236 QHQLAL 241
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 60 TNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
T+ + ELG G F V G+ + + K+L +++++E+ E I
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 60 LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLS-RLFPNHVTHVSTAPQ 224
+ ++ + H + I+HRD+K N+LL VK+ADFGL+ + + A
Sbjct: 111 -QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
GTPGY+ PE + D+++ GV+L I L+ P D +HR
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
+E + Y A+ +G G FG V+ + G+ VA+K++ N K E F + E+ IL
Sbjct: 15 DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L+H+N+V+L C ++ S + LV++F + +A L K +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
+K ++ + L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F PN
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
VT P+ G Y P D++ G ++ E+ + P +
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
+H++ L
Sbjct: 236 QHQLAL 241
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
+E + Y A+ +G G FG V+ + G+ VA+K++ N K E F + E+ IL
Sbjct: 14 DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
L+H+N+V+L C ++ S + LV++F + +A L K +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 125
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
+K ++ + L Y+H + I+HRD+K N+L+ + +K+ADFGL+R F PN
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
VT P+ G Y P D++ G ++ E+ + P +
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 269 RHEINL 274
+H++ L
Sbjct: 235 QHQLAL 240
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY---KRVEQ--FMNEVDILARLRHK 117
F+ + +G G FG V +L++ V ++ N + KR E F E D+L K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDSK 134
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIETASA 174
+ +L+ + L LV ++ G T+ + A + + IAI++
Sbjct: 135 WITTLHY-AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
L Y +HRD+K +NIL+D N +++ADFG T S+ GTP Y+ PE
Sbjct: 194 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 235 HQCYQ-----LTDKSDVFSFGVVLIELI 257
Q + + D +S GV + E++
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEML 275
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 28/303 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
++ + +G G FG V + R V +L KR + F E DI+A
Sbjct: 76 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
+V L+ + R L +V E++ G + + + W R A E AL +
Sbjct: 136 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA-EVVLALDAI 189
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H+ IHRDVK +N+LLD + +K+ADFG ++ + TA GTP Y+ PE +
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 248
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
Q D + D +S GV L E L+ P + + +N N N
Sbjct: 249 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
E + + +D +VR N V E L F+ Q + + LR + V+ D DI++
Sbjct: 308 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 367
Query: 343 YDD 345
+DD
Sbjct: 368 FDD 370
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 70/264 (26%), Positives = 117/264 (44%), Gaps = 49/264 (18%)
Query: 69 LGDGGFGTVY---------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
LG G F ++ YG+L + V +K L + + E F ++++L HK+L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
V YG C E +LV EF+ G++ +L + L W +L++A + A+A+ +L
Sbjct: 75 VLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFL 129
Query: 179 HASDIIHRDVKTNNILL--------DNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGY 229
+ +IH +V NILL N +K++D G+S + P + Q +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPW 183
Query: 230 VDPE-YHQCYQLTDKSDVFSFGVVLIELISS----MPAVDITRH------RHEINLSNLA 278
V PE L +D +SFG L E+ S + A+D R RH++ A
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA 243
Query: 279 INKIQNKALHELVDQTLGYESDNK 302
L L++ + YE D++
Sbjct: 244 -------ELANLINNCMDYEPDHR 260
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49 QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
QVF G +Y +G+G +G V Y + R VA+K++ ++ ++ +
Sbjct: 19 QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
E+ IL RH+N++ + T +++ +V + + HL +
Sbjct: 72 REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
+ L Y+H+++++HRD+K +N+LL+ +K+ DFGL+R+ P+H
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
T T T Y PE + KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 66 ARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRV---EQFM--NEVDILARLRHKN 118
A +LG G FG V+ R V + K+ Y + +V +Q + E+ IL RH+N
Sbjct: 10 AEDLGRGEFGIVH-------RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI--ETASALT 176
++ L+ + EL++++EFIS + ER A R ++ + AL
Sbjct: 63 ILHLHE-SFESMEELVMIFEFISGLDIF-----ERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 177 YLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSR-LFP-NHVTHVSTAPQGTPGYVDP 232
+LH+ +I H D++ NI+ + +K+ +FG +R L P ++ + TAP+ Y P
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE----YYAP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSM 260
E HQ ++ +D++S G ++ L+S +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGI 200
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 28/303 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
++ + +G G FG V + R V +L KR + F E DI+A
Sbjct: 76 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
+V L+ + R L +V E++ G + + + W R A E AL +
Sbjct: 136 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA-EVVLALDAI 189
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H+ IHRDVK +N+LLD + +K+ADFG ++ + TA GTP Y+ PE +
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 248
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
Q D + D +S GV L E L+ P + + +N N N
Sbjct: 249 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
E + + +D +VR N V E L F+ Q + + LR + V+ D DI++
Sbjct: 308 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 367
Query: 343 YDD 345
+DD
Sbjct: 368 FDD 370
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 85/303 (28%), Positives = 131/303 (43%), Gaps = 28/303 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
++ + +G G FG V + R V +L KR + F E DI+A
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
+V L+ + R L +V E++ G + +L P W R A E AL +
Sbjct: 131 VVQLF-YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEK--W-ARFYTA-EVVLALDAI 184
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
H+ IHRDVK +N+LLD + +K+ADFG ++ + TA GTP Y+ PE +
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 243
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
Q D + D +S GV L E L+ P + + +N N N
Sbjct: 244 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
E + + +D +VR N V E L F+ Q + + LR + V+ D DI++
Sbjct: 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 362
Query: 343 YDD 345
+DD
Sbjct: 363 FDD 365
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 39/254 (15%)
Query: 34 SSKVDLEKGGNYHGVQVFSYGELEEATNYFDSAR---ELGDGGFGTVYYG------ELQD 84
SS VDL G + + + T + D + ELG G F V +
Sbjct: 8 SSGVDL-------GTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYA 60
Query: 85 GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG- 143
+ + K+L +++++E+ E I L+H N+V L+ S L V++ ++ G
Sbjct: 61 AKIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYL-VFDLVTGGE 116
Query: 144 ----TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF 199
VA + E + + ++ ++H DI+HRD+K N+LL +
Sbjct: 117 LFEDIVAREYYSEADASHCIH---------QILESVNHIHQHDIVHRDLKPENLLLASKC 167
Query: 200 ---CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IE 255
VK+ADFGL+ + GTPGY+ PE + D+++ GV+L I
Sbjct: 168 KGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYIL 226
Query: 256 LISSMPAVDITRHR 269
L+ P D +H+
Sbjct: 227 LVGYPPFWDEDQHK 240
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 60 TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
++ ++ +++G G FG + Q VAVK + E K E+ LRH N
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIAANVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+V T H L +V E+ S G + + + G + S ++
Sbjct: 77 IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
Y HA + HRD+K N LLD + +K+ DFG S+ H ST GTP Y+ PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
+ K +DV+S GV L + L+ + P D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 60 TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
++ ++ +++G G FG + Q VAVK + E K E E+ LRH N
Sbjct: 18 SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+V T H L +V E+ S G + + + G + S ++
Sbjct: 77 IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
Y HA + HRD+K N LLD + +K+ADFG S+ H S GTP Y+ PE
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
+ K +DV+S GV L + L+ + P D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
+ N S + LG G GTV + GR VAVKR+ + + + E+ +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD 67
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
H N++ Y C+ R L + E + N + D + + L + + + A
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
S + +LH+ IIHRD+K NIL+ N + ++DFGL + + +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 220 ST---APQGTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
T P GT G+ PE +LT D+FS G V ++S ++
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
E N+ + + K LH D++L E+ + + + I+
Sbjct: 246 RESNIIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 281
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 21/148 (14%)
Query: 69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-CTS 127
+G G FG VY+G A+ + + +N +++ F EV + RH+N+V G C S
Sbjct: 41 IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 128 RHSRELLL-------VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
++ +Y + + + ++ R +IA E + YLHA
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR------------QIAQEIVKGMGYLHA 148
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGL 208
I+H+D+K+ N+ DN V + DFGL
Sbjct: 149 KGILHKDLKSKNVFYDNGKVV-ITDFGL 175
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 73 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 65/260 (25%), Positives = 121/260 (46%), Gaps = 29/260 (11%)
Query: 34 SSKVDLEKGGNYHGVQVFSYGELEEATNYFD-SARELGDGGFGTVYY----GELQDGRAV 88
SS VDL G + + +E N++ +++ELG G F V Q+ A
Sbjct: 8 SSGVDL-------GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 89 AVKRLYENNYKRVEQFMNEVDIL----ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT 144
+K+ R E ++E+ +L + R NL +Y TS E++L+ E+ + G
Sbjct: 61 FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTS----EIILILEYAAGGE 115
Query: 145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---V 201
+ E A+ + +++ + + YLH ++I+H D+K NILL + + +
Sbjct: 116 IFSLCLPELAE--MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SM 260
K+ DFG+SR H + GTP Y+ PE +T +D+++ G++ L++ +
Sbjct: 174 KIVDFGMSRKI-GHACELREI-MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
Query: 261 PAVDITRHRHEINLSNLAIN 280
P V +N+S + ++
Sbjct: 232 PFVGEDNQETYLNISQVNVD 251
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 63 FDSARELGDGGFGTVYY----GELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
F+ + LG G +G V+ G+ A+K L + K E E +L +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ET 171
R + + +L L+ ++I+ G + HL +R + T ++ I E
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERF------TEHEVQIYVGEI 168
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
AL +LH II+RD+K NILLD+N V + DFGLS+ F T + GT Y+
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 232 PEYHQCYQLT-DKS-DVFSFGVVLIELISS 259
P+ + DK+ D +S GV++ EL++
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYE-----NNYKRVEQFMNEVDILARLRHKNLVSL 122
+G+G +G V + G+ VA+K++ N KR + E+ IL +H N++++
Sbjct: 62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT---LRELKILKHFKHDNIIAI 118
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----IAIETASALTYL 178
R + EF S V D + + + P L+ + L Y+
Sbjct: 119 KDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYH 235
H++ +IHRD+K +N+L++ N +K+ DFG++R P + T T Y PE
Sbjct: 175 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 236 -QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN 280
++ T D++S G + E+++ + H++ L + +
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 47/263 (17%)
Query: 69 LGDGGFGTVY---------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
LG G F ++ YG+L + V +K L + + E F ++++L HK+L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
V YG E +LV EF+ G++ +L + L W +L++A + A A+ +L
Sbjct: 75 VLNYG-VCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLE 130
Query: 180 ASDIIHRDVKTNNILL--------DNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYV 230
+ +IH +V NILL N +K++D G+S + P + Q +V
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPWV 184
Query: 231 DPE-YHQCYQLTDKSDVFSFGVVLIELISS----MPAVDITRH------RHEINLSNLAI 279
PE L +D +SFG L E+ S + A+D R RH++ A
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA- 243
Query: 280 NKIQNKALHELVDQTLGYESDNK 302
L L++ + YE D++
Sbjct: 244 ------ELANLINNCMDYEPDHR 260
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 86 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYR 196
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + + ++ E+ +L
Sbjct: 29 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 89 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 84 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 37 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 97 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 84 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 23 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 83 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 73 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 22 IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 82 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 36 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 96 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 27 IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 87 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 141
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 142 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 197
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 244
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 23 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 83 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 28 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 88 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 22 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 82 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 69 LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYG-- 124
LG G V+ G + G A+K ++ R V+ M E ++L +L HKN+V L+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 125 --CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
T+RH +L+ EF G++ L E + LP L + + + +L +
Sbjct: 77 EETTTRHK---VLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 IIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
I+HR++K NI+ D K+ DFG +R + VS GT Y+ P+ ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHPDMYE 188
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 106 NEVDILARLRHKNLVSLYGCT-SRHSRELLLVYEFISNGT--VADHLHGERAKPGALPWP 162
E+ +L RLRHKN++ L + +++ +V E+ G + D + +R P
Sbjct: 55 KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVC 109
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVST 221
+ L YLH+ I+H+D+K N+LL +K++ G++ L P
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 222 APQGTPGYVDPEYHQCYQLTD--KSDVFSFGVVLIELISSMPAVD---ITRHRHEINLSN 276
QG+P + PE K D++S GV L + + + + I + I +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229
Query: 277 LAINKIQNKALHELVDQTLGYESDNK 302
AI L +L+ L YE +
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKR 255
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 37 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 97 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL N VK+ DFGL+R + +V P
Sbjct: 205 SFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y + KSDV+S+GV+L E+ S
Sbjct: 265 LKWMAPESIFDKIY--STKSDVWSYGVLLWEIFS 296
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 42 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 102 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 212
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 19 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 79 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 28 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 88 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 15 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 75 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 129
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 130 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 185
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 232
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 19 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 79 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 22 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 82 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 29 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 89 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 29 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 89 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 84 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 19 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 79 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 22 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 82 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 16 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 76 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 130
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 131 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 186
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 233
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
+ N S + LG G GTV + GR VAVKR+ + + + E+ +L
Sbjct: 29 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDD 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
H N++ Y C+ R L + E + N + D + + L + + + A
Sbjct: 86 HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
S + +LH+ IIHRD+K NIL+ N + ++DFGL + +
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 220 S---TAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
P GT G+ PE + +LT D+FS G V ++S ++ E N
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
+ + + K LH D++L E+ + + + I+
Sbjct: 264 IIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 295
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 14 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 74 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 36 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 96 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
+ N S + LG G GTV + GR VAVKR+ + + + E+ +L
Sbjct: 29 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDD 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
H N++ Y C+ R L + E + N + D + + L + + + A
Sbjct: 86 HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
S + +LH+ IIHRD+K NIL+ N + ++DFGL + +
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 220 S---TAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
P GT G+ PE + +LT D+FS G V ++S ++ E N
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
+ + + K LH D++L E+ + + + I+
Sbjct: 264 IIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 295
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 14 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 74 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 19 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 79 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 23 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 83 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 15/216 (6%)
Query: 60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
++ +D +++G G FG + + + + E E E+ LRH N+
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 120 VSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
V T H L ++ E+ S G + + + G + S ++Y
Sbjct: 79 VRFKEVILTPTH---LAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 178 LHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
H+ I HRD+K N LLD + +K+ DFG S+ H ST GTP Y+ PE
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVL 189
Query: 236 QCYQLTDK-SDVFSFGVVL-IELISSMPAVDITRHR 269
+ K +DV+S GV L + L+ + P D R
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYE-------------NNYK-- 99
E ++ N + R L G F + E +D + A+K+ YE NN K
Sbjct: 25 EKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKK-YEKSLLEKKRDFTKSNNDKIS 82
Query: 100 ---RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVA--DHLHGERA 154
+ + F NE+ I+ ++++ ++ G + + E+ ++YE++ N ++ D
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLD 141
Query: 155 KPGALPWPTR-LKIAIETA-SALTYLH-ASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
K P + +K I++ ++ +Y+H +I HRDVK +NIL+D N VK++DFG S
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 212 FPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTDKSDVFSFGVVL 253
V +GT ++ PE+ ++ K D++S G+ L
Sbjct: 202 M---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 69 LGDGGFGTVYYGELQ-DGRAVAVKRLYE-----NNYKRVEQFMNEVDILARLRHKNLVSL 122
+G+G +G V + G+ VA+K++ N KR + E+ IL +H N++++
Sbjct: 63 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT---LRELKILKHFKHDNIIAI 119
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----IAIETASALTYL 178
R + EF S V D + + + P L+ + L Y+
Sbjct: 120 KDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYH 235
H++ +IHRD+K +N+L++ N +K+ DFG++R P + T T Y PE
Sbjct: 176 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 236 -QCYQLTDKSDVFSFGVVLIELIS 258
++ T D++S G + E+++
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLA 259
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 60 TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
++ ++ +++G G FG + Q VAVK + E K E E+ LRH N
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+V T H L +V E+ S G + + + G + S ++
Sbjct: 77 IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
Y HA + HRD+K N LLD + +K+ FG S+ H ST GTP Y+ PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
+ K +DV+S GV L + L+ + P D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 73 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 19 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 79 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL R H T T Y
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 19 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 79 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
T + ELG G F V G+ + K+L +++++E+ E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRL 66
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L +++ ++ G VA + E +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 117
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ A+ + H ++HR++K N+LL + VK+ADFGL+ G
Sbjct: 118 -QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAG 175
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + D+++ GV+L I L+ P D +HR
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 25 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 85 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 37 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 97 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGXVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 17/225 (7%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
E + + +G G +G+V + + G VAVK+L + ++ E+ +L +
Sbjct: 19 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
+H+N++ L + +R L E ++ + HL G K L + +
Sbjct: 79 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
PE D++S G ++ EL++ T H ++ L
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 60 TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
T+ + ++G G F V G + + K+L +++++E+ E I
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
L+H N+V L+ S L V++ ++ G VA + E +
Sbjct: 60 LKHSNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
+ A+ + H ++HRD+K N+LL + VK+ADFGL+ + G
Sbjct: 111 -QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAG 168
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
TPGY+ PE + D+++ GV+L I L+ P D +H+
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHK 213
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 63 FDSARELGDGGFGTVYYGELQDG-RAVAVKRLYENNY---KRVEQ--FMNEVDILARLRH 116
F+ + +G G FG V ++++ R A+K L N + KR E F E D+L
Sbjct: 92 FEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL--NKWEMLKRAETACFREERDVLVNGDC 149
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+ + +L+ + L LV ++ G + L K LP E A+
Sbjct: 150 QWITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIGEMVLAID 205
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
+H +HRD+K +N+LLD N +++ADFG + T S+ GTP Y+ PE Q
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 237 CYQ-----LTDKSDVFSFGVVLIELI 257
+ + D +S GV + E++
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEML 291
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLVSLYGC 125
+G G +G V + + G VA+K+LY + ++ E+ +L +RH+N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 126 -----TSRHSRELLLVYEFISN--GTVADHLH-GERAKPGALPWPTRLKIAI-ETASALT 176
T + LV F+ G + H GE R++ + + L
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE----------DRIQFLVYQMLKGLR 142
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-----LFPNHVTHVSTAPQGTPGYVD 231
Y+HA+ IIHRD+K N+ ++ + +K+ DFGL+R + VT AP+ ++
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWM- 201
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
+ T D++S G ++ E+I+
Sbjct: 202 -------RYTQTVDIWSVGCIMAEMIT 221
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 63 FDSARELGDGGFGTVYYGELQDG-RAVAVKRLYENNY---KRVEQ--FMNEVDILARLRH 116
F+ + +G G FG V ++++ R A+K L N + KR E F E D+L
Sbjct: 76 FEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL--NKWEMLKRAETACFREERDVLVNGDC 133
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHG-ERAKPGALPWPTRLKIAIETASAL 175
+ + +L+ + L LV ++ G + L E P + R I E A+
Sbjct: 134 QWITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---ARFYIG-EMVLAI 188
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+H +HRD+K +N+LLD N +++ADFG + T S+ GTP Y+ PE
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 236 QCYQ-----LTDKSDVFSFGVVLIELI 257
Q + + D +S GV + E++
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEML 275
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 35/279 (12%)
Query: 57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
+ N S + LG G GTV + GR VAVKR+ + + + E+ +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD 67
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
H N++ Y C+ R L + E + N + D + + L + + + A
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
S + +LH+ IIHRD+K NIL+ N + ++DFGL + +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 220 S---TAPQGTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
P GT G+ PE +LT D+FS G V ++S ++
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
E N+ + + K LH D++L E+ + + + I+
Sbjct: 246 RESNIIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 281
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ D+GL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 73 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 69 LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYG-- 124
LG G V+ G + G A+K ++ R V+ M E ++L +L HKN+V L+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 125 --CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
T+RH +L+ EF G++ L E + LP L + + + +L +
Sbjct: 77 EETTTRHK---VLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 IIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
I+HR++K NI+ D K+ DFG +R + V GT Y+ P+ ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL--YGTEEYLHPDMYE 188
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 60 TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
++ ++ +++G G FG + Q VAVK + E K E E+ LRH N
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+V T H L +V E+ S G + + + G + S ++
Sbjct: 77 IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
Y HA + HRD+K N LLD + +K+ FG S+ H T GTP Y+ PE
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
+ K +DV+S GV L + L+ + P D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 40 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 100 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T
Sbjct: 155 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGYVATRW 210
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V +++ G +AVK+L + ++ E+ +L
Sbjct: 46 IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + + E ++ + HL G K L +
Sbjct: 106 HMKHENVIGLLDVFTPATS-----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 160
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DFGL+R H T T
Sbjct: 161 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 216
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
Y PE + + + D++S G ++ EL++
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 103 QFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
+ EV++L + + H+N++ L R LV+E + G++ H+H R
Sbjct: 56 RVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHF------ 108
Query: 162 PTRLKIAI---ETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFP-- 213
L+ ++ + ASAL +LH I HRD+K NIL ++ VK+ DFGL
Sbjct: 109 -NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 214 NHVTHVST----APQGTPGYVDPEYHQCY----QLTDK-SDVFSFGVVLIELISSMP 261
+ +ST P G+ Y+ PE + + + DK D++S GV+L L+S P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 107 EVDILARLRHKNLVSLYGCTSRHS-RELLLVYEFISNGT--VADHLHGERA--KPGALPW 161
E+ +L L+H N++SL H+ R++ L++++ + + +A KP LP
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF----- 212
+ + + YLHA+ ++HRD+K NIL+ VK+AD G +RLF
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 213 ------PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P VT AP+ G T D+++ G + EL++S P
Sbjct: 188 PLADLDPVVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 234
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 171 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 228
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 229 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 267
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 172 ASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T P TP
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPY 184
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
YV PE + D++S GV++ L+ P
Sbjct: 185 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 222
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 135 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 192
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 193 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 231
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 67 RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL--Y 123
++LG+GGF V E L DG A+KR+ + + E+ E D+ H N++ L Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 124 GCTSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
R ++ E L+ F GT+ + + + K L L + + L +HA
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV--------THVSTAPQGTPGYVDPEY 234
HRD+K NILL + + D G HV A + T Y PE
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 235 H--QCYQLTD-KSDVFSFGVVLIELI 257
Q + + D ++DV+S G VL ++
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMM 240
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 120 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 177
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 178 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 216
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 178
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 179 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 176
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ FGL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 54.7 bits (130), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 127 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 184
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 185 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 223
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 206 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 266 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 297
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 125 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 182
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 183 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 221
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 126 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 183
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 184 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 222
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 197 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
++ PE + + Y T +SDV+SFGV+L E+ S P V I
Sbjct: 257 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 299
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 204 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 264 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 295
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
+ + A + +L + IHRD+ NILL VK+ DFGL+R +V P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
++ PE + + Y T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 290
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNL 119
+ + +G G G V + G VAVK+L N ++ E+ +L + HKN+
Sbjct: 24 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 120 VSLYGC-----TSRHSRELLLVYEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+SL T +++ LV E + +N H+ + + L + +
Sbjct: 84 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY--------QMLC 135
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R ST TP YV
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------ASTNFMMTP-YVVTR 187
Query: 234 YHQCYQLT------DKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
Y++ ++ + D++S G ++ EL+ T H + N
Sbjct: 188 YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 233
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ DF L+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTE 176
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D++S GV++ L+ P
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 16/204 (7%)
Query: 63 FDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F LG G +G V+ +DGR AVKR + + LA + V
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 122 LYGCTSRHSRE-----LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
+ C R + +L + + ++ H A +LP +T AL
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALA 171
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
+LH+ ++H DVK NI L K+ DFGL L +G P Y+ PE Q
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
T +DVFS G+ ++E+ +M
Sbjct: 230 GSYGT-AADVFSLGLTILEVACNM 252
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 13/211 (6%)
Query: 69 LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
+G G F V G+ + V V + + E E I L+H ++V L
Sbjct: 32 IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL-PWPTRLKIAIETASALTYLHAS 181
S L +V+EF+ + + +RA G + + AL Y H +
Sbjct: 92 LETYSSDGM-LYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 182 DIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
+IIHRDVK N+LL +N+ VK+ DFG++ V+ GTP ++ PE +
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
DV+ GV+L L+S T+ R
Sbjct: 209 PYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ D GL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN------EVDILARLR----HK 117
LG GGFGTV+ G L D VA+K + N + EV +L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
++ L +L++ + + D++ E+ G P +R + +A+ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGP--SRCFFG-QVVAAIQH 154
Query: 178 LHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY-- 234
H+ ++HRD+K NIL+D C K+ DFG L + T GT Y PE+
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEWIS 211
Query: 235 -HQCYQLTDKSDVFSFGVVLIELISS 259
HQ + L + V+S G++L +++
Sbjct: 212 RHQYHAL--PATVWSLGILLYDMVCG 235
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ D GL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNL 119
+ + +G G G V + G VAVK+L N ++ E+ +L + HKN+
Sbjct: 26 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 120 VSLYGC-----TSRHSRELLLVYEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
+SL T +++ LV E + +N H+ + + L + +
Sbjct: 86 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY--------QMLC 137
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAPQGT 226
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
G D++S G ++ EL+ T H + N
Sbjct: 198 LG---------MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWN 235
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTV--YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56 LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
+ E + + +G G +G+V + + G VAVK+L + ++ E+ +L
Sbjct: 17 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
++H+N++ L + +R L E ++ + HL G K L +
Sbjct: 77 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
+ L Y+H++DIIHRD+K +N+ ++ + +K+ D GL+R H T T
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
Y PE + +++ D++S G ++ EL++ T H ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARL 114
E + S +G G +G+V + + G VA+K+L + ++ E+ +L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 115 RHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
+H+N++ L + R+ + LV F+ T + G + + + +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGLKFSEEKIQY-----LVY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ L Y+H++ ++HRD+K N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWY 189
Query: 230 VDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
PE + +++ D++S G ++ E+++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 23/185 (12%)
Query: 32 EPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAV 90
EP V+LE G E + + + LG G FG V+ + + + V V
Sbjct: 5 EPPKAVELEGLAACEG----------EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVV 54
Query: 91 K-----RLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN 142
K ++ E+ + ++ + E+ IL+R+ H N++ + LV E +
Sbjct: 55 KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF-FQLVME--KH 111
Query: 143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK 202
G+ D P L P I + SA+ YL DIIHRD+K NI++ +F +K
Sbjct: 112 GSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170
Query: 203 VADFG 207
+ DFG
Sbjct: 171 LIDFG 175
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 86 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 196 EVILG---------MGYKENVDIWSVGCIMGEMV 220
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 25 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 84 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 194 EVILG---------MGYKENVDIWSVGCIMGEMV 218
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 127
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 188 EVILG---------MGYKENVDIWSVGCIMGEMV 212
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 86 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 196 EVILG---------MGYKENVDIWSVGCIMGEMV 220
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 79 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 189 EVILG---------MGYKENVDIWSVGCIMGEMV 213
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/210 (21%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARL 114
E + S +G G +G+V + + G VA+K+L + ++ E+ +L +
Sbjct: 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 115 RHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
+H+N++ L + R+ + LV F+ T + G + + +
Sbjct: 99 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGMEFSEEKIQY-----LVY 151
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ L Y+H++ ++HRD+K N+ ++ + +K+ DFGL+R H T T Y
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWY 207
Query: 230 VDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
PE + +++ D++S G ++ E+++
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 79 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 189 EVILG---------MGYKENVDIWSVGCIMGEMV 213
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 172
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 233 EVILG---------MGYKENVDIWSVGCIMGEMV 257
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 127
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 128 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 188 EVILG---------MGYKENVDIWSVGCIMGEMV 212
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 85 IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
F R G G FGTV G E G +VA+K++ ++ R + D LA L H N+V
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNIVQ 83
Query: 122 L----YGCTSRHSRELLL--VYEFISNGTVADHLHG---ERAKPGALPWPTRLKIAI-ET 171
L Y R R++ L V E+ V D LH + P P +K+ + +
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 172 ASALTYLH--ASDIIHRDVKTNNILLDN-NFCVKVADFG----LSRLFPNHVTHVSTAPQ 224
++ LH + ++ HRD+K +N+L++ + +K+ DFG LS PN V ++ +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRYY 197
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P + H T D++S G + E++ P
Sbjct: 198 RAPELIFGNQH----YTTAVDIWSVGCIFAEMMLGEP 230
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
+ + + +G G G V Y + D R VA+K+L N ++ E+ ++ + HKN
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
++SL T +++ LV E + + L ER + +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 172
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
+ +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
+ G + D++S G ++ E++
Sbjct: 233 EVILG---------MGYKENVDIWSVGCIMGEMV 257
>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|B Chain B, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|C Chain C, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|D Chain D, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
Length = 400
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
+I A+ YLH+ +I HRDVK N+L + N +K+ DFG ++ +H + T
Sbjct: 165 EIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 222
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
P TP YV PE + D +S GV+ L+ P
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYP 261
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 103 QFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
+ EV++L + + H+N++ L R LV+E + G++ H+H R
Sbjct: 56 RVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHF------ 108
Query: 162 PTRLKIAI---ETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFP-- 213
L+ ++ + ASAL +LH I HRD+K NIL ++ VK+ DF L
Sbjct: 109 -NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 214 NHVTHVST----APQGTPGYVDPEYHQCY----QLTDK-SDVFSFGVVLIELISSMP 261
+ +ST P G+ Y+ PE + + + DK D++S GV+L L+S P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
E E ++ LG G FG V+ + Q G AVK++ R+E F + E+ A
Sbjct: 66 EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 119
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
L +V LYG R + + E + G++ + + G LP L +
Sbjct: 120 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 174
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
L YLH I+H DVK +N+LL ++ C++ G S L +++
Sbjct: 175 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 231
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
GT ++ PE K D++S +++ +++
Sbjct: 232 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 68 ELGDGGFGTVYYGE--LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
+LG+G + TVY G+ L D VA+K + E+ + EV +L L+H N+V+L+
Sbjct: 9 KLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDI 183
+ L LV+E++ L G + +K+ + + L Y H +
Sbjct: 68 IIHT-EKSLTLVFEYLDKD-----LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR 210
+HRD+K N+L++ +K+ADFGL+R
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R T+ TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
V Y++ ++ + D++S GV++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 85 GRAVAVKRLYENNYKRVE-----QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF 139
G+ A+K LY++ R E Q I+ ++ +Y R LL++ E
Sbjct: 54 GQKCALKLLYDSPKARQEVDHHWQASGGPHIVC------ILDVYENMHHGKRCLLIIMEC 107
Query: 140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---D 196
+ G + + ER A +I + +A+ +LH+ +I HRDVK N+L +
Sbjct: 108 MEGGELFSRIQ-ERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165
Query: 197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
+ +K+ DFG ++ + P TP YV PE + D++S GV++ L
Sbjct: 166 KDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222
Query: 257 ISSMP 261
+ P
Sbjct: 223 LCGFP 227
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R T+ TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
V Y++ ++ + D++S GV++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAP 223
I + SA++++H ++HRD+K N+L ++N +K+ DFG +RL P + T P
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-P 169
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
T Y PE + D++S GV+L ++S
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 85 GRAVAVKRLYENNYKRVE-----QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF 139
G+ A+K LY++ R E Q I+ ++ +Y R LL++ E
Sbjct: 35 GQKCALKLLYDSPKARQEVDHHWQASGGPHIVC------ILDVYENMHHGKRCLLIIMEC 88
Query: 140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---D 196
+ G + + ER A +I + +A+ +LH+ +I HRDVK N+L +
Sbjct: 89 MEGGELFSRIQ-ERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 146
Query: 197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
+ +K+ DFG ++ + P TP YV PE + D++S GV++ L
Sbjct: 147 KDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 203
Query: 257 ISSMP 261
+ P
Sbjct: 204 LCGFP 208
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 19 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 79 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 47/288 (16%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
E E ++ LG G FG V+ E Q G AVK++ R+E F E+ A
Sbjct: 87 EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRAEELMACA 140
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
L +V LYG R + + E + G++ + + G LP L +
Sbjct: 141 GLTSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQAL 195
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
L YLH+ I+H DVK +N+LL ++ C++ G S L +++
Sbjct: 196 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP--- 252
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSN--- 276
GT ++ PE K DV+S +++ +++ P R + +++
Sbjct: 253 ----GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPP 308
Query: 277 -----------LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAEL 313
L IQ E + + E KV R + V L
Sbjct: 309 PVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGL 356
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 63 FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH-KNLV 120
+ R+LG G + V+ + + V VK L ++++ E+ IL LR N++
Sbjct: 39 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPNII 95
Query: 121 SLYGCTSRH-SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
+L SR LV+E ++N ++ + R + E AL Y H
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKALDYCH 148
Query: 180 ASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
+ I+HRDVK +N+++D+ +++ D+GL+ + P +V A + G PE
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVD 205
Query: 238 YQLTDKS-DVFSFGVVLIELI 257
YQ+ D S D++S G +L +I
Sbjct: 206 YQMYDYSLDMWSLGCMLASMI 226
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 19 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 79 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 20 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 80 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 20 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 80 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 19 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 79 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 19 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 79 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2
pdb|2V62|B Chain B, Structure Of Vaccinia-Related Kinase 2
Length = 345
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 41/293 (13%)
Query: 34 SSKVDLEKGGNYHGVQVFSYGEL--EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVK 91
SS VDL Y F G++ + N + +++G GGFG +Y + +
Sbjct: 8 SSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDAR 67
Query: 92 RLYENNYKRVEQFMNEVDILARLRHKNLVSLY-----------------GCTSRHSRELL 134
+ + Y+ +E+ R+ K+ + + G T R
Sbjct: 68 HVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS-- 125
Query: 135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL 194
Y F+ + L + G T L++ I L Y+H ++ +H D+K N+L
Sbjct: 126 --YRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183
Query: 195 L--DNNFCVKVADFGLS-RLFP--NHVTHVSTAPQGTPG---YVDPEYHQCYQLTDKSDV 246
L N V +AD+GLS R P NH + +G G + + H+ L+ +SDV
Sbjct: 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 247 FSFGVVLIE-LISSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGY 297
G ++ L +P E NL + +A+ + L EL L +
Sbjct: 244 EILGYCMLRWLCGKLP--------WEQNLKDPVAVQTAKTNLLDELPQSVLKW 288
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 39 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 98
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 99 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 151
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 152 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 211
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 212 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 20 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 80 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELI 257
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
E E ++ +G G FG V+ + Q G AVK++ R+E F + E+ A
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 105
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
L +V LYG R + + E + G++ + + G LP L +
Sbjct: 106 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 160
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
L YLH I+H DVK +N+LL ++ C++ G S L +++
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 217
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
GT ++ PE K D++S +++ +++
Sbjct: 218 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 34 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 94 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 146
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 207 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55 ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
E E ++ +G G FG V+ + Q G AVK++ R+E F + E+ A
Sbjct: 68 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 121
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
L +V LYG R + + E + G++ + + G LP L +
Sbjct: 122 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 176
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
L YLH I+H DVK +N+LL ++ C++ G S L +++
Sbjct: 177 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 233
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
GT ++ PE K D++S +++ +++
Sbjct: 234 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 34 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 94 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 146
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 207 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 7 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 67 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 26 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 86 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 138
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 199 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 20 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 80 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELI 257
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN------EVDILARLR--HKNL 119
LG GGFG+VY G + D VA+K + ++ + N EV +L ++ +
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
+ L R +L++ + D + + GAL + A+ + H
Sbjct: 76 IRLLDWFERPDSFVLILERMEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCH 131
Query: 180 ASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
++HRD+K NIL+D N +K+ DFG L + V T GT Y PE+ + +
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYH 188
Query: 239 QLTDKS-DVFSFGVVLIELISS 259
+ +S V+S G++L +++
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCG 210
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 7 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 67 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 6 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 66 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 118
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 179 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 7 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 67 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKN 118
F+ + +G G F V ++ Q G+ A+K + + + + V F E D+L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALT 176
+ L+ + L LV E+ G + L GER P + R +A E A+
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEM---ARFYLA-EIVMAID 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
+H +HRD+K +NILLD +++ADFG T S GTP Y+ PE Q
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44 NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
+ H ++ E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 6 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 66 ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 118
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 179 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/221 (22%), Positives = 96/221 (43%), Gaps = 43/221 (19%)
Query: 58 EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
E R +G G +G+V Y L+ + VAVK+L + + E+ +L
Sbjct: 25 EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
L+H+N++ L + + E+ LV ++N + L E +
Sbjct: 83 HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQ-------- 134
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + L Y+H++ IIHRD+K +N+ ++ + +++ DFGL+R +T
Sbjct: 135 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------ 186
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
GYV +++ ++ D++S G ++ EL+
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 28 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + L ER +
Sbjct: 86 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 135
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 196 PEVILG---------MGYKENVDIWSVGCIMGEMI 221
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVK---RLYEN--NYKRVEQFMNEVDILARLRHKNLVSL 122
+G G +G VY + + VA+K R++E+ + KR+ + E+ IL RL+ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNRLKSDYIIRL 90
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK-IAIETASALTYLHAS 181
Y +LL E +AD + K +K I ++H S
Sbjct: 91 YDLII--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR 210
IIHRD+K N LL+ + VKV DFGL+R
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R T+ TP Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
V Y++ ++ + D++S G ++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 58 EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
E R +G G +G+V Y L+ + VAVK+L + + E+ +L
Sbjct: 17 EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 74
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
L+H+N++ L + + E+ LV ++N L E +
Sbjct: 75 HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ-------- 126
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + L Y+H++ IIHRD+K +N+ ++ + +++ DFGL+R +T
Sbjct: 127 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT------ 178
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
GYV +++ ++ D++S G ++ EL+
Sbjct: 179 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215
>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki
pdb|2WU7|A Chain A, Crystal Structure Of The Human Clk3 In Complex With V25
pdb|3RAW|A Chain A, Crystal Structure Of Human Cdc-Like Kinase 3 Isoform In
Complex With Leucettine L41
pdb|3RAW|B Chain B, Crystal Structure Of Human Cdc-Like Kinase 3 Isoform In
Complex With Leucettine L41
Length = 381
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/257 (22%), Positives = 97/257 (37%), Gaps = 36/257 (14%)
Query: 69 LGDGGFGTVYYGELQD---GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
LG+G FG V E D G++ ++ N K E E+++L +++ K+ + + C
Sbjct: 59 LGEGTFGKVV--ECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 116
Query: 126 TSRHSR-----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
+ + +E + T + L +P P P +A + AL +LH
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTF-EFLKENNFQP--YPLPHVRHMAYQLCHALRFLHE 173
Query: 181 SDIIHRDVKTNNILLDN-------------------NFCVKVADFGLSRLFPNHVTHVST 221
+ + H D+K NIL N N ++VADFG + +H H +
Sbjct: 174 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 231
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK 281
T Y PE DV+S G +L E +R + + +
Sbjct: 232 V--ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 289
Query: 282 IQNKALHELVDQTLGYE 298
I + +H Q Y+
Sbjct: 290 IPSHMIHRTRKQKYFYK 306
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + L ER +
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 134
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 195 PEVILG---------MGYKENVDIWSVGCIMGEMI 220
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 55 ELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
E E ++ LG G FG V+ E Q G AVK++ R+E F E+ A
Sbjct: 68 EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRAEELMACA 121
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
L +V LYG R + + E + G++ + + G LP L +
Sbjct: 122 GLTSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQAL 176
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFC-VKVADFG 207
L YLH+ I+H DVK +N+LL ++ + DFG
Sbjct: 177 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG 212
>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
pdb|2PZI|B Chain B, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
Length = 681
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 72 GGFGTVYYGELQD--GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGC--- 125
GG G +Y ++ GR V +K L + + + M E LA + H ++V ++
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150
Query: 126 TSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
T RH + +V E++ ++ +R+K LP + +E AL+YLH+ ++
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLV 204
Query: 185 HRDVKTNNILLDNNFCVKVADFG-LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
+ D+K NI+L +K+ D G +SR+ N ++ GTPG+ PE + T
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYL----YGTPGFQAPEIVRTGP-TVA 256
Query: 244 SDVFSFGVVLIELISSMP 261
+D+++ G L L +P
Sbjct: 257 TDIYTVGRTLAALTLDLP 274
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 58 EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
E R +G G +G+V Y L+ + VAVK+L + + E+ +L
Sbjct: 25 EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
L+H+N++ L + + E+ LV ++N L E +
Sbjct: 83 HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ-------- 134
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
+ + L Y+H++ IIHRD+K +N+ ++ + +++ DFGL+R +T
Sbjct: 135 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------ 186
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
GYV +++ ++ D++S G ++ EL+
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R T+ TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
V Y++ ++ + D++S G ++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 63 FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
+ + + +G G G V Y L+ R VA+K+L N ++ E+ ++ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
N++ L T + S E + +V E + + + L ER +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
+ + +LH++ IIHRD+K +NI++ ++ +K+ DFGL+R + P VT A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
P+ G + D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 69 LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
LG GGFG+VY G + D VA+K + ++ + N + +V L +S
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV-----PMEVVLLKKVSS 71
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKP-----------GALPWPTRLKIAIETASALT 176
S + L+ F + L ER +P GAL + A+
Sbjct: 72 GFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 177 YLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
+ H ++HRD+K NIL+D N +K+ DFG L + V T GT Y PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 186
Query: 236 QCYQLTDKS-DVFSFGVVLIELI 257
+ ++ +S V+S G++L +++
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 47 GVQVFSYG----ELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV 101
G++V G E E + + LG GGFG+VY G + D VA+K + ++
Sbjct: 13 GLEVLFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 72
Query: 102 EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP----- 156
+ N + +V L +S S + L+ F + L ER +P
Sbjct: 73 GELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLF 125
Query: 157 ------GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLS 209
GAL + A+ + H ++HRD+K NIL+D N +K+ DFG
Sbjct: 126 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 185
Query: 210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
L + V T GT Y PE+ + ++ +S V+S G++L +++
Sbjct: 186 ALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.135 0.390
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,716,378
Number of Sequences: 62578
Number of extensions: 446049
Number of successful extensions: 3584
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 1039
Number of HSP's successfully gapped in prelim test: 76
Number of HSP's that attempted gapping in prelim test: 1040
Number of HSP's gapped (non-prelim): 1131
length of query: 375
length of database: 14,973,337
effective HSP length: 100
effective length of query: 275
effective length of database: 8,715,537
effective search space: 2396772675
effective search space used: 2396772675
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 52 (24.6 bits)